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1.1. THE CARDIOVASCULAR SYSTEM: THE BODY’S LIFELINE 
The cardiovascular circulation delivers blood to the individual organs and 
tissues and therefore is of utmost importance to maintain body function and 
survival. The blood flow is set to some degree by the number and size of 
arteries feeding the organ, but also varies according to the metabolic needs 
of the tissue in order to maintain homeostasis. Furthermore, it carries out 
compensatory adjustments to challenges faced in everyday life (e.g. 
gravitational changes or exercise) or in disease (e.g. inflammation, shock or 
hypertension). One of the most important ways to control the blood flow 
through a vascular bed is by alteration of the diameter of the resistance 
vessels. Neural, humoral or local chemical mechanisms dilate or constrict 
the vessels of a tissue, thereby regulating the regional blood supply. The 
systemic circulation is made up of numerous circuits in parallel, which 
permits such wide regional variations in blood flow without affecting the 
total systemic flow. 
 
In the present study, we concentrated on small mesenteric or gastric 
arteries, two vessels belonging to the splanchnic circulation (figure 1). The 
splanchnic circulation refers to the vascular system which brings blood to 
and from the major abdominal organs. It is one of the major blood 
reservoirs of the body, containing between 20 % (under resting conditions) 
and 40 % (after food intake) of total blood volume. The blood flow to the 
abdominal organs is arranged in a series of parallel circuits, with all the 
blood from the stomach, intestines, pancreas and spleen draining via the 
portal vein to the liver. From the liver, the blood continues via the hepatic 
veins to the inferior vena cava. 
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The gastrointestinal vasculature consists of intramural and extramural 
components. The intramural system contains plexuses in the different 
layers from the wall of the digestive tract and contains specialisations 
adapted to the functions of the different organs. The extramural arterial 
supply to the abdominal organs is provided by three major arteries arising 
from the thoracic aorta: the celiac trunk and the superior and  inferior 
mesenteric arteries (figure 1). The branches of these vessels form an 
arcade network, providing a rich blood supply to the different organs. The 
main arterial blood supply to the stomach, for example, arises from the 
celiac axis. The common hepatic artery branches into the gastroduodenal 
artery and the right gastric artery, which then joins the left gastric artery 
along the lesser curvature of the stomach. Short gastric arteries and the 
right and left gastroepiploic arteries provide the blood supply along the 
greater curvature of the stomach. The intestines, on the other hand, are 
supplied by a series of parallel circulations via branches of the superior and 
inferior mesenteric arteries (figure 1). 
 
Gastrointestinal blood flow varies locally along the alimentary canal. 
Several factors are implicated in the regulation of splanchnic circulation, 
e.g. neurohumoral or paracrine substances or food intake.  The 
gastrointestinal blood flow can be regulated by changes in metabolism, but 
is also controlled by the autonomous nervous system.  
 
Furthermore, some pathological conditions in the gastrointestinal system 
are associated with abnormalities in the splanchnic circulation. 
Gastrointestinal ischemia results from the obstruction of one of the major 
arteries of the splanchnic circulation. Collaterals open immediately to 
compensate for the resulting decrease in arterial pressure. The bowel may 
tolerate remarkable reductions in blood flow without damage. However, 
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below a certain crucial flow level ischemic damage will occur as a result of 
hypoxia. Regions with abundant collateral circulation, such as the stomach, 
duodenum and rectum, show a decreased risk for ischemic injury. Portal 
hypertension is one of the major complications of cirrhosis and results from 
increased resistance to portal blood flow. It is characterized by a pathologic 
increase in portal venous pressure that leads to the formation of an 
extensive network of collaterals that divert a large part of the portal blood to 
the systemic circulation, omitting the liver. In the later state, increased 
portal venous inflow, promoted by an increased splanchnic circulation, 
contributes to maintenance and aggravation of portal hypertension. 
 
 
 
Aorta
Celiac trunk Left gastric artery
Right gastric artery
Gastroduodenal artery
Common hepatic artery
Right gastroepiploic artery
Left gastroepiploic artery
Superior mesenteric artery
Inferior mesenteric artery
 
Figure 1: Schematic overview of the splanchnic circulation, showing the most important 
arteries. 
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Blood flow (F) through a vascular bed is directly proportional to the 
pressure gradient (∆P) over the vascular bed and inversely proportional to 
the resistance (R) of the system to blood flow (F ~ ∆P/R). In conditions of 
laminar flow, vascular resistance (R) is inversely related to the fourth power 
of the radius (r) of the blood vessel, as expressed in the equation of 
Poiseuille: R = 8Lη/πr4 (with L being the length of the vessel and η the 
viscosity of the blood).  Consequently, blood flow is markedly affected by 
small changes in diameter of the vessels. 
 
 
1.2. CARDIOVASCULAR LOCAL CONTROL MECHANISMS 
As mentioned above, local control mechanisms match the perfusion of a 
given organ with its metabolic demands, despite variations in blood 
pressure. Blood flow in a vascular bed is regulated in part by 
autoregulation.  Additionally, it is controlled by circulating or locally 
produced vasoactive metabolites and affected by substances secreted by 
the endothelium or the nerves innervating the vessel. All of these 
mechanisms influence blood flow by altering the diameter of the vessels. 
 
 
1.2.1. Autoregulation 
Most vascular beds have the intrinsic capacity to compensate for moderate 
changes in perfusion pressure by changing the vascular resistance, thereby 
keeping the blood flow relatively constant. This is referred to as 
autoregulation, a mechanism of which the importance varies among 
different vascular beds and seems to depend on the diameter of the 
arteries. It has been shown to be well developed in the kidney 1 and has 
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also been observed in cerebral and coronary arteries and the mesenteric 
vascular bed 2-5. 
 
The exact mechanism by which autoregulation takes place is still elusive, 
but it has been proposed to rely on both myogenic and metabolic 
mechanisms. An increase in perfusion pressure (and thus also an increase 
in transmural pressure) distends the blood vessel wall causing contraction 
of the smooth muscle cells. Similar myogenic control has been shown to 
contribute significantly to autoregulation in different vascular beds such as 
the mesenteric, skeletal muscle, cerebral, renal and coronary circulation 1-4, 
6, 7. However, the exact mechanism responsible for this myogenic response 
remains unclear. Evidence suggests that it is accompanied by 
depolarisation of the membrane potential and an increase of the 
intracellular Ca2+ concentration of the vascular smooth muscle cells via 
activation of voltage operated Ca2+ channels 8, 9. In case of metabolic 
regulation, changes in the concentration of local metabolites contribute to 
the autoregulation. For example, a decrease in perfusion of the vascular 
bed results in accumulation of metabolically produced vasodilatory 
substances and the subsequent dilatation of the blood vessel. 
 
 
1.2.2. Vasoactive factors released by the endothelium 
A single layer of endothelial cells lines the entire vascular system. The cell 
structure and functional integrity are important in the maintenance of the 
vessel wall and circulatory function. The endothelium is strategically located 
between the blood components on one hand and vascular smooth muscle 
cells in the blood vessel wall on the other. In 1980 Furchgott and Zawadzki 
reported that the relaxation response to acetylcholine and other agonists of 
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the muscarine receptor critically depended on the presence of a functional 
endothelium  and hence demonstrated the existence of an endothelium-
derived relaxing factor (EDRF) 10. This pivotal observation in isolated rabbit 
arteries has since been extended to a wide range of arteries from different 
species including human 11.  At present it is known that the endothelium 
produces different vasodilating and vasoconstricting mediators, both under 
basal conditions and in response to different chemical or mechanical 
stimuli. The endothelial cells are activated by a number of agonists acting 
on G-protein-coupled receptors (GPCR), including acetylcholine, 
bradykinin, substance P and histamine or by physical stimuli such as shear 
stress or changes in oxygen levels. The former leads to the activation of 
stretch activated non-selective cation channels 12. Activation of the 
endothelial cells  results in an increase in their intracellular Ca2+ 
concentration ([Ca2+]i), triggering the release of several vasoactive 
mediators from the endothelium. The most important among them are 
discussed below.  
 
 
1.2.2.1. Nitric oxide 
A few years after the discovery of the EDRF, the agent responsible for a 
large portion of the endothelium-dependent relaxation has been identified 
as nitric oxide (NO) 13-15. NO is synthesised from L-arginine by an enzyme 
known as nitric oxide synthase (NOS), which exists in three distinct 
isoforms: the constitutive enzymes endothelial NOS (eNOS) and neuronal 
NOS (nNOS) and the inducible NOS (iNOS). The endothelial eNOS 
catalyses within seconds the formation of small amounts (pM) of NO, 
required to maintain cardiovascular homeostasis. It is a Ca2+ - and 
calmodulin-dependent enzyme and requires a high intracellular Ca2+ 
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concentration 16. The other constitutive enzyme, nNOS, is found in the 
central and the peripheral nervous system 17 and has similar characteristics 
as eNOS. Finally, the inducible isoform iNOS is especially found in inflamed 
or damaged tissues and catalyses the formation of large amounts (nM) of 
NO. Its activation does not require Ca2+ and the release of NO may 
continue for several hours or days. 
 
Upon stimulation of the endothelial cells, the increased free [Ca2+]i  
activates eNOS and thus the production of NO (figure 2). Subsequently, 
NO diffuses to the adjacent vascular smooth muscle cells where it interacts 
with soluble guanylate cyclase (sGC) causing an increase in cytosolic 
cGMP. cGMP subsequently reduces the intracellular Ca2+ concentration 
through multiple signaling pathways, finally causing relaxation (figure 2). 
 
Several mechanisms are involved in this, each requiring a cGMP-
dependent protein kinase. For example, cGMP activates plasma membrane 
Ca2+ ATPases, reducing the intracellular Ca2+ concentration 18-20. On the 
other hand, [Ca2+]i is lowered by stimulation of the Ca2+ reuptake in the 
endoplasmic reticulum through activation of the sarco/endoplasmic 
reticulum Ca2+ ATPase (SERCA) 21. Additionally, cGMP causes Ca2+ 
desensitization of the contractile apparatus by activating myosin light chain 
phosphatases 22. 
 
On the other hand, NO can also directly activate Ca2+-dependent potassium 
channels in the vascular smooth muscle cells, promoting vasodilation 
through a cGMP-independent decrease in [Ca2+]i 23, 24. NO has also been 
reported to activate other K+-channels 25-27 and Na+/K+-ATPases 28. These 
pathways may be of crucial importance in atherosclerotic arteries, in which, 
according to some authors 23, 29, the cGMP-dependent pathway of 
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relaxation is compromised (although other studies report a reduced NO 
bioavailability which can be caused by a lack of L-arginine or cofactors or a 
reduced expression of NOS 30, 31). 
 
 
 
R
Ca2+↑
PGI2 EDHF NO
Ca2+
Agonist Shear stress
L-Arg
NOSCOX
AA
PGI2 EDHF NO
R
AC
ATP cAMP↑
sGC
cGMP↑ GTP
Ca2+↓
RELAXATION
Hyp
SACCSKCa
IKCa
K+
Hyp
EC
VSMC
 
Figure 2: Schematic overview of the different endothelium-derived relaxing factors. EC = 
endothelial cell; VSMC = vascular smooth muscle cell; R = receptor; SACC = stretch 
activated cation channel; L-Arg = L-arginine; NOS = nitric oxide synthase; NO = nitric 
oxide; sGC = soluble guanylate cyclase; AA = arachidonic acid; COX = cyclooxygenase; 
PGI2 = prostacyclin; AC = adenylate cyclase; EDHF = endothelium-derived hyperpolarizing 
factor; SKCa = small conductance Ca2+ activated K+ channels; IKCa = intermediate 
conductance Ca2+ activated K+ channels; hyp = hyperpolarization. 
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Since the discovery of the NO-pathway, several NOS inhibitors have been 
described and used to study the role of NO in endothelium-dependent 
relaxations. The production of NO can be inhibited by calmodulin 
antagonists in most arteries. However, these substances did not affect 
relaxations mediated by NO and evoked by agonists in canine and porcine 
coronary arteries 32. The synthesis of NO can also be inhibited by 
analogues of L-arginine (e.g. Nω-nitro-L-arginine (L-NA) and its methyl ester 
(L-NAME)) or inhibitors for the required cofactors of eNOS (e.g. flavoprotein 
inhibitors or depletors of tetrahydrobiopterin). More recently, selective 
inhibition of the endothelial NO production was obtained in mutant eNOS-/- 
mice where the gene encoding for eNOS was disrupted 33-35. 
 
 
1.2.2.2. Prostaglandins 
Prostaglandins are derivatives of arachidonic acid which are formed in 
various parts of the vascular wall in a reaction catalysed by cyclooxygenase 
(COX). Currently, two COX isoforms are known: COX-1 and COX-2. Both 
enzymes act basically in the same fashion. COX-1 is a constitutive enzyme 
and is expressed in a large number of cells. On the other hand, COX-2 is 
regarded as an inducible enzyme, undetectable in most normal tissues, 
which becomes abundant in activated macrophages and other cells at sites 
of inflammation. However, recent reports about the atherothrombotic side 
effects of some selective COX-2 inhibitors (coxibs), together with 
experimental and clinical studies, have shown that COX-2 can also be 
constitutively expressed in a variety of tissues. For example, constitutive 
expression of COX-2 has been reported in brain, kidney, gastrointestinal 
tissues and vascular endothelium 36-38. 
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Once activated by chemical or mechanical stimuli, the enzyme 
phospholipase A2 in the endothelial cells of the vascular wall converts 
membrane phospholipids to arachidonic acid. COX converts arachidonic 
acid to prostaglandin H2 which is then  acted upon by various synthases 
resulting in the production of potent vasoactive prostaglandins. Prostacyclin 
(PGI2) is the major vasodilator prostaglandin produced by the endothelium 
39, 40 and causes relaxation predominantly through the adenylyl 
cyclase/cAMP transduction pathway (figure 2) 41, 42. The formed cAMP 
activates protein kinase A to phosphorylate selective target proteins, 
thereby causing vasorelaxation 43. Furthermore, several other vasoactive 
prostaglandins are produced by the endothelium upon activation of 
cyclooxygenase, such as the vasodilators PGE2 44 and PGD2. 
 
The production of prostaglandins can be blocked by the use of 
cyclooxygenase inhibitors such as indomethacin 45. Recent studies 
obtained specific inhibition of prostacyclin synthesis with COX knock-out 
mice, in which the gene encoding for the COX-1 isoform was disrupted 34. 
The fact that blood pressure is little affected in these mice, suggests that in 
normal physiological circumstances, prostaglandins play little role. 
 
 
1.2.2.3. Endothelium-derived hyperpolarizing factor 
In many vessels the pharmacological inhibition of both NOS (with L-
arginine analogues) and cyclooxygenase (for example with indomethacin) 
does not result in the total loss of endothelium-dependent relaxations to 
chemical and mechanical stimulation, indicating the involvement of another 
vasodilator mechanism. The cellular action of this putative non-NO/non-
PGI2 vasodilator system is usually associated with a hyperpolarization of 
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the membrane potential of the vascular smooth muscle cells (figure 2) 46, 47. 
There are two primary mechanisms that can account for endothelium-
derived hyperpolarization. On one hand, hyperpolarization of the smooth 
muscle cells can be attributed to the release of a diffusible substance from 
the endothelium, also called the endothelium-derived hyperpolarizing factor 
or EDHF. The identity of this EDHF is still controversial and during the past 
years several candidates have been put forward, such as residual NO, 
H2O2, K+-ions, epoxyeicosatrienoic acids (EETs) and anandamide (figure 3) 
48-52. Therefore, it has been suggested that EDHF is not a single substance 
and that its nature and cellular targets may show considerable tissue and 
species variability 53, 54. An alternative pathway for endothelium-dependent 
hyperpolarization is transmission of the agonist-induced hyperpolarization 
of the endothelial cells to the vascular smooth muscle via myoendothelial 
gap junctions (figure 3). This heterocellular coupling allows the spread of an 
electrical current or the transfer of small hydrophilic messenger molecules 
such as cAMP or IP3 and ions (e.g. Ca2+) 55-58.  
 
It is, however, generally accepted  that the action of EDH(F) is dependent 
on the endothelial release of intracellular Ca2+ and the activation of a 
specific set of K+-channels. The EDH(F)-mediated responses are 
completely blocked by the combination of apamin (a selective inhibitor of 
small conductance Ca2+ sensitive K+-channels (SKCa)) and charybdotoxin 
(inhibitor of intermediate and large conductance KCa-channels (IKCa and 
BKCa, respectively) 59, but not by iberiotoxin (selective inhibitor of BKCa 
channels) 59, 60, suggesting that activation of IKCa- and SKCa-channels on the 
endothelium is involved. This has more recently been confirmed in rat 
carotid and mesenteric arteries by using apamin in combination with the 
new and selective inhibitors of IKCa TRAM-34 and TRAM-39 61-63. 
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Chapter 1 
It has been established that a change in the membrane potential of the 
smooth muscle cells with a few mV can result in a substantial change in 
vessel diameter 64, 65. Furthermore, hyperpolarization of the vascular 
smooth muscle cells produces a rapid effect on contractile tone, compared 
to the relaxation mediated by second messengers. Together with the 
observation that the relative contribution of the endothelium-dependent 
hyperpolarization augments with decreasing vessel diameter 66-68, it is now 
generally accepted that changes in the synthesis or release of EDHF or in 
the magnitude of EDH are of critical importance in the regulation of organ 
blood flow and contribute to pathophysiological states such as hypertension 
69. 
 
 
1.2.2.4. Endothelium-derived contracting factor 
In most vascular diseases, the vasodilator function of the endothelium is 
attenuated or even abolished. It has been reported that under pathological 
conditions the endothelium can induce contractile responses in certain 
vessels. For example, contraction of canine arteries arising during anoxia 
was markedly reduced after removal of the endothelium 70. Therefore, it 
was concluded that under certain, mostly pathological, conditions, the 
endothelium can produce endothelium-derived contracting factors (EDCF). 
The identity of the released EDCFs, however, can differ strongly among 
species, but also among different vascular beds 71. Over the years, several 
EDCFs have been identified, such as vasoconstricting prostaglandins (e.g. 
thromboxane A2) 72, endoperoxides 73, endothelin 74 and superoxide anions 
75, which can be produced by the endothelium in response to various stimuli 
such as stretch, acetylcholine, angiotensin I and II, arachidonic acid, ADP, 
ATP, substance P and noradrenaline. 
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The most potent vasoconstrictor peptide released from the endothelium 
described today is endothelin. Under normal circumstances, endothelin 
plays only a minor role in vascular homeostasis. Any tendency to 
(over)produce the peptide in healthy endothelial cells will be offset by an 
increased release of NO and possibly also of PGI2 and EDHF, which 
themselves reduce the production of endothelin 76, 77. Only when the 
endothelium looses its ability to generate EDRFs, endothelin can be 
produced in sufficient amounts and may contribute to vascular disease 78. 
 
 
1.2.3. Vasoactive factors released from sensory nerves 
Sensory nerves are a type of neurons regulating vascular blood flow. All 
sensory neurons have their cell bodies in the dorsal root ganglia. Their 
function is primary afferent as they send nerve impulses to the spinal cord. 
However, the impulses initiated in sensory nerves can also be relayed 
antidromically down collateral branches of these nerve fibres which directly 
innervate blood vessels. This local neural mechanism is called the axon 
reflex. Through the release of a number of vasoactive peptides including 
substance P, neurokinin A (NKA), neurokinin B (NKB) and calcitonin gene-
related peptide (CGRP), the sensory nerves can produce immediate local 
responses. This phenomenon plays an important role in the reaction to skin 
injury. When the skin is hurt, the axon reflex will cause an immediate 
dilatation of the local capillaries and an increase in their permeability, 
respectively leading to typical reddening (red reaction) and swelling (wheal)  
at the site of injury.  Dilatation of the arterioles is responsible for the 
redness spreading out from the injury (flare).  Sensory nerves are 
capsaicin-sensitive. Capsaicin is a naturally occurring substance derived 
from hot chilli peppers and interacts with vanilloid (TRPV1) receptors on 
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sensory afferents. Chronic exposure to capsaicin stimulates the TRPV1 
receptor and causes local depletion of neuropeptides. 
 
The perivascular sensory nerves may contain different combinations of 
neuropeptides, which usually induce vasodilatation 79. In general, 
substance P, NKA and NKB induce endothelium-dependent vasodilatation 
through the release of NO and EDHF 80, 81. However, contractile responses 
to these peptides have been demonstrated, resulting from the activation of 
smooth muscle receptors 82, 83. CGRP is a potent vasodilator in a number of 
vascular preparations 84. The effects of CGRP are generally due to direct 
activation of receptors on the vascular smooth muscle and a decrease in 
intracellular Ca2+ regulated by adenylate cyclase 85. However, CGRP has 
also been reported to activate ATP-sensitive K+-channels in arterial smooth 
muscle 86, while  in rat aorta the CGRP-mediated vasodilatation is 
endothelium-dependent and involves the release of NO 87, 88. 
 
 
1.3. ENDOTHELIUM-DERIVED HYPERPOLARIZATION 
As mentioned above, several hypotheses have been suggested with regard 
to the mechanism of action and the nature of EDH(F). As outlined in the 
previous chapter,  two principle mechanisms have been proposed by which 
EDH(F) can cause smooth muscle cell hyperpolarization, namely the 
transfer of a diffusible factor (EDHF) across the extracellular space and the 
transmission of endothelial hyperpolarization (EDH) via myoendothelial gap 
junctions. A schematic overview of the different mechanisms proposed for 
EDH(F) is depicted in figure 3. 
 
 
 16
General introduction 
1.3.1. Diffusible factors 
In several arteries, EDHF was reported to be a diffusible factor released 
from the endothelium which initiates hyperpolarization and relaxation of the 
smooth muscle cells by activation of specific smooth muscle cell receptors 
or ion channels. The identity of EDHF is still elusive, but different putative 
candidates have been proposed. Residual NO, H2O2, K+, EETs, 
anandamide, C-type natriuretic peptide (CNP), carbon monoxide and L-
citrulline have all been suggested as an EDHF in certain vascular beds 49, 
51, 52, 89-91. The most important candidates are discussed below. 
 
 
1.3.1.1. Residual NO 
As mentioned above, NO is now accepted to be the major mediator of 
endothelium-dependent smooth muscle relaxation. However, whether or 
not NO can account for the endothelium-dependent hyperpolarization is 
controversial. At least in some vessels such as the guinea-pig uterine 
artery, rabbit aorta and rat small mesenteric artery, exogenous NO caused 
hyperpolarization of the vascular smooth muscle cells 23-25, 92. Also 
prostacyclin has been described to cause hyperpolarization 93. Therefore, 
EDHF responses should always be measured in the continuous presence 
of both inhibitors of NOS and cyclooxygenase. 
 
In rabbit carotid arteries stimulated with acetylcholine, it was shown that the 
application of L-NAME, in a concentration originally considered to be 
sufficient to completely inhibit NOS in most tissues (30 µM), decreased but 
did not completely inhibit the release of NO. The additional application of L-
NA, another inhibitor of NO, further reduced the release of NO and the 
hyperpolarization and relaxation of these vessels to acetylcholine. 
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Therefore, it was suggested that NO was the mediator of both endothelium-
dependent relaxation and hyperpolarization 48. Correspondingly, in several 
other vascular beds it was shown that, although NOS was inhibited with L-
arginine analogues, there was still some resistant NO released from the 
endothelium 53, 91. In rat superior mesenteric arteries 91, acetylcholine still 
evoked relaxations in the presence of L-nitroarginine (L-NA). Since the NO 
scavenger oxyhaemoglobin further reduced these L-NA resistant 
relaxations, it was suggested that they were due to residual NO, which 
could be derived from a source other than L-arginine.  However, in studies 
using both NOS-inhibitors and NO-scavengers a large part of the 
endothelium-derived hyperpolarization persists. 
 
Moreover, if indeed NO fully accounts for the endothelium-dependent 
hyperpolarization in the presence of NOS-inhibitors, exogenous NO should 
be able to evoke comparable hyperpolarizations when applied in 
physiological concentrations. In rat aorta, nitroglycerin (10 µM) induced only 
a hyperpolarization of about 2 mV 94. Similarly, application of other NO-
donors only caused a fraction of the membrane potential change induced 
by acetylcholine 94. Comparable observations were found in the main 
mesenteric artery 95, 96. Moreover, while the membrane potential of the 
smooth muscle cells of these arteries showed comparable sensitivity to 
exogenous NO, the EDHF-induced hyperpolarization was much more 
expressed in the mesenteric artery than in the rat aorta 94-96. Taken 
together, these findings suggest that although residual NO might be 
present in some conditions and contribute to some minor extent in EDH, a 
separate but NO-unrelated EDHF exists 53, 97,98. 
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1.3.1.2. Hydrogen peroxide 
H2O2 may be produced in the endothelium from superoxide anions via 
superoxide dismutase and has been implicated as an EDHF, namely in 
human and mouse mesenteric and porcine coronary arteries 49, 99, 100. This 
hypothesis arose from the report that catalase, an enzyme that dismutates 
H2O2 to water and oxygen, inhibited the EDHF-mediated hyperpolarization 
and subsequent relaxation 49, 99, 100. However, this was not consistent with 
several other studies in the same vascular beds, where catalase had no 
effect on the EDHF-response 101, 102. Similarly, in other vascular 
preparations, catalase was unable to inhibit the EDHF response 103, 104. In 
contrast to the reports about its vasodilating action, several studies have 
shown that H2O2 can cause a vasoconstriction and suggested that it might 
act as an EDCF in some vessels 105. Therefore, the physiological relevance 
of H2O2 as an EDHF is questioned. 
 
 
1.3.1.3. Potassium ions 
In some arteries such as the rat hepatic and small mesenteric arteries, K+ 
was proposed as an EDHF 50. More specifically, acetylcholine was shown 
to stimulate the opening of SKCa and IKCa channels of the endothelial cells, 
thereby causing hyperpolarization. The resulting K+ efflux would cause a 
raise in the extracellular K+ concentration ([K+]o) in the restricted 
myoendothelial space 50. In turn, this increase would activate Na+/K+-
ATPases and inwardly rectifying K+-channels (KIR channels) located on the 
adjacent vascular smooth muscle cells, resulting in a hyperpolarization of 
these latter 50. The evidence for the involvement of these mechanisms is 
mainly derived from studies using ouabain and Ba2+, respective blockers of 
Na+/K+-ATPases and KIR channels. In these studies, it has been shown that 
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the hyperpolarization and relaxation induced by small increases in [K+]o 
could be inhibited by these blockers, administered either alone or in 
combination 50, 106, 107. 
 
More recently, however, it was reported that exogenous increases in [K+]o 
elicited relaxation in only 30-40% of preconstricted rat small mesenteric 
arteries, while responses to acetylcholine were always present 108. 
Moreover, the relaxations caused by a raise in [K+]o were endothelium-
dependent and significantly smaller than the acetylcholine responses 108. 
Correspondingly, in small mesenteric arteries from the same species 
mounted isometrically, a raise in [K+]o caused no relaxation of endothelium 
intact and denuded arteries, whereas acetylcholine only failed to relax 
endothelium denuded preparations 109. Furthermore, in pressurised 
arteries, raising [K+]o dilated only 30% of the arteries, while the 
acetylcholine-response was consistently present in all vessels 109. 
 
The absence of K+-induced hyperpolarization in endothelium-denuded rat 
small mesenteric arteries was confirmed after stimulating the vessels with 
phenylephrine 110. Blockers of vascular smooth muscle delayed rectifier and 
large conductance Ca2+-sensitive K+-channels (4-aminopyridine and 
iberiotoxin, respectively) were able to restore the hyperpolarizations in 
these stimulated vessels. It was suggested, therefore, that activation of the 
smooth muscle with phenylephrine, which is known to increase K+ efflux 
from the myocytes by opening of smooth muscle K+ channels 111, resulted 
in a K+-cloud in the myoendothelial spaces, preventing the vasodilator 
action of exogenous added K+ 110. This explains the observation that the K+-
channel blockers could restore the K+-induced hyperpolarization in 
stimulated vessels. A key component in the K+-induced responses is the 
smooth muscle Na+/K+-ATPase 112, a family of proteins of which the 
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different isoforms display different affinities for [K+]o. The α1-containing 
isoforms would perform a ‘housekeeping’ role, and are fully activated at 
physiological concentrations of [K+]o. α2- and α3-containing isoforms, on the 
other hand, are not saturated at normal [K+]o and might be further activated 
by small increases in [K+]o 113, 114. Therefore, it was suggested that the 
observed K+-induced effects under resting conditions are due to stimulation 
of Na+/K+-ATPases containing α2- and/or α3-subunits. However, 
extracellular accumulation of K+ ions  as the result of activation of the 
smooth muscle cells with phenylephrine (the K+-cloud), would fully activate 
and saturate the Na+/K+ pumps containing α2- and α3-subunits 110, 115, 116, 
favouring the alternative gap junctional pathway for endothelium-dependent 
smooth muscle hyperpolarization 110, 116. The hyperpolarization of the 
endothelial cells thereby is transferred to the underlying smooth muscle 
cells through gap junctional coupling (as discussed in § 1.3.2). 
 
 
1.3.1.4. Epoxyeicosatrienoic acids 
A number of enzymes can metabolise arachidonic acid into a variety of 
metabolites, all of which are able to influence smooth muscle tone. EETs 
are cytochrome P450 (CYP) epoxygenase metabolites of arachidonic acid 
which have been shown to activate smooth muscle BKCa 117, 118, resulting in 
hyperpolarization and subsequent relaxation of cerebral, coronary and 
renal arteries of several species 119-121.  
 
A number of studies suggest that EETs may account for EDHF in a number 
of vascular preparations. They reported that the EDHF response could be 
inhibited by CYP inhibitors 122-125 and was also associated with the release 
of EETs from endothelial cells 51. In addition, in porcine coronary arteries 
the EDHF mediated response was precisely mimicked by 11,12-EET 126. 
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Furthermore, the vasodilator potency of EETs seems to increase with 
decreasing vessel diameter 127, a typical characteristic of EDHF. 
 
However, considerable evidence also argues against the role of EETs as 
“universal” EDHF. Some of the CYP inhibitors used are now known to exert 
non-specific effects. For example, proadifen, clotrimazole and the 
antimycotic imidazole can directly inhibit vascular smooth muscle K+-
channels 128-130. Moreover, in rat hepatic, guinea-pig carotid and porcine 
coronary arteries, chemically unrelated inhibitors of CYP had no effect 
whatsoever on the EDHF-mediated responses 131-133. EETs seem to 
hyperpolarize vascular smooth muscle cells via the activation of iberiotoxin-
sensitive BKCa-channels 117, 134. Taken together, these observations clearly 
show that the hypothesis that EETs represent EDHF, requires further 
investigation and certainly can not be a universal one. 
 
 
1.3.1.5. Anandamide 
The endogenous cannabinoid anandamide (N-arachidonylethanolamine) is 
another arachidonic acid derivative which is formed via the action of a 
transacylase enzyme and has been shown to exert potent vasodilatory 
effects in a number of vascular preparations 52, 135-139. The properties of the 
endogenous cannabinoids (also called endocannabinoids) are discussed in 
more detail in a next paragraph (§ 1.4., p25). 
 
In the perfused mesenteric bed of the rat, where anandamide caused 
endothelium-independent vasodilatation, the cannabinoid receptor 
antagonist SR141716A inhibited the EDHF-mediated response induced by 
carbachol 52. Moreover, the investigators found that anandamide and EDHF 
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exerted similar characteristics in these preparations 140, suggesting they 
were identical. 
 
Nonetheless, a number of later studies could not confirm this proposal and 
proved that anandamide and EDHF did not share the same 
pharmacological and physiological profile 60, 139, 141-145. Further doubt about 
the early reports arose with the report that SR141716A, besides blocking 
cannabinoid receptors, also exerted additional, non-selective effects such 
as disrupting myoendothelial gap junctional communication 146 or 
influencing Ca2+ influx initiated by agonists 147. 
 
 
1.3.2. Gap junctional coupling 
An alternative pathway for endothelium-dependent hyperpolarization is 
transmission of the agonist-induced hyperpolarization of the endothelial 
cells to the adjacent smooth muscle cells via gap junctions. Gap junctions 
are formed by docking of two connexons or hemichannels, supplied by the 
two interacting cells at points of cell-cell contact. They form an aqueous 
pore allowing the spread of electrical current or the transfer of small 
hydrophilic molecules (< 1 kDa), including cAMP, cGMP, IP3, as well as 
inorganic ions, such as Ca2+ 55-57, 148. Gap junctions are seen in virtually all 
cells that contact other cells in tissues. In the vascular wall gap junctions 
can occur between cells of the same type, such as between endothelial 
cells or between smooth muscle cells and are hence called homocellular 
gap junctions. On the other hand, gap junctions can also be formed 
between endothelial cells and vascular smooth muscle cells. These 
heterocellular gap junctions are referred to as myoendothelial gap 
junctions. In many arteries, the endothelial cell layer is coupled to the 
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smooth muscle cell layer by pentalaminar myoendothelial gap junctions 
located at the end of thin projections that originate from the endothelial cells 
149, 150. 
 
Each connexon is constructed from six connexin (Cx) protein subunits 
traversing the cell membrane 151, 152. Several Cx isotypes have been 
identified 153, 154 and are named according to their predicted molecular 
weights in kDa. A hemichannel may be comprised of a single Cx isotype or 
multiple isotypes, resulting in the formation of homomeric or heteromeric 
connexons, respectively. Complete gap junction channels may be either 
homotypic, if comprised of two identical hemichannels, or heterotypic if the 
hemichannels supplied by each cell are different 155. Changes in Cx 
composition can have significant effects on the properties of gap junctions 
present in a tissue. This explains why different Cx are observed in different 
tissues, providing their distinct characteristics. 
 
Within the vascular tissue, four connexins have been reported so far: Cx37, 
Cx40, Cx43 and Cx45 156. The endothelial cells lining the arterial lumen are 
well coupled and have been found to express Cx37, Cx40 and Cx43. Cx37, 
Cx40 are the most abundant connexins and have been detected in 
endothelial cells of most vessels, while Cx43 is the least well expressed 
and is even absent in some vessels such as the intramural coronary 
arteries 156, 157. In the vascular smooth muscle Cx43 is the most abundant, 
followed by Cx40 and 45 158. Cx37 is usually thought to be restricted to the 
endothelial cells, but it has also been found in smooth muscle cells 159.  
Although the exact Cx isotype present in myoendothelial gap junctions 
remains unknown, recent evidence suggest that Cx40 plays a critical role in 
heterocellular signalling 160. 
 
 24
General introduction 
It has been hypothesised that myoendothelial gap junctions are more 
important in resistance than in conduit arteries 161, 162, which may explain 
the predominance of EDH in the resistance vasculature. However, the role 
of myoendothelial gap junctions in the EDH remains controversial since the 
specificity of the gap junction uncouplers used in most studies was 
questioned. Indeed, agents such as heptanol, 18α- and 18ß-glycyrrhetinic 
acid and carbenoxolone all have been shown to exert non-specific effects 
in a dose- and tissue-dependent manner 163-165. Therefore, a more specific 
inhibitor has been designed, based on the amino acid sequence of a 
portion of the extracellular loop of Cx43. This peptide, Gap 27, contains 11 
amino acids and prevents the formation of the connexon hemichannel 163, 
166, 167. Another problem in the study of gap junctional coupling is that none 
of the used uncouplers, including Gap 27, can selectively inhibit the 
myoendothelial cell coupling versus coupling between adjacent endothelial 
cells or smooth muscle cells 168, 169. Therefore, additional studies are 
required before the contribution of myoendothelial gap junctions in 
endothelium-derived hyperpolarizations can be further established. 
 
 
1.4. ENDOCANNABINOIDS 
The hemp plant (Cannabis sativa) has been used for millennia as a 
medicine and for social and religious purposes. The term cannabis is 
generally used to describe a single entity. However, research in the past 
century has revealed that cannabis is the source of more than 60 different 
compounds, collectively referred to as cannabinoids 170, 171. Cannabinol was 
the first of these plant cannabinoids to be isolated and described. The most 
abundant cannabinoid, primarily responsible for the psychotropic effects of 
cannabis, is ∆9-tetrahydrocannabinol (THC). Other, well described naturally 
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occurring cannabinoids are ∆8-THC and cannabidiol 172. Compared to ∆9-
THC, cannabinol has much more lower potency as a psychotropic agent, 
whereas cannabidiol lacks any psychotropic activity. At first, cannabinoid 
experiments focused mainly on the psychotropic properties. However, later 
studies showed that cannabinoids could also exert potent cardiovascular 
effects 173, 174. 
 
To date, two distinct receptor subtypes for cannabinoids have been 
identified and cloned. Type 1 cannabinoid (CB1) receptors 175 are mainly 
localised on neurons but are also present in some peripheral tissues 
including heart, lung and gastrointestinal tissues and in vasculature 136, 176-
178. On the other hand, type 2 cannabinoid (CB2) receptors 179 are primarily 
expressed in immune cells, although there is some evidence that these 
receptors are also expressed by neuronal tissue 180. In several arteries, the 
vasorelaxant effect of cannabinoids has been reported to be mediated by 
stimulation of CB1 receptors, since SR141716A, a CB1 receptor antagonist, 
inhibits relaxations by anandamide 52, 136, 181. Recently, it was suggested 
that in some vessels the vasodilator response to cannabinoids is mediated 
by stimulation of a novel, not yet identified, non-CB1/CB2 receptor located 
on the endothelium 182-184. 
 
In the early 1990’s, endogenous cannabinoids have been identified. The 
first of these endocannabinoids described was anandamide 185. In addition 
to their neurobehavioral effects, they have a profound influence on the 
cardiovascular system 173. Both, endogenous and synthetic cannabinoids 
have potent vasodilatory effects in a variety of isolated vascular 
preparations 52, 135, 136, 186. Their precise mechanisms of action, however, are 
still unknown and seem to vary with species, vessel type and size 139, 187. 
Also the site of action, whether they act on the endothelial cells, the 
 26
General introduction 
vascular smooth muscle cells or the perivascular nerves of the vessel wall 
is still elusive (figure 4). 
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Figure 4: Schematic presentation of the possible mechanisms of action of 
(endo)cannabinoids in the vessel wall. EC = endothelial cell; VSMC = vascular 
smooth muscle cell; PVN = perivascular nerves; EDHF = endothelium-derived 
hyperpolarizing factor; PGI2 = prostacyclin; NO = nitric oxide; hyperpol = 
hyperpolarization; NPept = neuropeptides; CGRP = calcitonin gene-related 
peptide; CB1 = type 1 cannabinoid receptor; CB2 = type 2 cannabinoid receptor; 
CBx = non-CB1/non-CB2 cannabinoid receptor; TRPV1 = type 1 vanilloid 
receptor; TRPV4 = type 4 vanilloid receptor. 
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In some vascular preparations, the anandamide-induced responses have 
been shown to be entirely endothelium-dependent 137, 146, 183, and 
associated with the release of prostanoids 135, 188, NO 136 or EDHF 146. Most 
studies, however, have shown that the vasorelaxations caused by 
anandamide are completely 52 or partly 146 endothelium-independent.  
 
The endothelium-independent pathway by which cannabinoids induce 
vasodilatation is still elusive. Some studies report that cannabinoids directly 
stimulate cannabinoid receptors on the vascular smooth muscle cells 52, 136, 
146. Moreover, some studies demonstrated that, in the isolated perfused 
mesenteric bed of the rat,  the endothelium-dependent vasodilator 
response of bradykinin was also inhibited by the CB1 inhibitor SR141716A 
and concluded that anandamide could be EDHF in these arteries 52. 
However, later studies have provided convincing evidence against this 
hypothesis, so that it is now generally accepted that EDHF and 
anandamide are different factors with other physiological and 
pharmacological properties 60, 139, 141, 143, 189, 190.  
 
Besides as an endocannabinoid, anandamide could also act as an 
endovanilloid in a number of vascular preparations. Indeed, the 
vasorelaxant influence of cannabinoids has been reported to be due to 
stimulation of vanilloid TRPV1 receptors on the perivascular sensory nerves 
and the subsequent release of sensory neuropeptides such as the powerful 
vasodilator calcitonin gene related peptide (CGRP). It has been shown that 
anandamide binds and activates TRPV1 receptors. Moreover, its 
vasorelaxant response was antagonised by the TRPV1 receptor antagonist 
capsazepine and the CGRP receptor antagonist CGRP(8-37), but not by the 
CB1 receptor antagonist SR141716A 138.  The picture is further complicated 
by more recent studies that identified endocannabinoids as potential 
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activators of the vanilloid TRPV4 receptor 191. This receptor is highly 
expressed on vascular endothelial cells, and its stimulation enhances Ca2+ 
influx, an essential trigger to release various vasoactive factors including 
NO, prostaglandins and the EDHF mechanism 192. Moreover, the TRPV4 
receptor was recently also found in the myocytes of cerebral arteries, and 
its activation was shown to cause smooth muscle cell hyperpolarization via 
BKCa channel activation 193. The endocannabinoids stimulate the TRPV4 
receptor indirectly, after conversion to its metabolite 5’,6’-
epoxyeicosatrienoic acid 191.  
 
 
1.5. STUDY AIM 
During the past 25 years, the important paracrine role of the vascular 
endothelium in the regulation of blood vessel tone and blood flow has 
become increasingly clear. While the role of the endothelium-derived 
vasorelaxing factors nitric oxide (NO) and prostacyclin (PGI2) is well 
established,  the mechanism underlying the endothelium-dependent 
hyperpolarization in various vessels is still debated. Several hypotheses 
have been put forward and there seem to be considerable tissue and 
species differences. The starting point of this work was to further explore 
the identity and the characteristics of the endothelium-derived 
hyperpolarizing factor (EDHF). 
 
In resting rat hepatic and small mesenteric arteries, K+ was proposed as 
EDHF 50, 116. On the other hand, the endothelium-derived hyperpolarization 
in stimulated rat hepatic and mesenteric arteries seemed to rely more on 
gap junctional coupling 115, 116. It was proposed, therefore, that the 
increased K+ efflux from the myocytes upon activation of the smooth 
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muscle with phenylephrine, resulted in a K+-cloud in the myoendothelial 
space. This process would saturate Na+/K+-pumps and favour the gap 
junctional pathway for smooth muscle hyperpolarization 110, 116. In chapter 3  
we further explore the functional consequences of modulation of basal 
smooth muscle K+ efflux for endothelium-dependent hyperpolarizations. We 
more specifically investigate the involvement of gap junctional coupling, 
Na+/K+-ATPases and inward rectifying K+ (KIR) channels in the 
acetylcholine-induced hyperpolarization of smooth muscle cells of rat small 
mesenteric arteries. 
 
Previous tension measurements performed in our lab revealed the 
existence of endothelium-dependent, but NO- and PGI2-independent 
vasorelaxations in rat gastric arteries stimulated with acetylcholine 194. 
However, as far as we knew, no data were available of endothelium-
derived membrane potential responses in these arteries. In chapter 4 we 
extend these observations by directly measuring the membrane potential 
responses of the gastric arteriolar smooth muscle cells to acetylcholine. We 
further characterise the observed endothelium-dependent 
hyperpolarizations by investigating the involvement of KIR-channels and 
Na+/K+-ATPases. 
 
Since the discovery of the existence of EDHF, several candidates have 
been proposed and their properties were intensively investigated and 
compared with those of EDHF. The endogenous cannabinoid anandamide, 
a derivative of arachidonic acid, has also been suggested as EDHF 52. 
Later studies, however, found convincing evidence against this hypothesis 
and it is now generally accepted that anandamide and EDHF are different 
factors. Nonetheless, endocannabinoids are potent vasodilators in a variety 
of vascular preparations. Previous work showed that anandamide and its 
 30
General introduction 
stable analogue methanandamide exert potent hyperpolarizing effects in rat 
mesenteric arteries, possibly through the activation of vanilloid TRPV1 
receptors on perivascular nerves and the subsequent release of the 
vasodilatory neuropeptide calcitonin gene-related peptide (CGRP) 139. In 
chapter 5 we examine the influence of these cannabinoids on the 
membrane potential in isolated small gastric arteries and compare this with 
the responses to exogenous CGRP. We further investigate the  
involvement of TRPV1 receptors in the cannabinoid responses using the 
specific antagonist capsazepine. Chapter 6 explores the relaxant effects of 
cannabinoids in small gastric arteries. More specifically, we characterise 
the relaxation induced by methanandamide and compared this with the 
response to exogenous CGRP. We assess the involvement of TRPV1 
receptors and the different types of cannabinoid receptors in the 
methanandamide response. Finally, we test the hypothesis that the 
relaxation induced by methanandamide could be due to an inhibitory action 
on voltage activated Ca2+ channels. 
 
The processes of vasorelaxation and vasoconstriction of arteries involves 
changes in intracellular Ca2+ concentration in the vascular smooth muscle 
cells. In chapter 7 we attempt to visualise and characterise changes in the 
intracellular Ca2+ concentration in smooth muscle cells of isolated small 
mesenteric arteries in response to different vasorelaxing and 
vasoconstricting substances using microscope Ca2+ imaging techniques. 
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2.1. INTRODUCTION 
Vasodilatation plays an important role in the regulation of blood flow and 
blood supply to the organs. Several techniques have been developed to 
study the pharmacodynamics of isolated small resistance arteries. Such in 
vitro experiments with segments of isolated arteries offer a useful approach 
to analyse the influence of local mechanisms controlling blood flow, without 
other interfering with other regulatory mechanisms as may be present in in 
vivo experiments. 
 
In the studies composing this work, different techniques have been used to 
study the mechanism of action of endothelium derived hyperpolarizing 
factor and endocannabinoids. Membrane potentials of the vascular smooth 
muscle cells were measured using electrophysiological microelectrode 
techniques. Tension measurements were performed in a wire myograph to 
study relaxation and contractile responses. Finally, intracellular Ca2+ 
changes were monitored using fluorescent dyes and confocal microscopy. 
 
 
2.2. TISSUE PREPARATION 
All experiments were performed on isolated arterial ring segments from 
adult female Wistar rats (180 – 280 g) and were approved by the ethical 
committee on animal research of Ghent University. The animals were 
anesthetized by a lethal dose (200 mg kg-1) of pentobarbitone and killed by 
cervical dislocation.  
 
For the studies described in this thesis, small mesenteric or gastric arteries 
were used. Therefore, the mesentery or the stomach, as appropriate, were 
rapidly excised and placed in cold (4°C) Krebs-Ringer bicarbonate (KRB) 
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solution. Second and third order branches of the arteries were dissected 
free and transferred to fresh KRB solution, gassed with 5% CO2 in O2 (pH 
7.4). Then the vessels were cleaned from surrounding connective tissue. 
For the electrophysiological and tension measurements, the isolated 
vessels were cut into segments of about 4 mm in length and transferred to 
the respective experimental chambers. For the Ca2+ imaging studies, larger 
segments were used. These vessel segments were cannulated with a thin 
glass capillary (borosilicate glass, Hilgenberg, Malsfeld, Germany) with 
flame polished tip that was inserted into the lumen over the entire segment 
length. The diameter of the glass capillary was slightly (~15 %) larger than 
the vessel lumen diameter and cannulation was done to stabilize the 
preparation against possible movement upon stimulation with low 
concentrations of norepinephrine. 
 
 
2.3. ELECTROPHYSIOLOGICAL EXPERIMENTS 
Hyperpolarization of the vascular smooth muscle cells is one of the 
possible ways to induce vasorelaxation and subsequent vasodilation. It is 
generally accepted that a change in the membrane potential of a few mV 
can result in a substantial change in vessel diameter 1, 2. Furthermore, 
hyperpolarization of the vascular smooth muscle cells produces a rapid 
effect on blood flow. Therefore, membrane potential measurements are of 
great importance in the study of vasodilatation. 
 
 
2.3.1. Experimental setup 
The experimental set-up for membrane potential measurements is depicted 
in figure 1. A small cut-away (with a volume of approximately 5 ml) in a 
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Perspex block (6 x 8 x 8 cm), heated by a Lauda bath (37 °C, Haake, 
Berlin, Germany), forms the experimental chamber. Since vibration is to be 
avoided to allow cell impalements for an extended period, the whole 
experimental set-up is mounted on a pneumatic vibration isolation table. 
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Figure 1: Experimental set-up for membrane potential measurements: (1) vessel segment 
pinned down to a silicone base with insect pins and fixed to the bottom of the experimental 
chamber; (2) bath-clamp; (3) pre-amplifier for impedance compensation; (4) amplifier; (5) the 
measured membrane potential is monitored on an oscilloscope and a computer and traced 
with a pen recorder. 
 
The isolated arterial rings are pinned down to a silicone base using two 
small insect pins. Small incisions are made at the distal endings to facilitate 
diffusion of added vasoactive agents to the lumenal side. The preparations 
are then fixed on the bottom of the experimental chamber under an angle of 
45°, permitting visualisation from the front with a binocular microscope, the 
penetrating microelectrode being in focus with the preparation. The 
chamber is perfused with warmed KRB solution (35 °C), gassed with 95% 
O2 and 5% CO2 in an external bath. A roller pump (minipuls 2, Gilson) 
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transfers the solution through a polyethylene tubing to the experimental 
chamber at a flow rate of 5 ml/min. Before reaching the vessel segment, 
the solution passes a spiral shaped glass tubing at the bottom of the 
experimental block, to compensate for possible cooling during the transfer. 
The volume in the organ chamber is kept as low as necessary just to cover 
the vessel by adjusting the outflow, facilitating impalements and 
visualisation of the preparations through the binocular microscope. After 
mounting in the experimental chamber, the arteries are equilibrated for at 
least 60 minutes before starting the microelectrode impalements. 
 
 
2.3.2. Membrane potential measurements 
The experimental bath was continuously clamped at ground potential using 
a bath clamp circuit. The operational amplifier of this circuit is connected at 
the non-inverting input with the virtual ground, while the inverting input is 
connected to the bath through an Ag/AgCl electrode. The output of the 
amplifier is connected back to the experimental bath fluid via an agar-KCl 
bridge. Hereby, possible fluctuations of the ground potential are 
immediately corrected by supplying the appropriate current to the bath. 
Hence, the bath potential is always clamped at the same virtual ground 
level. 
 
Transmembrane potentials of the vascular smooth muscle cells are 
measured by penetrating the cells with conventional microelectrodes pulled 
with a vertical pipette puller (David Kopf, Tujunga, CA) from filamented 
borosilicate glass tubings (1 mm o.d., Hilgenberg, Malsfeld, Germany). The 
microelectrodes are filled with 1 M KCl and fixed on a preamplifier which is 
mounted on an oil driven micromanipulator (Narishige MO-388, Nikon) . A 
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short Ag/AgCl wire provides electrical contact between the preamplifier and 
the solution in the electrode. The electrical resistance of the 
microelectrodes, measured in normal KRB solution, ranges from 40 – 80 
MΩ. The used preamplifiers have high impedance compared with the 
microelectrode (MOS/FET operational amplifier with an impedance of 1.5 x 
103 MΩ) and hence serve for impedance compensation. The electrodes 
and the pre-amplifier are shielded by an aluminium plate, protecting them 
from environmental electrostatic influences (Faraday cage). The output of 
the preamplifier is connected to an amplifier where the bath potential is 
subtracted from the measured potential. The resulting potential is 
monitored on an oscilloscope and followed on a computer monitor after AD-
conversion using a data acquisition processor board (Microstar 
Laboratories) with appropriate software (DAPview Plus 1.10; Microstar 
Laboratories). The measured potential is also traced with a pen recorder at 
low speed. In some experiments, the recorded pen traces are digitized off-
line with a digitizing tablet connected to a PC. 
 
The micromanipulator allows advancing the electrodes in very small steps 
until stable cell penetration is reached. Successful impalements of the 
vascular smooth muscle cells are characterised by an extremely sharp 
voltage deflection on entering the cell and a fast return to the baseline on 
exit of the microelectrode from the cell. Absolute values for the membrane 
potential (Em) are taken as the difference of the stabilised potential after cell 
impalement and the zero potential as obtained upon electrode 
dislodgement. During a successful impalement, membrane potential 
responses produced by vasoactive substances are measured under control 
conditions and after preincubation with inhibitors. All drugs are added into a 
know volume in the outside mixing chamber and perfused at known 
concentrations into the experimental chamber.  
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2.4. TENSION MEASUREMENTS 
 
The mechanical properties of ring segments of small resistance vessels 
were investigated using a wire myograph. This technique allows the study 
of the contractile reactivity of isolated arteries. It is based on the methods 
developed by Mulvany and Halpern (1976) 3. Briefly, vessel segments are 
mounted in the organ chamber of a wire myograph onto two thin (40 µm 
diameter) wires (figure 2). One of the wires is connected to a force 
transducer, which allows measurement of isometric tension changes of the 
ring segments. 
 
 
2.4.1. The wire myograph 
For the tension measurements, a manual wire myograph was used 
constructed by the technical staff of our laboratory (Mr. Dirk De Gruytere 
and Mr. Cyriel Mabilde). Each preparation is mounted under a dissecting 
microscope onto two thin stainless steel wires that are fixed at two holders. 
One holder is connected to a micrometer which is used to change the 
distance between the wires in the beginning of the experiment, in order to 
apply a passive force on the vessel. The other holder was connected to a 
force-displacement transducer that measures the isometric tension 
changes in the vessel segment (figure 2). 
 
 
2.4.2. Mounting of a ring segment 
Before mounting, the first thin wire is cut to length (approximately 2.5 cm) 
and is clamped between the two holders in the organ bath (figure 3A). The 
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far end of the wire is then fixed on the left holder with a screw. The near 
end, pointing towards the operator, is kept free so that a ring segment can 
be slipped over it (figure 3B and C). Next, using a pair of extra fine 
tweezers, the arterial ring is pulled over the free end of the wire, taking care 
not to injure the endothelium (figure 3D). The holders are then set apart 
and the vessel is drawn further over the wire, until it is situated between the 
holders (figure 3E). The near end of the wire can then be fixed with a screw 
to the other side of the left holder (figure 3F).  
FORCE
TRANSDUCER
MICRO-
METER
 
Figure 2: A photograph of the organ bath of the wire myograph and a schematic detail of a 
pair of holders. Arterial segments are mounted on two thin wires, fixed on the two holders in 
the organ bath. One holder is connected to a micrometer which is used to change the 
distance between the wires. The other holder is connected to a force transducer which 
allows measurement of isometric tension changes in the vessel segment 
 
The second wire can now be guided carefully through the lumen of the 
artery (figure 3G).  The holders are brought together, and both ends of the 
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second wire are fixed on the right holder. It should be noted that wires must 
be levelled, so that they both lay in the same horizontal plane (figure 3H 
and I). Once the vessel is mounted, the length of the segment (l) is 
measured with a micrometer eyepiece (Zeiss, Germany). The preparations 
are then allowed to equilibrate for at least 30 minutes in gassed KRB 
solution (pH 7.4) at 37 °C before proceeding with the experiment. 
 
A CB
D
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Figure 3: Schematic presentation of the different steps involved in the mounting of an 
arterial segment on two thin stainless steel wires, fixed on the holders 
 
 
 
2.4.3. The normalisation procedure 
In small arteries, the vascular smooth muscle cells are circumferentially 
arranged. Hence, stretching the vessel will influence the length of these 
smooth muscle cells 4. Since active force development of a muscle cell 
depends on its length 4, 5, the vessels must be distended to bring the actin-
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myosin fibres into alignment for optimal force development. It is generally 
accepted that the active force development in vascular tissue peaks at a 
certain internal circumference or diameter, which corresponds to a 
particular length of the smooth muscle cell. Therefore, at the beginning of 
each experiment, the vessels should be stretched to their optimal lumen 
diameter, affording optimal experimental conditions. 
 
It has been found experimentally, that active force production is maximal 
when the internal circumference is 0.9 times the internal diameter that the 
relaxed vessel would have under a transmural pressure of 100 mmHg 
(IC100). The normalisation procedure allows us to calculate the IC100 for the 
mounted vessel and to determine the position of the holders stretching the 
segment to its ideal internal circumference. Additionally, the size of the 
vessel can be calculated through this normalisation procedure. The size of 
a vessel is defined as its size when fully relaxed and under a transmural 
pressure of 100 mmHg. 
 
Prior to the normalisation procedure, the micrometer setting corresponding 
to a force of 0 mN is determined. Therefore, the holders are brought 
together until the two wires touch. This is characterized by a negative force 
registered by the transducer. The holders are then gently pulled back until 
the registered force returns to baseline. At this point, the force registered by 
the transducer is 0 mN (y0) and the distance between the two wires is 0 µm. 
The corresponding micrometer setting is x0. 
 
During the normalisation procedure the vessel is stretched in steps by 
moving the micrometer as required to drift the wires apart. One minute after 
each step (i), the corresponding micrometer setting (xi) and force (yi) are 
registered. These measurements allow the calculation of the internal 
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circumference (ICi) and the wall tension (Ti). With these values, the 
transmural pressure (Pi) can be calculated that would yield this ICi in the 
ring segment.  
 
 Calculation of the internal circumference (ICi) 
The ICi is calculated from the distance between the wires (xi – x0) and 
the diameter of the mounting wires (40 µm) (figure 4): 
 
ICi  = 2 x ((2π x 20 µm) / 2) + 4 x 20 µm + 2 x (xi – x0) 
= 205.66 µm + 2 x (xi – x0) 
 
 Calculation of the wall tension (Ti) 
The Ti is the measured force (yi) divided by the length of the vessel wall. 
Since there is both an upper and a lower wall, the total length of the 
vessel wall equals two times the length of the vessel as measured with 
the micrometer eyepiece (l) after mounting. 
Ti = yi / (2 x l) 
 
 Calculation of the transmural pressure (Pi) 
The pressure (Pi) leading to the calculated ICi can be deduced from the 
law of Laplace, which states that in a cylinder, wall tension is 
proportional to the pressure times the radius of the cylinder. Since the 
radius (r) can be calculated from the ICi (ICi = 2π r), the Pi can be 
determined with the following formula: 
 
Pi = Ti / (ICi / 2π) 
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It should be noted that the calculated pressure is only an estimate for 
the intraluminal pressure that would be necessary to stretch the vessel 
to the measured ICi. 
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 µ
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Figure 4: A schematic representation of the blood vessel after distention i. 
 
For each pair of readings (xi and yi), the corresponding pressure is 
calculated. The stepwise stretching of the vessel segments is stopped 
when the pressure exceeds 100 mm Hg (= 13.3 kPa). Subsequently, a 
graph is constructed expressing the pressure in function of the 
corresponding internal circumference. The points are fitted on an 
exponential curve of the form y = a.ebx (figure 5). On this curve, the point 
corresponding with a pressure of 100 mm Hg represents the IC100. Next, 
the ideal position of the holders to obtain an internal circumference of 0.9 x 
IC100 can be calculated by inserting this value in the formula for ICi. At the 
end of the normalisation procedure, the holders are set in this position and 
the experiment can be started. Furthermore, the IC100 value allows us to 
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calculate the diameter the ring segment would have when exposed to a 
transmural pressure of 100 mm Hg (IC = 2π r). 
 
 
2.4.4. A detailed example of a normalisation procedure 
The following example shows the different steps in the normalisation 
procedure for a rat gastric artery with a length of 2.52 mm. 
 
Starting parameters: 
y0 = 0.00 mN  (force registered by the transducer at the beginning of the 
normalisation procedure) 
x0 = 3611 µm (position of the micrometer when the distance between the 
two wires is 0 µm) 
P0 = 0.00 kPa (at the start of the normalisation procedure, there is no 
force on the wall of the vessel, so there is no pressure) 
1 minute after the first distension: 
y1 = 3.92 mN 
x1 = 3889 µm 
x1 –x0 (distance between the wires) = 278 µm 
From these values, we can calculate the following parameters: 
IC1 = 205.66 µm + (2 x (x1 – x0)) µm = 761.66 µm 
T1 = y1 / (2 x l) = 3.92 mN /  (2 x 2.52 mm) = 0.778 mN/mm 
P1 = T1 / (IC1 / 2π) = 0.778 mN/mm /(0.121 mm) = 6.42 kPa  
 
The same calculations were made for the following distensions. The 
readings of xi and yi, obtained 1 minute after each distension, and the 
calculated values of ICi, Ti and Pi are summarized in table 1. 
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Table 1: values of yi, xi, xi-x0, ICi, Ti and Pi for each distension step in the normalisation 
procedure of a rat gastric artery with a length of 2.52 mm.  
Step (i) 
yi  
(mN) 
xi  
(µm) 
xi-x0  
(µm) 
ICi  
(µm) 
Ti  
(mN/mm) 
Pi  
(kPa) 
1 3.92 3889 278 761.66 0.778 6.42 
2 6.44 3940 329 863.66 1.278 9.30 
3 8.68 3971 360 925.66 1.722 11.69 
4 10.64 3993 382 969.66 2.111 13.68 
 
The relation between the internal circumference and the pressure is then 
expressed in an exponential curve, presented in figure 5. On this curve, the 
point corresponding with a pressure of 13.3 kPa corresponds with an IC100 
of  961.6 µm. With this value, both the ideal position of the holders and the 
size of the artery can be calculated: 
 
The ideal internal circumference IC90 = 0.9 x IC100 = 865.44 µm 
The ideal micrometersetting (x1’) yielding this IC90 can be calculated with 
the following equation: IC90 = 205.66 µm + (2 x (x1’ – x0)) µm  
⇒  x1’ = ((IC90 -205.66 µm)/2) + x0 µm = 3941 µm 
The diameter of the ring segment, when it would be exposed to a transmural 
pressure of 13.3 kPa (l100) can also be calculated: 
l100 = IC100 / π = 306.1 µm 
 
Before the start of the experiment, the micrometer is set at 3941 µm. 
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Figure 5: Relation between the internal circumference of the ring segment and the 
corresponsding intraluminal pressure necessary to extend the vessel to this internal 
circumference. The calculated points are fitted on an exponential curve (The equation for the 
curve in this example is: y=0.40048.e0.00364264x). From this curve, the internal circumference 
can be deduced corresponding to a pressure of 13.3 kPa. 
 
 
2.4.5. The experiment 
After the normalisation procedure, the preparations are repeatedly 
activated with KRB solution containing 120 mM K+ (K120) and 10-5 M 
norepinephrine. 
 
During the actual experiments, the arterial segments are contracted by 
adding 10-5 M norepinephrine to the organ bath or by replacing the 
standard KRB solution in the organ bath by a KRB solution containing 120 
mM K+. When a stable contraction is obtained, concentration-response 
curves are constructed by cumulative addition of an agonist under control 
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conditions or in the presence of an antagonist. The presence of functional 
endothelium is assessed at the start of each experiment by the ability of 10-
5 M acetylcholine to induce more than 80 % relaxation. 
 
In some experiments, the influence of methanandamide on the influx of 
extracellular Ca2+ through plasma membrane Ca2+ channels is studied. 
Therefore, intracellular Ca2+ stores are first depleted by washing the 
vessels with nominally Ca2+-free KRB solution (same composition as 
normal KRB solution, but without added CaCl2), exposing them 
subsequently to Ca2+-free, EGTA (1 mM) containing solution, and 
repeatedly challenging the vessels to 10-5 M norepinephrine. After 
thoroughly washing the preparations with Ca2+-free KRB solution, 
norepinephrine (10-5 M) is added and a concentration-contraction curve for 
CaCl2 (10-5 to 10-2 M) is constructed in control conditions and after 30 min 
preincubation with 10-5 M methanandamide. Contractions are expressed as 
a percentage of the maximum contraction induced by CaCl2 in control 
conditions. 
 
In some experiments the endothelium has to be removed from the vessels. 
For this purpose, the arteries are first unstretched in the myograph. Then, 
an L-shaped micropipette is placed at the proximal end of the segment and 
gas (95 % O2 and 5 % CO2) is bubbled through the lumen of the 
preparations for 2 min. Subsequently, the vessels were again stretched to 
their optimal lumen diameter. After an equilibration period of 30 min, the 
absence of functional endothelium was confirmed by the lack of relaxation 
to acetylcholine. 
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2.5. CALCIUM IMAGING 
In the Ca2+ imaging experiments, Ca2+ responses are studied in the smooth 
muscle cells of intact small mesenteric arteries using confocal microscopy. 
Briefly, the vessel preparations are loaded with the Ca2+ indicator fluo-3 
(fluo-3) which is essentially non-fluorescent unless bound to Ca2+. This 
allows us to visualize changes in free intracellular Ca2+ concentration upon 
addition of several agonists by measuring changes in fluorescence. 
Differences in efficiency of loading between different reparations were 
annihilated by setting baseline fluorescence as 100% and expressing 
changes in fluorescence as percentage of this baseline.  
 
 
2.5.1. Confocal microscopy 
Conventional light microscopes are probably the most well-known and used 
research tools, affording an easy and direct method for studying cells. 
Using transillumination or epifluorescence microscopy, one is able to obtain 
a lot of information from a single layer of cells. However, when studying for 
example cell-cell interactions in living cells or Ca2+ dynamics in tissues, 
these microscopes are unusable. Furthermore, images obtained with these 
microscopes often appear blurred and have poor contrast, due to light 
scattered around the image. A confocal laser scanning microscope is 
capable of observing selected thin layers of a thick specimen. Such 
microscope is not only able to produce three dimensional reconstructions of 
preparations, but it also creates sharp images of a specimen that would be 
hazy when viewed with a conventional microscope. 
 
If light is incident on a molecule, it may absorb the light and subsequently 
emit light of a different colour. This process is known as fluorescence. In 
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the experiments performed for this thesis, excitation was done with the 488 
nm line of an argon-laser (blue light). When a molecule of the fluorescent 
dye loaded in the cells of the preparation absorbs a photon of this high 
energetic light, its energy increases, subsequently bringing it to an 
electronically excited state (S1 in figure 6). Some of the absorbed energy is 
quickly lost internally through collisions with surrounding molecules, which 
brings the molecule to a lower energy level (S1’ in figure 6). Finally, the 
molecule can fall back to its original energetic state (S0 in figure 6), thereby 
causing spontaneous emission of light with a larger wavelength than the 
excitation light (λ=520 nm, corresponding with green light). 
 
 
S1
S1’
S0
1
2
3Excitation Emission
 
Figure 6: Single photon excitation of a fluorescent probe. The fluorescent probe may absorb 
a photon of light (blue light, λ=488 nm), increasing the energy of the molecules and causing 
an electron to jump to a singlet excited state (1). The electron jumps from a lower, but stable 
energy level (S0) to a higher unstable level (S1). The molecule quickly loses some of the 
absorbed energy through collisions with neighbouring molecules, causing the electron to 
drop (2) to a lower energy level (S1’). Finally, the electron returns (3) to its ground state (S0), 
thereby losing the remaining energy by emitting light of a longer wavelength (green light, 
λ=520 nm). 
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The term “confocal” refers to the fact that only light from the focal point of 
the objective lens is used to construct the image. This is obtained using a 
pinhole (figure 7) which only allows light from the focal point to pass, 
resulting in a sharper image (figure 8).  
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Figure 7: Diagram showing the principle of confocal microscopy.  Light from a laser reflects 
off a dichroic mirror directing it through the objective lens to the preparation. The dye in the 
preparation is excited by the laser light and fluoresces. The returning fluorescent light of 
longer wavelength is allowed to pass through the dichroic mirror. The light that makes it 
through the pinhole is measured by the photomultiplier. 
 
Using this principle, it is possible to view one cell layer in a multilayer 
preparation, namely the layer situated in the focus of the objective lens. By 
changing the depth of scanning, different cell layers can be focused 
separately. Under optimal conditions, preparations of about 100 µm thick 
 69
Chapter 2 
can be visualised.  When the preparation depth is larger than 100 µm, the 
intensity of the excitation light is insufficient to produce enough emission 
light, gradually decreasing the quality of the captured images. 
 
10 µm
A CB
 
Figure 8: Image of a fluorescein-labeled pollen grain (taken from a slice containing mixed 
fluorescent pollen grains (30-4264; Carolina Biological Supply)). Comparison of the images 
obtained with a conventional epifluorescence microscope (A) and a confocal microscope 
(B&C) (x 40 oil immersion objective, NA 1.30). (A) Image obtained in epifluorescence mode 
(excitation at 470 nm (bandpass, 40 nm bandwidth); emission at 520 nm (longpass)). In 
epifluorescence mode, out-of-focus light significantly blurs the image and reduces the 
contrast. (B & C) Images of the same preparation taken with the confocal microscope 
(excitation at 488 nm; emission at 522 nm (bandpass, 25 nm bandwidth)), using a large and 
a very small pinhole, respectively. The spiculae protruding from the spherical soma of the 
pollen grain can be best appreciated in C. The focal plane was situated close to the 
spherical soma surface.   
 
 
Briefly, the laser light reflects off a dichroic mirror, which directs it through 
the objective lens to the preparation. The dye in the specimen (Fluo-3 in 
our experiments) is excited by the laser light and fluoresces. Returning 
fluorescent (green) light is of longer wavelength and is allowed to pass 
through the dichroic mirror. Thereafter, it is focused onto a pinhole. Only 
light from the focal point of the objective lens can make it through the 
pinhole and is measured by a detector such as a photomultiplier. For 
visualisation, the detector is coupled to a computer which builds up the 
image pixel per pixel. 
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2.5.2. Calcium imaging 
In our experiments we use laser scanning confocal microscopy in 
combination with the fluorescent Ca2+ probe Fluo-3 (figure 9A) to measure 
the free Ca2+ concentration. Fluo-3 is part of a group of Ca2+ indicators 
which are excitable by visible light. Figure 9B shows its Ca2+-dependent 
emission spectrum for excitation at 488 nm (argon-laser sources) 6. 
Fluorescent Ca2+ indicators excited with visible light offer several 
advantages over UV light-excitable indicators (e.g. Fura-2 and indo-1). For 
example, they show efficient excitation with most laser-based 
instrumentation and exhibit less cellular photodamage and light scatter. 
Also, there is a reduced interference from sample autofluorescence and 
due to stronger absorption by the dye, lower concentrations may be used, 
reducing phototoxicity. Fluo-3 is essentially non-fluorescent unless bound 
to Ca2+ and exhibits a Kd for Ca2+ of 390 nM. It shows a very large increase 
in fluorescence intensity in response to Ca2+ binding, resulting in sensitive 
detection of Ca2+ transients. The Fluo-3 used in the present experiments 
exhibits an at least 100-fold Ca2+-dependent increase in fluorescence.  The 
acetoxymethyl (AM) ester derivative of Fluo-3 is an uncharged molecule 
that can easily permeate the cell membranes. The intact acetoxymethyl 
(AM) ester derivative of fluo-3 is also non-fluorescent, unlike the AM esters 
of fura-2. Once inside the cells, the molecule is cleaved by non-specific 
esterases resulting in a charged form able to bind Ca2+ ions. 
 
The cannulated arterial segments are loaded with the Ca2+ dye by 
incubation overnight at 4°C in a loading buffer (Hanks’ balanced salt 
solution buffered with 25 mM HEPES (HBSS-HEPES)) containing 20 µM 
Fluo-3-AM and 0.05 % pluronic. The morning of the experiments, the 
preparations are transferred to loading buffer (same fluo-3-AM 
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concentration) now at 37°C and incubated for 90 min. The arteries are then 
washed in HEPES-buffered physiological salt solution (PSS, pH 7.4). 
 
A.
B.
 
Figure 9: (A) Structure formula of the visible light-excitable Ca2+ indicator Fluo-3. (B) Ca2+ 
dependent Fluorescence emission spectra of Fluo-3 at various levels of free [Ca2+]i. (From: 
Invitrogen/Molecular Probes – A Guide to Fluorescent Probes and Labeling Technologies) 
 
 
Ca2+ imaging is done with a custom developed real-time laser scanning 
microscope built around a Nikon Eclipse TE300 (Analis, Ghent, Belgium) 7 
and a x40 oil immersion objective with high numeric aperture (CFI Plan 
Fluo, Nikon - 1.4 NA). A cannulated vessel segment is placed on a glass 
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coverslip and immobilized by covering it with a fine nylon mesh attached to 
a ring. The coverslip with the vessel is placed on the stage of the inverted 
microscope and is continuously superfused in situ with PSS at a rate of 1 
ml/min. Excitation is done with the 488 nm line of an argon-laser (type 
543R-AP-A01, Melles Griot, Carlsbad, CA, U.S.A.), the dichroic is a dual-
wavelength dichroic XF2043 (490-550DBDR) and the emission light is 
bandpass filtered at 522 nm (25 nm bandwidth - all filters from Omega 
Optical, Brattleboro, VT, U.S.A. - details can be found in Leybaert et al., 
J.Microscopy 7). Images of an optical section of the arterial wall (~ 123 µm x 
93 µm and containing about 30-40 cells) are obtained at 2 frames s-1 and 
transferred directly to a PC equipped with an image acquisition and 
processing board (DT3155, Data translation, Marlboro, MA, USA). Off-line 
image analysis is done with software (Fluoframes) developed in Microsoft 
Visual C.  
 
 
2.5.3. Experimental procedures and analysis 
The experiments are performed at room temperature. After recording 2 min 
(240 images) in control conditions, norepinephrine (10-6 M) is added to the 
superfusate and recording is continued for another 3 min (360 images). 
Thereafter, still in the presence of norepinephrine, the tissues are exposed 
to various pharmacological agents and the responses are monitored over 
another 8 min (960 images) or 3 min (360 images), as appropriate. The first 
stage image analysis consists of counting the number of cells showing 
clear Ca2+ responses under control conditions, in the presence of 
norepinephrine and in the presence of the various pharmacological 
substances. The responding cells are subdivided in those showing 
oscillatory spiking activity upon stimulation with norepinephrine and those 
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reacting with an increase in fluorescence relative to the baseline level. In a 
second stage of the analysis, the number of Ca2+ spikes per cell, the 
spiking frequency (over the last 240 frames, expressed as spikes per 
minute) and the change in fluorescence relative to the baseline level is 
calculated (from the last 150 frames, baseline level was assumed 100 %).  
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Abstract 
In rat small mesenteric arteries, the influence of modulation of basal 
smooth muscle K+-efflux on the mechanism of endothelium-dependent 
hyperpolarization was investigated. The membrane potentials of the 
vascular smooth muscle cells were measured using conventional 
microelectrode techniques. Incubation of resting arteries with the gap 
junction uncoupler carbenoxolone (20 µM) decreased the endothelium-
dependent hyperpolarization elicited by a submaximal concentration of 
acetylcholine (3 µM) to about 65 % of the control. In the presence of 
Ba2+ (200 µM), which depolarized the membrane potential by 10 mV, 
the acetylcholine-induced membrane potential response was doubled in 
magnitude, reaching values not different from control. Moreover, the 
hyperpolarization was more resistant to carbenoxolone in these 
conditions. Finally, both in the absence and in the presence of 
carbenoxolone, the combined application of Ba2+ and ouabain (0.5 mM) 
did not abolish the acetylcholine response. These results suggest that 
gap junctional coupling plays a role in endothelium-dependent 
hyperpolarization of smooth muscle cells of resting rat small mesenteric 
arteries. Additionally, these findings show that the hyperpolarization 
does not rely on activation of inward rectifying K+ channels. Although a 
minor contribution of Na/K-pumping cannot be excluded, the Ba2+ 
experiments show that the membrane electrical response is mediated by 
activation of a Ba2+-resistant K+ conductance.  
 
Keywords: EDHF, carbenoxolone, potassium channels, vascular smooth 
muscle cell membrane potential, vasodilation 
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3.1. INTRODUCTION 
Agonists such as acetylcholine dilate blood vessels through several 
endothelium-dependent mechanisms. These include the synthesis and 
release of nitric oxide (NO) and prostacyclin by the endothelial cells. 
Moreover, in various arteries an endothelium-dependent vasodilation 
resistant to inhibitors of NO synthases and cyclooxygenases has been 
demonstrated. This type of relaxation of the vascular tissue is associated 
with a hyperpolarization of the smooth muscle cells 1,2. 
 
Earlier evidence suggested that the NO- and prostacyclin-independent 
smooth muscle hyperpolarization is caused by a factor diffusing from the 
endothelial cells. This humoral substance has been termed endothelium-
derived hyperpolarizing factor (EDHF). As yet, the identity of EDHF is still 
elusive. Epoxyeicosatrienoic acids (EETs), K+ ions, anandamide, H2O2 and 
C-type natriuretic peptide have all been suggested as an EDHF in certain 
vascular beds 3-7. An alternative pathway for endothelium-dependent 
hyperpolarization is transmission of the agonist-induced hyperpolarization 
of the endothelial cells to the vascular smooth muscle via myoendothelial 
gap junctions. This heterocellular coupling, which is also documented in rat 
mesenteric arteries 8, allows the spread of electrical current or the transfer 
of a small hydrophilic messenger molecule such as cAMP 9-12.  
 
In rat hepatic and small mesenteric arteries, K+ was proposed as EDHF 5. 
More specifically, acetylcholine was shown to stimulate the opening of 
apamin- and charybdotoxin-sensitive K+-channels in the endothelial cell 
membrane (causing hyperpolarization), and the resulting K+ efflux would 
transiently raise the extracellular K+-concentration ([K+]o) in the restricted 
myoendothelial spaces within the vessel wall 5. In turn, this increase would 
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activate the Na/K-ATPases and inwardly rectifying K+ channels (KIR 
channels) in the membrane of the adjacent smooth muscle cells, as is 
documented for exogenous small increases in [K+]o in some vessels 13,14. 
This activation results in the hyperpolarization of the vascular smooth 
muscle cells 5. More recently, however, it was reported that exogenous 
increases in [K+]o elicited relaxation in only 30% - 40% of preconstricted rat 
small mesenteric arteries, while all vessels relaxed in response to 
acetylcholine 15. Moreover, relaxations caused by a rise in [K+]o were 
significantly smaller than the acetylcholine-responses and were absent 
after removal of the endothelium 15. In another study, raising [K+]o similarly 
dilated only 30% of pressurized rat small mesenteric arteries, while all 
vessels dilated to acetylcholine 16. Moreover, in this study an increase in 
[K+]o caused no relaxation of preconstricted arteries that were isometrically 
mounted, either with or without destroyed endothelium 16.  
 
The absence of K+-induced hyperpolarization in endothelium-denuded rat 
small mesenteric arteries was confirmed after stimulating the vessels with 
phenylephrine 17. Since blockers of vascular smooth muscle K+ channels 
restored hyperpolarizations in these stimulated vessels, it was suggested 
that activation of the smooth muscle, which is known to increase K+ efflux 
from the myocytes 18, resulted in a K+ cloud in the myoendothelial spaces. 
This extracellular accumulation of K+ ions would saturate Na/K-pumps 
17,19,20 and favour the alternative gap junctional pathway for smooth muscle 
hyperpolarization 17,20.  
 
In this paper, we further explore the possible existence of local depletions 
and (or) accumulations of extracellular K+ within the vessel wall, and 
assessed the functional consequences of modulation of basal smooth 
muscle K+ efflux for endothelium-dependent hyperpolarization. More 
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specifically, we measured the acetylcholine-induced hyperpolarization of 
the smooth muscle cells in rat mesenteric arteries, and investigated the 
separate and combined influence of inhibition of gap junctional coupling 
with carbenoxolone and of membrane Na/K-ATPases with ouabain in the 
absence and the presence of the KIR channel inhibitor Ba2+. Low 
concentrations of Ba2+ are known to specifically block KIR currents 21, and 
blocking tonically open KIR channels is expected to reduce resting K+ efflux 
and consequently, diminish the K+ load in the myoendothelial spaces. 
 
 
3.2. MATERIALS AND METHODS 
 
3.2.1. Preparations 
Small mesenteric arteries from female Wistar rats (180 – 230 g) were used. 
The animals were treated in accordance with the principles and guidelines 
of the Canadian Council on Animal Care for the use of laboratory animals. 
Experiments were approved by the ethical committee on animal research of 
Gent University. The rats were killed by cervical dislocation. Branches of 
the mesenteric arteries were rapidly removed and placed in cold (4°C) 
Krebs-Ringer bicarbonate solution containing the following (in mM): NaCl, 
135; KCl, 5; NaHCO3, 20; CaCl2, 2.5; MgSO4.7H2O, 1.3; KH2PO4, 1.2; 
EDTA, 0.026; glucose, 10. The solution was bubbled with 95% O2 – 5% 
CO2. 
 
Second and third order arteries were cleaned from surrounding connective 
tissue and cut into segments of about 4 mm in length. The vessels were 
pinned down to the bottom of an experimental chamber and were 
continuously superfused with the Krebs-Ringer solution (37 °C) of the 
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above composition, supplemented with NG-nitro-L-arginine (L-NA)(10-4 M) 
and indomethacin (5×10-5 M) to avoid interference from NO and 
prostacyclin, respectively. The solution was continuously gassed with a 
95% O2 – 5% CO2 gas mixture (pH ~ 7.4). The preparation was allowed to 
equilibrate for at least 60 min. 
 
 
3.2.2. Electrophysiological measurements 
Membrane potentials of the vascular smooth muscle cells were measured 
with sharp microelectrodes, pulled from filamented borosilicate glass 
tubings (Hilgenberg, Malsfeld, Germany) with a vertical pipette puller (David 
Kopf Instruments, Tujunga California, USA), and filled with 1 M KCl. 
Electrical signals were monitored on an oscilloscope and recorded with a 
pen recorder. Successful cell impalements were characterized by an 
extremely sharp voltage deflection on entering the cell and a fast return to 
the baseline upon withdrawal of the microelectrode. Values of the 
transmembrane potential (Em) were taken as the difference between the 
stabilized membrane potential after cell impalement and the zero potential 
upon dislodgement of the electrode from the cell. Changes in membrane 
potential produced by exposing the cells to acetylcholine in control 
conditions and after incubation with various substances (Ba2+, 
carbenoxolone, ouabain) were measured. 
 
Ba2+ was added to the superfusate for at least 10 min before application of 
acetylcholine to the preparations. In the experiments where the influence of 
carbenoxolone and the combined influence of carbenoxolone and ouabain 
were tested, the preparation was pre-exposed for at least 20 min to these 
drugs. 
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3.2.3. Drugs 
Acetylcholine chloride, carbenoxolone, indomethacin, L-NA, ouabain and 
BaCl2 were obtained from Sigma Chemical Co. (St. Louis, Mo). All 
concentrations mentioned are the final molar concentrations in the 
experimental chamber. Stock solutions of 10-2 M acetylcholine were made 
in 50 mM potassium hydrogen phthalate buffer, pH 4.0. Further dilutions 
(1:10 or 1:1000) were made in the control fluid. L-NA, BaCl2, and 
carbenoxolone were dissolved in water while stock solutions of 
indomethacin were made in anhydrous ethanol. Ouabain was added as a 
solid directly to the superfusate. 
 
 
3.2.4. Statistics 
Results are expressed as means ± SEM. Statistical evaluation was 
performed using student’s t test for paired or unpaired data, as appropriate. 
Values of P < 0.05 were considered significantly different. The number of 
preparations, each obtained from a different rat, is indicated as n. 
 
 
3.3. RESULTS 
In control conditions (in the presence of L-NA and indomethacin), the 
resting membrane potential of the mesenteric artery smooth muscle cells 
averaged -60.3 ± 0.9 mV (n = 30). Preliminary experiments showed that 
acetylcholine (3 µM) evoked submaximal hyperpolarizations of the 
membrane potential in these vessels. In endothelium-denuded arteries, the 
membrane potential does not appreciably change after application of 
acetylcholine 22. 
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3.3.1. Influence of carbenoxolone 
In a first series of experiments (n=10), we compared the hyperpolarization 
elicited by acetylcholine (3 µM) in the absence and in the presence of the 
gap junction inhibitor carbenoxolone (figure 1). In control conditions, the 
addition of the endothelium-dependent vasodilator to the superfusate 
induced a hyperpolarization of the smooth muscle cell membrane potential, 
averaging 7.8 ± 0.6 mV, to a peak value of -68.9 + 1.9 mV (n = 10). After 
reaching this peak change, the membrane potential slowly recovered 
towards its control level, recovery of which was accelerated by washout of 
the agonist (figure 1).  
 
 
Figure 1: Tracing of rat mesenteric artery smooth muscle cell membrane potential (Em) 
responses to application of acetylcholine (ACh, 3 µM) in control conditions and after pre-
exposure to carbenoxolone (cbx, 20 µM). 
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Pre-exposure to carbenoxolone (20 µM) did not significantly change the 
resting membrane potential (-61.9 ± 1.8 mV vs -61.6 ± 1.8 mV in this 
subset of experiments, n=10). In the presence of carbenoxolone, the 
hyperpolarization elicited by acetylcholine was significantly decreased. The 
membrane potential reached a peak value of -67.0 ± 1.9 mV, significantly 
different from -68.9 ± 1.9 mV (P < 0.05). The average value for the 
hyperpolarization in the presence of the gap junction inhibitor, 5.1 ± 0.7 mV 
(P < 0.001), represents a reduction to 64.4 ± 6.8 % of that in control 
conditions. 
 
 
3.3.2. Influence of Ba2+ and of Ba2+/carbenoxolone 
In the next series of experiments, the influence of carbenoxolone was 
tested after inhibition of the inward rectifying K+ channels with Ba2+. Pre-
exposure to 200 µM Ba2+ depolarized the resting Em to -50.5 ± 1.1 mV 
(mean depolarization of 9.5 ± 0.8 mV, n = 20). In the presence of the KIR 
inhibitor, the amplitude of the hyperpolarization caused by acetylcholine 
was more than doubled (-17.0 ± 1.0 mV as compared with -7.8 mV; n = 
20)(figure 2). A mean peak value of -67.4 ± 1.3 mV (n=20) was reached, 
being not significantly different from the membrane potential reached in the 
control acetylcholine exposures (-68.9 ± 1.9 mV, P = 0.51).  
After additional pre-exposure to carbenoxolone (20 µM), the 
hyperpolarization induced by acetylcholine was significantly reduced. The 
mean hyperpolarization (-15.4 ± 1.2 mV, n = 7, P < 0.005 from that in Ba2+ 
alone) represents 79.5 ± 3.2 % of the membrane potential response to 
acetylcholine in Ba2+ alone (figure 3). The mean peak value of -64.0 ± 3.0 
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mV was slightly but not significantly less negative than that reached in the 
control exposures (-68.9 ± 1.9 mV) or in Ba2+ alone (-67.4 ± 1.3 mV).  
 
 
 
Figure 2: Smooth muscle cell membrane potential (Em) hyperpolarization induced by 
acetylcholine (ACh, 3 µM) in control conditions and after pre-exposure to Ba2+ (200 µM). 
 
Since carbenoxolone apparently had less influence after inhibition of the KIR 
channels, a next series of experiments was performed with a higher 
concentration of the gap junction inhibitor. 
 
Application of 100 µM carbenoxolone in the continuous presence of Ba2+ 
increased the membrane potential by 3.4 ± 1.2 mV to -57.1 ± 0.7 mV (n=7). 
In the combined presence of 200 µM Ba2+ and 100 µM carbenoxolone, the 
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peak hyperpolarization induced by acetylcholine was reduced from 14.7 ± 
0.5 mV to 9.7 ± 0.9 mV (n = 7; P < 0.001; figure 4), or to 65.3 ± 5.0 % of the 
peak change observed in the absence of carbenoxolone in Ba2+. This 
degree of inhibition is comparable to that observed with the lower 
concentration of carbenoxolone in the absence of Ba2+ (cf. figure 3). The 
peak Em value reached after addition of acetylcholine in the presence of 
carbenoxolone and Ba2+ (-66.8 ± 1.1 mV, n = 7) was not significantly 
different from that in Ba2+ alone (-67.4 ± 1.3 mV).  
 
 
 
Figure 3: Comparison of the influence of carbenoxolone in the absence and the presence of 
Ba2+. The columns represent the hyperpolarization obtained in the presence of 20 µM or 100 
µM carbenoxolone (cbx 20 or 100) before and after pre-treatment with 200 µM Ba2+, as 
indicated by the lower horizontal bar. Values are means ± SEM of 7 to 10 experiments. In 
each experiment, the hyperpolarization observed in the absence of carbenoxolone served 
as the control reference (100%). * P<0.005; ** P<0.001). 
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Figure 4: Recording of the membrane potential (Em) responses to acetylcholine (ACh, 3 µM) 
in the presence of Ba2+ (200 µM) and in the combined presence of Ba2+ and carbenoxolone 
(cbx, 100 µM). Parallel vertical deflections in the trace indicate a moment of microelectrode 
dislodgement and reimpalement. 
 
 
3.3.3. Influence of ouabain and of ouabain + carbenoxolone 
In the next series of experiments, the influence of ouabain (0.5 mM) on the 
acetylcholine-induced hyperpolarization was investigated. In the presence 
of Ba2+, the additional application of ouabain depolarized the membrane 
potential by 4.0 ± 0.8 mV (n = 4). In the combined presence of Ba2+ and 
ouabain, the peak Em change elicited by acetylcholine was reduced to 10.0 
± 1.6 mV as compared with 13.1 ± 1.0 mV in Ba2+ alone. 
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Simultaneous application of ouabain and carbenoxolone (20 µM) in the 
continuous presence of Ba2+ depolarized the smooth muscle cells by 5.7 ± 
0.6 mV (n = 5). In the combined presence of Ba2+, ouabain and 
carbenoxolone, the acetylcholine-induced hyperpolarization was 
significantly reduced to 10.4 ± 2.0 mV (n = 6, P < 0.001) as compared with 
the amplitude measured in the presence of Ba2+ alone (-16.8 ± 2.7 mV, n = 
6). A representative experiment is depicted in figure 5. The peak Em value 
reached after addition of acetylcholine in the combined presence of 
ouabain, carbenoxolone and Ba2+ (-55.8 ± 3.5 mV, n = 6) was significantly 
different (P < 0.02) from that in Ba2+ alone (-67.4 ± 1.3 mV).  
 
 
 
Figure 5: Tracing of the smooth muscle cell membrane potential (Em) responses to 
acetylcholine (ACh, 3 µM) in the presence of Ba2+ and in the combined presence of Ba2+, 
ouabain (oua, 0.5 mM) and carbenoxolone (cbx, 20 µM).  
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3.4. DISCUSSION 
In the present study, we used the KIR channel inhibitor Ba2+ as a possible 
modulator of myoendothelial extracellular K+ concentration, and examined 
the contribution of gap junctional coupling to the acetylcholine-induced 
hyperpolarization. The main findings of the present study are that: (1) 
carbenoxolone partially inhibited the endothelium-dependent 
hyperpolarization elicited by acetylcholine, (2) after inhibition of the KIR 
channels, the acetylcholine-induced membrane potential response was 
more resistant to carbenoxolone, and (3) the combined application of Ba2+ 
and ouabain, either in the absence or in the presence of the gap junction 
inhibitor, did not abolish the acetylcholine-response. 
 
It is generally accepted that the mechanism of endothelium-dependent 
hyperpolarization is heterogeneous and varies among different species and 
vascular beds 1,2. Furthermore, the state of activation of a vessel might 
influence the way hyperpolarization comes about 23. In resting rat hepatic 
and small mesenteric arteries, K+ was proposed as the diffusible EDHF 5,20, 
while stimulated hepatic and mesenteric vessels would rely more on gap 
junctional coupling 5,20. Other studies, however, reported that gap junctions 
play a critical role in endothelium-dependent hyperpolarization of resting rat 
mesenteric arteries 24,25.  
 
In the present findings, carbenoxolone (20 µM) did not abolish the 
acetylcholine-induced membrane potential response to acetylcholine, but 
decreased the peak hyperpolarization by about 35 %. This is consistent 
with earlier relaxation experiments in rat mesenteric arteries 26, in which 
100 µM of the gap junction uncoupler 18α-glycyrhetinic acid (18α-GA) had 
no dramatic inhibitory effect on the endothelium-dependent relaxation. In 
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these arteries a depressed dilatation in response to acetylcholine was 
found with the uncouplers Gap27 (300 µM) and 18α-GA (100 µM) 16. Also 
membrane potential measurements confirm the rather limited effect of gap 
junctional uncouplers on the response to acetylcholine in this vessel. Thus, 
a small reduction (by about 25 %) of the acetylcholine-induced 
hyperpolarization of the vascular smooth muscle cells of resting rat small 
mesenteric arteries was observed with 100 µM of carbenoxolone 19. In this 
vessel the amplitude of the EDHF-mediated hyperpolarization was reduced 
to 33 % of the control after incubation with 300 µM Gap27 24. Another study 
recently described that 100 µM 18α-GA partially inhibited, while 300 µM 
carbenoxolone completely abolished the acetylcholine-induced 
hyperpolarization 25. However, since the endothelium-independent 
hyperpolarization in response to levcromakalim, a direct opener of ATP-
dependent K+ channels, was also inhibited by 300 µM carbenoxolone but 
not by 100 µM 18α-GA 25, the possibility that higher concentrations (300 
µM) of carbenoxolone have non-specific effects might be considered 12,27. 
 
In resting rat hepatic and mesenteric arteries, the endothelium-dependent 
hyperpolarization was described to be largely insensitive to carbenoxolone 
and Gap27 19, and completely inhibited by the combined application of Ba2+ 
and ouabain 19, indicating the importance of stimulation of KIR channels and 
Na/K-pumps by K+ ions liberated from the endothelium. Molecular 
experiments using the RT-PCR technique indicated that messenger RNA 
encoding for a KIR isoform (KIR2.1) is present in rat mesenteric vascular 
smooth muscle cells 28. In a second series of experiments, therefore, we 
examined the influence of Ba2+. Low concentrations of Ba2+ are known to 
block the KIR-current 21 and correspondingly, in the present study, the 
addition of 200 µM Ba2+ significantly depolarized the smooth muscle cell 
membrane. After inhibition of the KIR channels, the magnitude of the 
 89
Chapter 3 
acetylcholine-induced hyperpolarization was doubled. This is consistent 
with earlier results from our laboratory 29. Inhibition of the KIR channels of 
the vascular smooth muscle cells is expected to increase the membrane 
resistance and, therefore, to enlarge the impact of any hyperpolarizing 
current on the membrane potential. However, this decrease in membrane 
conductance is unlikely to double the amplitude of the acetylcholine-
induced hyperpolarization. An additional increase, therefore, results from 
the Ba2+-induced depolarization of the membrane potential, enlarging the 
driving force on K+. This depolarization is unlikely to drastically influence 
Na/K-pump activity since both the inwardly directed Na+ and the outwardly 
directed K+ electrochemical gradients are simultaneously altered. 
Therefore, the substantially increased acetylcholine-induced 
hyperpolarization in the presence of Ba2+ indicates that an EDHF acts by 
opening of a Ba2+-insensitive conductance rather than by pump stimulation. 
The additional application of ouabain, indeed, did not abolish the EDHF 
response, although it was somewhat decreased. These results are fully 
consistent with activation of an outwardly rectifying K+ current, insensitive to 
Ba2+ and (or) ouabain, underlying the hyperpolarization due to EDHF 12. 
 
After stimulation of hepatic and mesenteric arteries with phenylephrine, 
endothelium-dependent membrane potential responses became more 
sensitive to gap junction inhibitors 19. It was proposed, therefore, that the 
activation of Na/K-ATPases and KIR channels was hampered by a 
presumed K+-cloud in the vessel wall, originating from an increased basal 
K+-efflux from the smooth muscle cells in these conditions, and making the 
endothelium-dependent hyperpolarization more dependent on the 
alternative pathway, gap junctional coupling. In the present experiments 
with Ba2+, the reverse might be expected. Thus, on assuming a restricted 
diffusion of extracellular K+-ions within the vessel wall, blocking tonically 
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open KIR channels (as shown by the evoked membrane depolarization) by 
pre-exposure to Ba2+ might be expected to lower the steady state 
extracellular K+ concentration around the smooth muscle cells and, hence, 
to increase any K+ efflux dependent hyperpolarizing mechanism that is 
Ba2+-insensitive when switched on by EDHF. The present finding that, after 
pre-exposure to Ba2+, carbenoxolone was less efficient at inhibiting the 
acetylcholine-response is fully consistent with the view that in these 
conditions the endothelium-dependent hyperpolarization relies to less 
extent on gap junctional coupling. Therefore, the substantially potentiated 
EDHF-mediated hyperpolarization in the continuous presence of Ba2+ might 
also be due, in addition to the above mentioned influence on membrane 
conductance and on membrane potential, to a decreased steady state 
extracellular K+ concentration in the vessel wall. This would both enlarge 
the outward driving force on K+ ions and make more Na/K-pumps available 
for activation by EDHF. However, the experiments in which we additionally 
applied ouabain preclude a substantial role for Na/K-pump activation in the 
response to EDHF. To inhibit all Na/K-ATPase isoforms, high 
concentrations (0.5 mM) of the inhibitor were used 30,31. In the presence of 
Ba2+, the application of ouabain reduced acetylcholine-responses to the 
level observed in control conditions. Also after inhibition of both the gap 
junctional and the membrane inward rectifying K+ conductances by 
simultaneous treatment with carbenoxolone and Ba2+, the additional 
application of ouabain did not abolish endothelium-dependent 
hyperpolarization. These findings are not consistent with Na/K-pump 
activation by endothelially derived K+ ions being the main gap junction-
independent hyperpolarizing mechanism in these resting vessels. In this 
respect, increasing extracellular K+ concentration by 4 or 5 mM was 
previously found to consistently and reproducibly depolarize the smooth 
muscle cells of rat mesenteric arteries at rest 29. 
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Besides some possible contribution of increased Na/K-pumping to the 
EDHF-mediated hyperpolarization, several alternatives might underlie the 
somewhat diminished hyperpolarization after pre-exposure to ouabain. 
First, ouabain might cause a depolarization of the endothelial cell 
membrane, which decreases the driving force for Ca2+ entry upon 
stimulation with the agonist 32,33. Because it is generally accepted that a rise 
in intracellular Ca2+ is a crucial step in the release of endothelial factors 
34,35, a smaller response might be expected under these conditions. A 
second possibility for the inhibitory action of ouabain on the acetylcholine-
response arises from the reported attenuation of intercellular gap junctional 
communication exerted by this substance 36. Furthermore, besides 
decreasing the intracellular K+ concentration, ouabain pre-exposure 
eventually might increase the steady state extracellular K+ concentration in 
the vessel wall, both of which influence the outward gradient for K+ efflux. 
 
In conclusion, we found that gap junctions play some role in the 
endothelium-dependent hyperpolarization of rat small mesenteric arteries. 
Our data also demonstrate that this endothelium-derived hyperpolarization 
does not rely on the activation of KIR channels. Although a minor 
contribution of activation of Na/K-ATPases can not be excluded, our results 
rather point to the activation of an as yet unidentified but Ba2+-resistant 
conductance underlying a significant fraction of the endothelium-dependent 
hyperpolarization. Furthermore, our results are consistent with the 
hypothesis that basal K+ efflux might influence local extracellular K+ 
concentration within the vessel wall, pointing toward K+ channels mediating 
the endothelium-dependent hyperpolarization. It is stressed, however, that 
presumed local accumulations or depletions of extracellular K+ will not only 
influence the steady state activity of the Na/K-pumps (and their capacity to 
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respond to EDHF), but are likely to affect all transmembrane potassium 
fluxes. 
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Abstract 
Objective: In many blood vessels, stimulation of the endothelium with 
various vasoactive substances induces, besides the nitric oxide (NO) and 
prostacyclin pathways, a third mechanism evoking dilatation. It is based 
on hyperpolarization of the vascular smooth muscle cell membrane. In 
the present study, we investigated the existence of endothelium-
dependent hyperpolarization in small gastric arteries of the rat and 
explored its underlying mechanism. Methods: Membrane potentials 
were recorded by conventional microelectrode techniques in isolated 
segments of small gastric arteries, the normalized diameter of which 
was determined from the passive wall tension-internal circumference 
characteristics as measured with a myograph. Results: After blocking 
NO and prostaglandin synthesis, application of acetylcholine (3 x 10-7 M) 
resulted in a membrane hyperpolarization in endothelium intact but not 
in endothelium-denuded arteries. This membrane potential change was 
increased by pre-exposure to a low concentration (30 µM) of Ba2+, which 
selectively inhibits inward rectifying potassium channels. Moreover, the 
acetylcholine-induced hyperpolarization was unaffected by additional 
pre-exposure to high concentrations (0.5 mM) of the Na+/K+- ATPase 
inhibitor ouabain, which by itself caused a secondary slow endothelium-
independent hyperpolarization after an initial peak depolarization. 
Conclusions: We conclude that acetylcholine produces endothelium-
dependent hyperpolarization in gastric small arteries, which does not 
rely on activation of smooth muscle cell inward rectifying K+ channels or 
Na+/K+-pumps, and might prove to be another important regulator of 
gastric mucosal blood flow.    
 
Keywords: blood flow, vascular smooth muscle membrane potential, 
vasoactive agents, endothelial factors  
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4.1. INTRODUCTION 
Gastric mucosal blood flow is of primary importance in maintaining the 
integrity of the mucosa. The blood provides oxygen, nutrients and 
gastrointestinal hormones to maintain mucosal function and turnover. The 
production and secretion of mucus, and the secretion of bicarbonate ions 
which protect the mucosa, are fully dependent on this blood flow. Moreover, 
the circulating blood removes waste materials and back-diffusing hydrogen 
ions. Therefore, disturbances in the mucosal microcirculation can result in 
mucosal injury and influence the development of peptic ulcers 1. 
  
An increase in gastric mucosal blood flow is brought about by dilation of 
submucosal arterioles. Systemic as well as local factors such as 
prostaglandins, leukotrienes and other endogenous chemical mediators of 
the mucosa influence arteriolar tone. Moreover, gastric blood flow is 
substantially increased by stimulation of cholinergic vasodilator nerves, 
within seconds 2, and the reduction in blood flow immediately after 
vagotomy suggests a basal vasodilatory tone exerted by the vagus nerve 3. 
Often, the vasodilators act primarily on the arteriolar endothelial cells to 
stimulate the production of endothelium derived relaxing substances. 
 
During the last two decades, the important paracrine role of the vascular 
endothelium in regulation of blood vessel tone has become increasingly 
clear. Nitric oxide (NO), formed by the constitutive NO synthase (NOS) in 
response to stimulation by acetylcholine and other vasodilators, is a well 
known endothelium-dependent relaxing factor 4,5, also involved in the 
regulation of the gastric mucosal blood flow 6-8. Besides NO, prostacyclin 
(PGI2) is liberated by the endothelial cells upon stimulation with various 
agonists, similarly eliciting vasorelaxation 9. Moreover, in the presence of 
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inhibitors of NOS and prostaglandin synthesis, endothelium-dependent 
dilation persists in most arteries. This NO- and PGI2-independent relaxation 
is associated with a hyperpolarization of the membrane of the vascular 
smooth muscle cells 10,11. Hyperpolarization of the membrane potential 
immediately brings about dilatation of blood vessels 12. It decreases the 
open probability of voltage dependent Ca2+ channels, lowering Ca2+ influx 
13. In addition, it reduces Ca2+ release from internal stores 14 and also 
diminishes the impact of intracellular Ca2+ on the contractile proteins by 
altering their Ca2+ sensitivity 15. 
 
The mechanism underlying the endothelium-dependent hyperpolarization in 
various vessels is still debated (for recent reviews, see refs. 16-18. In hepatic 
and small mesenteric arteries of the rat, a transient rise in K+ concentration 
in the restricted myoendothelial extracellular space, resulting from K+ efflux 
through agonist-induced activation of Ca2+-dependent K+ channels on the 
endothelial cells, was reported 19,20 to act as endothelium derived 
hyperpolarizing factor (EDHF). Indeed, in some vessels, small increases in 
extracellular K+ might influence the inward rectifier and stimulate the 
Na+/K+-ATPases of vascular smooth muscle cells, producing the expected 
membrane potential change. In the superior mesenteric artery of the rabbit, 
however, it was shown that acetylcholine-induced EDHF-mediated 
relaxation requires the transfer of a cytosolic factor from the endothelial 
cells to the smooth muscle cells via heterocellular gap junctions 21. In 
smaller arteries, such as intestinal submucosal arterioles, the flow through 
gap junctions of hyperpolarizing current from endothelial cells might be 
sufficient to hyperpolarize the electrotonically coupled smooth muscle cells 
22,23. It appears, therefore, that different hyperpolarizing mechanisms may 
exist in different vascular beds. Moreover, the smooth muscle cells of some 
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arteries such as the femoral artery of the rat are devoid of endothelium-
dependent hyperpolarization responses 24.   
 
In previous tension measurements, we showed endothelium-dependent, 
NO- and PGI2-independent vasorelaxations to occur in isolated small 
gastric arteries stimulated with acetylcholine 25. In the present study, we 
extended these observations by directly measuring the membrane potential 
responses of the gastric arteriolar smooth muscle cells to acetylcholine 
using electrophysiological techniques. Moreover, the endothelium-
dependent hyperpolarization was further characterized by investigating the 
involvement of inward rectifying K+ channels and Na+/K+-ATPases by the 
use of the blockers Ba2+ and ouabain, respectively. To the best of our 
knowledge, this study reports the first detailed measurements of 
endothelium-dependent membrane potential responses in small gastric 
arteries.  
 
 
4.2. MATERIALS AND METHODS 
 
4.2.1. Animals 
Young female Wistar rats (200-250 g body weight) were purchased from 
Iffa Credo (Brussels, Belgium). The animals were treated in accordance 
with the Guide for the Care and Use of Laboratory Animals published by 
the US National Institutes of Health (NIH Publication No 85-23, revised 
1996).  
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4.2.2. Preparation 
Experiments were approved by the ethical committee on animal research of 
Ghent University. Animals were killed with an intraperitoneal injection of a 
lethal dose (200 mg/kg) of pentobarbitone and laparotomized. The stomach 
was rapidly excised and transferred to a chilled medium of the following 
composition (mM): NaCl 135, KCl 5, NaHCO3 20, CaCl2 2.5, MgSO4.7H2O 
1.3, KH2PO4 1.2, EDTA 0.026 and glucose 10, gassed with 95% O2, 5% 
CO2.  Several segments of first and second order branches of the gastric 
artery were dissected and transferred to fresh oxygenated medium. After 
removal of the adherent tissue, one of these segments was reduced to 1.5 
mm, taking care not to injure the endothelium, and transferred to a small 
recording chamber where it was continuously superfused at 35 °C with 
control fluid. The control fluid consisted of the isolation medium 
supplemented with NG-nitro-L-arginine (10-4 M) and indomethacin (5 x 10-5 
M), to exclude interference from NO and prostanoids, respectively. In some 
experiments, the endothelium was removed from the arteries by rubbing 
the intimal surface.   
 
For electrophysiological recordings, the preparation was pinned down to 
the silicone bottom of the experimental chamber using small pins. Near 
both attachment sides, the vessel was incised such as to facilitate later 
access of acetylcholine to the endothelium. After mounting, the vessel 
segment was allowed to equilibrate for at least 60 min before starting the 
microelectrode impalements. Microelectrode penetrations were performed 
from the adventitial side. At the end of the experiments, some representative 
vessels were moved to an automated wire myograph (model 500A, JP 
Trading, Aarhus, Denmark) in order to calculate their internal diameter. For 
this purpose, two stainless steel wires were guided through the lumen, one 
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was connected to a force transducer and the other fixed to a micrometer, and 
the passive wall tension-internal circumference characteristics were 
determined. From this relation, the mean internal diameter of these vessels at 
an effective transmural pressure of 100 mm Hg was calculated according to 
the method of Mulvany and Halpern 26.  
 
 
4.2.3. Electrophysiological measurements 
Transmembrane potentials were measured with standard microelectrode 
techniques, as described previously 27,28. Briefly, conventional micro-
electrodes were pulled with a vertical pipette puller (David Kopf, model 750, 
Tujunga, CA) from 1 mm o.d. filamented glass tubings (Hilgenberg, 
Germany). Micropipettes were filled with 1 M KCl and connected to the input 
stage of a laboratory made MOS/FET operational amplifier. The electrical 
resistance of the microelectrodes, measured in the normal Krebs-Ringer 
solution, ranged from 40 to 80 MΩ. The measured potential was followed on 
an oscilloscope and traced with a pen recorder at low speed. Absolute values 
of membrane potential were taken as the difference of the stabilized potential 
after cell impalement and the zero potential upon withdrawal of the 
microelectrode from the cell. Changes in membrane potential produced by 
applications of acetylcholine in control conditions and after experimental 
intervention (Ba2+, ouabain) were usually measured in the same cell during 
continuous recordings. Barium chloride was added to the superfusate for at 
least 10 min before challenging the preparations with acetylcholine. With 
ouabain, pre-exposure time was minimally 5 min but varied between 
experiments, as described in the Results. Exposures to Ba2+ and 
acetylcholine were made by addition of these substances from the 
appropriate stock solutions to the superfusion solution.  
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4.2.4. Chemicals 
Indomethacin, L-NA, acetylcholine chloride, ouabain and barium chloride 
were obtained from Sigma (St. Louis, MO). All concentrations are expressed 
as final molar concentrations in the superfusion chamber. Stock solutions of 
L-NA and BaCl2 were made in pure water, indomethacin was dissolved in 
anhydrous ethanol. Acetylcholine was dissolved in 50 mM potassium 
hydrogen phthalate buffer, pH 4.0, as a 10-2 M solution. Further dilutions (1:10 
or 1:100) were made in the control fluid immediately before addition of 
aliquots to the superfusate. Ouabain was dissolved directly in the warmed 
superfusion solution. 
 
 
4.2.5. Statistics  
Results are expressed as means + SEM. Statistical significance was evalua-
ted using Student's t test for paired or unpaired observations, as appropriate, 
a P value < 0.05 indicating a significant difference; n indicates the number of 
preparations, each obtained from a different animal. 
 
 
4.3. RESULTS 
The small gastric arteries used in this study had an average normalized 
diameter (at a transmural pressure of 100 mm Hg) of 214 ± 26 µm, as 
determined in 4 preparations at the end of the experiments (see Materials 
and Methods).  Smooth muscle cells of such arteries, superfused wih the 
normal L-NA (10-4 M) and indomethacin (5x10-5 M) containing Krebs-Ringer 
solution, had a stable resting membrane potential with a mean value of -
64.5 ± 1.3 mV (n=15).  
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Exposure of intact vessels to a submaximal concentration of acetylcholine 
(3x10-7 M), a concentration previously shown to relax norepinephrine 
preconstricted gastric arteries by about 50% of the developed active 
tension, induced a transient peak hyperpolarization of 5.1 ± 0.6 mV (n=14). 
In the continuous presence of the vasodilator, the membrane potential 
slowly recovered towards its control level. Recovery was accelerated by 
washout of the agonist (figure 1A).  
 
 
 
 
Figure 1: Endothelium-dependent hyperpolarization induced by acetylcholine (ACh). Typical 
tracings of the membrane potential (Em) recorded in smooth muscle cells from small gastric 
arteries during application of 0.3 µM ACh in the presence (A, C) and the absence (B) of a 
functional endothelium (E) and after pre-exposure to 30 µM of Ba2+, an inhibitor of inward 
rectifying K+ channels (C). Notice the larger endothelium-dependent membrane potential 
response in the presence of Ba2+. 
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In endothelium-denuded arteries (cf. figure 1B) the smooth muscle cells 
had a mean resting membrane potential not significantly different from the 
control vessels (-65.0 ± 3.1 mV, n=4). Hyperpolarization of the membrane 
potential did not occur after exposing endothelium-denuded arteries to 
acetylcholine. 
 
In a next series of experiments (n=8), the influence on the membrane 
potential and its response to acetylcholine of pre-exposure to low 
concentrations of Ba2+, known to inhibit the inward rectifying K+ channels, 
was tested. Figure 1C shows an original trace from a representative 
experiment. Superfusion with 30 µM Ba2+ containing fluid caused a 
depolarization of the resting membrane potential by 5.6 ± 0.5 mV. Pre-
exposure to this inhibitor, however, did not decrease the magnitude of the 
endothelium-dependent hyperpolarization elicited by acetylcholine. 
Conversely, in this series of experiments an increase of the endothelium-
dependent hyperpolarization was observed. The peak hyperpolarization 
induced by acetylcholine in the presence of Ba2+ averaged 6.2 ± 0.8 mV, 
vs. 4.7 ± 0.6 mV in control conditions in this subset of arteries. This 
difference is statistically significant (p < 0.05). 
 
Application of a large concentration (0.5 mM) of ouabain in the continuous 
presence of Ba2+ produced a transient peak depolarization followed by a 
slow return of the membrane potential towards baseline. Traces from two 
succesfull long-term impalements in which the microelectrode was kept in a 
cell for several hours are shown in figure 2A and 2B. Due to the more 
compressed time scale used to construct these figures, acetylcholine-
induced hyperpolarizations merely appear as inverted peaks. 
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Figure 2: Influence of additional pre-exposure to the Na+/K+-ATPase inhibitor ouabain. 
Original recordings of the membrane potential (Em) recorded in smooth muscle cells of small 
gastric arteries, showing its responses to superfusion with acetylcholine (0.3 µM) containing 
fluid (as indicated by the short horizontal lines) in control conditions, in the presence of Ba2+ 
(30 µM), and during and after additional exposure to ouabain (0.5 mM). 
 
 
Ouabain depolarized the smooth muscle cells by 6.4 ± 0.7 mV (n=8). When 
acetylcholine was applied shortly after exposure to ouabain, at a time when 
the membrane potential was still more depolarized with respect to its level 
in Ba2+ alone (cf. figure 2A and 2B), the endothelium-dependent 
hyperpolarization averaged 7.0 ± 1.7 mV (n=4), a value not significantly 
different from that observed in the absence of ouabain. After prolonged pre-
exposure to ouabain, acetylcholine still evoked membrane 
hyperpolarization, averaging 4.3  ± 0.8 mV (n=4), a value slightly but not 
significantly smaller than that observed in the absence of ouabain. Effective 
inhibition of the Na+/K+-pump by ouabain was additionally demonstrated by 
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the transient hyperpolarizations of the smooth muscle cells after washout of 
the drug, being, evidently, more important with increasing exposure time to 
the inhibitor (figure 2A and 2B). From all ouabain experiments, the mean 
values for the resting membrane potential before application of 
acetylcholine and for the magnitude of the peak vasodilator-induced 
hyperpolarization are summarized in figure 3. In the combined presence of 
Ba2+ and ouabain, the endothelium-dependent hyperpolarization evoked by 
acetylcholine was not significantly different from that in Ba2+ alone, or from 
that in control conditions. 
 
 
Figure 3: Acetylcholine-induced hyperpolarizations of gastric artery smooth muscle cells in 
control conditions (Co), in the presence of barium (Ba2+, 30 µM) and after additional 
application of ouabain (Ba2+/ouabain). Data are means + SEM (n=8) and represent the 
membrane potential (Em) values before and after application of acetylcholine. * Significantly 
different from control value (P<0.05). 
 
It might be argued that the rather unexpected secondary hyperpolarization 
of the membrane potential in the continuous presence of 0.5 mM ouabain is 
due to incomplete inhibition of all membrane Na+/K+-ATPases, some 
 108
Endothelium-dependent hyperpolarization in gastric arteries 
residual pump activity being stimulated by the rise in intracellular sodium 
concentration caused by the inhibited pumps. To test this possibility, the 
ouabain concentration was doubled during the slow hyperpolarization 
phase in some experiments. Increasing the concentration of the glycoside 
from 0.5 to 1 mM did not further depolarize the membrane or otherwise 
modify the course of the slow hyperpolarization (figure 4A). Moreover, the 
slow membrane potential change in the presence of ouabain was 
independent of an intact endothelium, as depicted in figure 4B (n=4).  
 
 
Figure 4: Typical tracings showing the effect of doubling the ouabain concentration (A) and 
of endothelium (E) removal (B) on the membrane potential (Em) of gastric artery smooth 
muscle cells. Vessels were exposed to Ba2+ (30 µM) throughout. Short horizontal lines in A 
show times of application of acetylcholine (0.3 µM). 
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4.4. DISCUSSION 
The membrane potential of the smooth muscle cells is an important 
determinant of arterial tone 12. In this study, the resting membrane potential 
of smooth muscle cells of small gastric arteries was measured, and the 
membrane response to cholinergic stimulation of the intact vessel was 
quantified and characterized.  
 
A physiological concentration (3x10-7 M) of acetylcholine, previously shown 
to relax norepinephrine-stimulated arteries in an NO- and prostacyclin-
independent way to about 50 % of their preconstriction level, caused a 5 
mV hyperpolarizing shift of the smooth muscle cell membrane potential 
from a resting level of about -65 mV. The experiments with the 
endothelium-denuded arteries showed that the acetylcholine-induced 
hyperpolarization was completely endothelium-dependent, and that the 
agonist did not exert a direct depolarizing action on the smooth muscle 
cells as has been reported for some arteries.  These direct measurements, 
therefore, confirm the existence of endothelium-dependent 
hyperpolarization in gastric arteries, as has been suggested from earlier 
tension measurements 25,29. 
 
The magnitude of the membrane potential response to the submaximal 
acetylcholine concentration might seem relatively small. However, it should 
be noted that a change in membrane potential of just a few millivolts can 
result in a substantial change in vessel diameter 30. In rat mesenteric 
arteries in the presence of NG-nitro-L-arginine, an acetylcholine induced 
hyperpolarization of 1 mV corresponded to a 4.3 % decrease of the induced 
tone 31. This implies, therefore, that the endothelium-dependent 
hyperpolarization as measured in the present study makes an important 
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contribution to the regulation of the diameter of small gastric arteries in situ. 
Moreover, alterations of the membrane potential generally evoke faster 
changes in arteriolar diameter than those mediated by second messengers, 
which more slowly influence gastric blood flow. 
 
Low concentrations of Ba2+ are known to specifically block the inward 
rectifier K+ current in vascular tissue. In the present conditions, we found 30 
µM of Ba2+ to significantly depolarize the smooth muscle cells of small 
gastric arteries, indicating that the inward rectifier contributes to the setting 
of the resting membrane potential in these vessels. After inhibition of the 
inward rectifyer, however, endothelium-dependent smooth muscle cell 
responses to submaximal concentrations of acetylcholine were not inhibited 
but significantly increased. This excludes a role for inward rectifying K+ 
channels in the acetylcholine-induced endothelium-dependent 
hyperpolarization of small gastric arteries. It also suggests that in tonically 
contracted vessels, in which the membrane potential is similarly 
depolarized with respect to resting conditions, endothelium-dependent 
hyperpolarization might be larger than observed in the resting arteries as 
used in the present study. The increased response might be due to the 
enhanced driving force on intracellular K+ after Ba2+-induced depolarization, 
or to the diminished total membrane conductance after blocking the open 
K+ channels with Ba2+, enlarging the impact of any hyperpolarizing current 
on the smooth muscle cell membrane potential. With submaximal 
concentrations of acetylcholine, this current is not expected to drive the 
membrane potential to values as negative as EK, explaining the less 
negative absolute level of membrane potential after the Ba2+-induced 
depolarization. Similarly, in smooth muscle cells from guinea-pig coronary 
arteries, 100 µM BaCl2 increased EDHF-attributed hyperpolarization 32, 
while in cells of ilial submucosal arterioles and of mesenteric arterioles of 
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the same species 500 µM Ba2+ was used to depolarize the membrane 
potential away from the K+ equilibrium potential in order to observe 
significant endothelium-dependent hyperpolarizations after application of 
acetylcholine 22,33. 
 
In gastric arteries, the additional inhibition of the Na+/K+-pump with 0.5 mM 
ouabain further depolarized the smooth muscle cells, as expected from the 
sudden loss of electrogenic pump activity. Since the Kd value for ouabain of 
the ubiquitous low affinity α1-isoform containing Na+/K+-ATPase in rat tissue 
is about 15 µM 34, and the other isoenzymes are much more sensitive to 
the cardiotonic steroid 35, it can reasonably be assumed that in the present 
conditions all pump isoenzymes are effectively inhibited by 0.5 mM of the 
cardiotonic steroid. In mesenteric arteries of the rat, the vasodilation 
occurring on readmission of K+ ions after K+-free perfusion was completely 
inhibited by 100 µM of ouabain 36. Moreover, in the present study the 
complete inhibition of Na+/K+-ATPase activity by 0.5 mM ouabain was 
directly verified by the lack of additional depolarization on doubling the 
ouabain concentration.  
 
In the combined presence of barium and ouabain, the magnitude of the 
endothelium-dependent hyperpolarization induced by acetylcholine was not 
significantly changed. These observations strongly suggest that small 
gastric artery smooth muscle cells do not rely on their inward rectifiers and 
Na+/K+-pumps to produce this hyperpolarization. In a previous study, it was 
found that small increases in extracellular K+ concentration were unable to 
consistently relax preconstricted gastric arteries 25. Taken together, these 
findings argue against a role for extracellular K+ to act as an EDHF in this 
preparation.  
 
 112
Endothelium-dependent hyperpolarization in gastric arteries 
In the prolonged presence of ouabain, the membrane potential slowly 
became more hyperpolarized than before exposure to the cardiotonic 
glycoside, in an endothelium-independent way. A plausible explanation for 
this observed shift is that the ouabain-induced rise in intracellular Na+ 
concentration leads, via an influence on the Na/Ca exchanger, to a 
secondary rise in intracellular Ca2+ concentration, as has been documented 
in several cell types. This raised Ca2+ is expected to subsequently open the 
Ca2+-dependent K+ channels of the smooth muscle cell. In the pancreatic B-
cell, e.g., ouabain was shown to increase 86Rb (used as a tracer for K+) 
outflow 37. Thus, a gradually increasing membrane K+ conductance might 
explain both the slow hyperpolarization as well as the observed tendency 
for the endothelium-dependent hyperpolarization to decrease in magnitude 
after prolonged ouabain exposure. 
 
In a previous study, shorter exposures to ouabain were found to inhibit the 
EDHF-mediated relaxation of gastric arteries 25. The present measurements 
showing that the endothelium-dependent hyperpolarization of the vascular 
smooth mucle cells is not affected by the pump inhibitor suggest, therefore, 
a defective coupling between the change in membrane potential and the 
mechanical response, presumably involving a hampered Ca2+ extrusion. 
Moreover, they stress the importance of electrophysiological 
measurements when studying the EDHF phenomenon 38. 
 
In summary, we have shown that acetylcholine hyperpolarizes the 
membrane potential of the vascular smooth muscle cells of small gastric 
arteries. This electrical change, expected to exert a substantial influence on 
vessel tone and resistance, is entirely dependent on an intact endothelium, 
but independent from the endothelial NO/prostacyclin pathways. The 
mechanism underlying the endothelium-dependent hyperpolarization does 
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not seem to rely on the stimulation of inward rectifying K+ channels or 
Na+/K+-pumps, as was shown for rat hepatic arteries. Endothelium-
dependent hyperpolarization might prove to be another important and rapid 
regulator of gastric mucosal blood flow, of utmost importance in the 
maintenance of mucosal function and integrity. 
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Abstract 
 
Endogenous as well as synthetic cannabinoids have potent vasodilatory 
actions in a variety of vascular preparations. Their precise mechanism of 
action is as yet unclear but several studies point to the activation of type 
1 vanilloid (TRPV1) receptors on primary afferent perivascular nerves, 
stimulating the release of calcitonin gene-related peptide (CGRP). Given 
the documented gastroprotective function of these nerves, and the 
various gastrointestinal effects reported for cannabinoids, we explored a 
possible link between these systems in the gastric circulation by 
comparing responses of small gastric arteries to cannabinoids and to 
CGRP using conventional microelectrode techniques. Exposure of small 
gastric arteries to the stable endocannabinoid analogue 
methanandamide caused a hyperpolarization of the vascular smooth 
muscle cells, which was completely abolished by the vanilloid receptor 
antagonist capsazepine (p<0.01). Exposure to exogenous CGRP evoked 
fully reproducible (p>0.05) hyperpolarizations with similar time course, 
unaffected by capsazepine. Preincubation with glibenclamide, an 
inhibitor of ATP-sensitive potassium (KATP) channels, reversed both 
responses to methanandamide (p<0.01) and CGRP (p<0.05). Similar 
results were found in rat mesenteric arteries. These findings show that 
cannabinoids stimulate TRPV1 receptors, presumably causing the release 
of CGRP, which hyperpolarizes the smooth muscle cells by activation of 
KATP channels. Since membrane hyperpolarization is a powerful mediator 
of vasorelaxation, this novel pathway might prove to be an important 
mechanism affording gastroprotection. 
 
Keywords: vascular smooth muscle membrane potential, vasoactive 
agents, endothelial factors, blood flow, cannabinoids
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5.1. INTRODUCTION 
Plant derived, synthetic as well as endogenous cannabinoids have a 
pronounced influence on gastrointestinal motility and secretion 1-4. Effects 
reported for stimulation of type I cannabinoid receptors (CB1) include 
inhibition of gastric acid secretion and reduction of the development of 
stress-induced gastric ulcers in rats 5,6. The integrity of the gastric mucosa, 
however,  also depends on an appropriate microcirculatory blood flow. 
Indeed, the production and secretion of mucus, and the secretion of 
bicarbonate ions which protect the mucosa, are fully dependent on this 
circulation. Moreover, the blood removes waste materials and back-
diffusing hydrogen ions. Disturbances in the mucosal microcirculation 
therefore lead to mucosal injury and peptic ulcers 7. Among the defence 
mechanisms, a group of sensory neurons originating from the dorsal root 
ganglia constitute a separate alarm system in the stomach 8. They express 
type 1 vanilloid (TRPV1) receptors, which are activated by noxious stimuli 
including molecules with a vanillyl moiety such as capsaicin, but also by 
heat and protons. Stimulation of this receptor triggers the local release of 
neuropeptides from their peripheral endings, the most important of which is 
the powerful vasodilator calcitonin gene related peptide (CGRP) 9. CGRP 
containing nerves are also present in the human gastric mucosa, and with 
increased density at the margin of ulcers 10. The gastroprotective role of 
CGRP released from sensory nerves has been shown in various studies, 
and results from the rise in mucosal blood flow the peptide produces11-13. 
CGRP might act directly on the vascular smooth muscle cells and/or 
stimulate the endothelium to release relaxing substances such as nitric 
oxide (NO), prostacyclin and the as yet unidentified endothelium-derived 
hyperpolarizing factor (EDHF) 14,15. 
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Since the original observation that vasorelaxation by cannabinoids can be 
mediated by stimulation of TRPV1 receptors on CGRP containing 
perivascular nerves 16, several recent studies have documented TRPV1 
stimulation by the endogenous CB1 agonist anandamide, and stressed that 
the agent should be considered both an endocannabinoid and an 
endovanilloid 17,18. In a previous study, we showed that the cannabinoids 
anandamide and its stable derivative methandamide produce a substantial 
hyperpolarization of smooth muscle cells of isolated small mesenteric rat 
arteries, an effect attributed to cannabinoid-induced release of CGRP from 
the perivascular nerves 19. CGRP-induced hyperpolarization of vascular 
smooth muscle cells, indeed, immediately brings about dilation of the blood 
vessels. 
 
Given the documented important role played by primary afferent nerves in 
the gastric mucosa, we explored the influence of cannabinoids on the 
membrane potential of smooth muscle cells in isolated small gastric 
arteries, compared this with their response to exogenous CGRP, and 
investigated the involvement of TRPV1 receptors using the specific 
antagonist capsazepine. Their effect was compared with that of the 
endothelium-dependent vasodilator acetylcholine. To the best of our 
knowledge, this study reports the first detailed measurements of membrane 
potential responses to cannabinoids and to CGRP in gastric arteries. It 
shows that cannabinoids locally stimulate TRPV1 receptors releasing a 
substance like CGRP, which hyperpolarizes the blood vessels by opening 
ATP-dependent potassium channels. This local action of cannabinoids 
might prove to constitute an alternative pathway affording gastroprotection.  
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5.2. MATERIALS AND METHODS 
 
5.2.1. Preparations 
Small gastric and mesenteric arteries from female Wistar rats (180 – 280 g) 
were used. The animals were treated in accordance with the Guiding 
Principles in the Care and Use of Animals and the experiments were 
approved by the ethical committee on animal research of Ghent University. 
The animals were anesthetized by a lethal dose (200 mg kg-1) of 
pentobarbitone and killed by cervical dislocation. Both the stomach and the 
mesentery were rapidly excised and placed in cold (4°C) normal Krebs-
Ringer bicarbonate solution, bubbled with a 95% O2 – 5% CO2 gas mixture. 
Second and third order branches of the gastric and mesenteric arteries 
were dissected free and transferred to fresh and gassed medium, where 
they were cleaned from surrounding connective tissue and cut into 
segments of about 2 mm in length.  
 
 
5.2.2. Tension measurements 
For tension measurements, the arterial segments were mounted into the 
organ bath of an automated dual small-vessel myograph (model 500 A; J. 
P. Trading, Aarhus, Denmark), filled with 10 ml Krebs-Ringer bicarbonate 
solution. Two stainless steel wires (40 µm in diameter) were guided through 
the lumen of the segments. Each wire was fixed to a holder of the 
myograph: one holder was connected to a micrometer which was used to 
change the distance between the wires, the other holder was connected to 
a force-displacement transducer to measure the isometric tension changes. 
After mounting, the preparations were allowed to equilibrate for at least 30 
min in warmed (37 °C), oxygenated (5% CO2 in O2; pH 7.4) Krebs-Ringer 
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bicarbonate solution. At the start of each experiment the vessels were 
stretched to their optimal lumen diameter for active force development, as 
calculated on the basis of the passive wall tension-internal circumferences 
relationship 20. Subsequently, the arteries were repeatedly activated with a 
Krebs-Ringer bicarbonate solution containing 120 mM K+ and 10-5 M 
norepinephrine to assess maximal contractility. After this preparation 
procedure, the gastric arteries were contracted by adding 10-5 M 
norepinephrine to the standard Krebs-Ringer bicarbonate solution in the 
organ bath. When a stable contraction was reached, a concentration-
response curve was constructed by cumulative additions of 
methanandamide.  
 
 
5.2.3. Electrophysiological measurements 
For the membrane potential measurements, the isolated segments were 
pinned down to the silicone bottom of an experimental chamber and were 
continuously superfused with warmed (35 °C), oxygenated (5% CO2 in O2; 
pH 7.4) Krebs-Ringer solution, supplemented with NG-nitro-L-arginine (L-
NA, 10-4 M) and indomethacin (5 × 10-5 M) to rule out the interference of NO 
and prostanoids, respectively. After mounting, the preparations were 
allowed to equilibrate for at least 60 min before starting the 
electrophysiological measurements. 
 
Membrane potentials of the vascular smooth muscle cells were measured 
using standard microelectrode techniques as described previously 21,22. 
Conventional sharp microelectrodes were pulled from filamented 
borosilicate glass tubings (Hilgenberg, Germany) with a vertical pipette 
puller (David Kopf Instruments, Tujunga California). Micropipettes were 
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filled with 1 M KCl. Their electrical resistance, measured in normal Krebs-
Ringer solution, ranged from 40 to 80 MΩ. The measured potential was 
monitored on an oscilloscope and traced with a pen recorder. Successful 
impalements of the vascular smooth muscle cells were characterized by a 
sharp voltage deflection on entering the cell and a fast return to the 
baseline upon dislodgement of the microelectrode from the cell. Absolute 
values for the membrane potential (Em) were taken as the difference of the 
stabilized potential after cell impalement and the zero potential as obtained 
upon electrode dislodgement. At the beginning of each experiment, the 
presence of a functional endothelium was assessed by the ability of 
acetylcholine (3 µM) to induce a substantial hyperpolarization. Changes in 
membrane potential produced by application of anandamide (10 µM), 
methanandamide (10 µM), CGRP (3 × 10-9 M) or acetylcholine (3 µM) in 
control conditions and in the presence of various inhibitors (capsazepine, 3 
µM; glibenclamide, 10 µM) were measured. Given the technical difficulty of 
the experiments and the limited time period a cell impalement could be 
maintained, only one concentration of the respective dilator was tested. 
Glibenclamide was added to the superfusate for at least 10 min before 
application of a vasodilator, whereas in the experiments in which the 
influence of capsazepine was tested, pre-exposure time was minimally 20 
min. All tested agents were added from the appropriate stock solutions to 
the superfusate. 
 
 
5.2.4. Chemicals 
All experiments were performed in a Krebs-Ringer bicarbonate solution of 
the following composition (in mM): NaCl 135, KCl 5, NaHCO3 20, CaCl2 2.5, 
MgSO4.7H2O 1.3, KH2PO4 1.2, EDTA 0.026 and  glucose 10. Acetylcholine 
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chloride, anandamide, indomethacin, L-NA, norepinephrine, capsazepine 
and glibenclamide were purchased from Sigma-Aldrich (St. Louis, MO). 
Methanandamide was obtained from two different sources: Research 
Biochemicals International (Natick, MA) and Tocris (Bristol, UK). CGRP 
was obtained from Tocris (Bristol, UK). Acetylcholine was dissolved in 50 
mM potassium hydrogen phtalate buffer, pH 4.0. L-NA, norepinephrine and 
CGRP were dissolved in water; indomethacin, anandamide, 
methanandamide and capsazepine in anhydrous ethanol and glibenclamide 
in dimethyl sulfoxide. All concentrations mentioned are expressed as final 
molar concentrations in the experimental chamber. 
 
 
5.2.5. Statistics 
Data were computed as means ± S.E.M. and evaluated statistically using 
student’s t-test for paired or unpaired samples or repeated measures 
ANOVA with Bonferroni’s post hoc test when appropriate. A p value < 0.05 
indicates a significant difference. n represents the number of preparations 
tested, each obtained from a different rat. In the tension measurements, 
relaxation is expressed as the percentage decrease in norepinephrine-
induced tone. 
 
 
5.3. RESULTS 
 
5.3.1. Tension measurements 
The small gastric arteries as used in the present relaxation measurements 
had a mean normalized diameter of 307.4 ± 28.5 µm (n=5). After 
norepinephrine (10-5 M) had induced a stable contraction (10.2 ± 1.8 mN; 
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n=5), cumulative addition of the anandamide analogue methanandamide 
(from 10-7 M to 10-5 M) elicited concentration-dependent relaxations (n=5; 
figure 1). Since hyperpolarization is one mechanism to induce relaxation, 
we further performed electrophysiological measurements to investigate and 
characterize the influence of the cannabinoid on the smooth muscle 
membrane potential of gastric arteries. 
 
 
 
Figure 1: Relaxation induced by methanandamide in rat gastric arteries. Concentration-
response curve for methanandamide (n=5) in arteries precontracted with norepinephrine. 
Relative responses are expressed as the percentage relaxation induced by the cannabinoid. 
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5.3.2. Electrophysiological measurements 
 
5.3.2.1. Characterization of the membrane electrical response 
to the cannabinoid methanandamide and to CGRP 
 
In the continuous presence of L-NA (10-4 M) and indomethacin (5 × 10-5 M), 
smooth muscle cells of rat small gastric arteries had a stable resting 
membrane potential with a mean value of –54.7 ± 1.2 mV (n=23). 
 
The addition of acetylcholine (3 µM) evoked hyperpolarizations peaking 
within the first 2 min of application at a mean level 7.9 ± 1.4 mV (n=7) more 
negative than the resting membrane potential. In the presence of 
acetylcholine, membrane potential slowly recovered towards its control 
level. A typical tracing is depicted in figure 2.  
 
After washout of the agonist, the membrane potential quickly recovered to 
its initial level. After exposure of intact vessels to methanandamide (10 µM), 
the membrane potential rather slowly hyperpolarized by a mean value of 
8.5 ± 1.2 mV. The maximal change was reached 8.8 ± 0.9 min (n=4) after 
application of the cannabinoid. As can be seen more clearly in figure 3A, in 
which continuous recordings from the same cell are shown, the membrane 
potential recovered very slowly from exposure to methanandamide. 
Moreover, a second application of the cannabinoid after a washout period 
of at least 30 min hardly evoked any electrical response (+1.3 ± 1.3 mV 
upon second exposure vs –3.7 ± 0.5 mV at first exposure in this subset of 3 
experiments; p<0.05).  
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Figure 2: Original tracing of the membrane potential (Em) recorded in a vascular smooth 
muscle cell of a small gastric artery, showing the different time course of the 
hyperpolarization elicited by acetylcholine (ACh, 3 × 10-6 M)and methanandamide (METH, 
10-5 M). During the break in the trace, the artery was continuously superfused with the 
control fluid for about 30 min without dislodgement of the microelectrode from the cell. 
 
 
The application of calcitonin gene related peptide to the vessels produced 
hyperpolarizations of the membrane potential comparable to those obtained 
with methanandamide (figure 3B). With 3 × 10-9 M a mean change of –8.8 ± 
1.8 mV (n=5) was observed. As was observed with the cannabinoid, the 
membrane potential slowly recovered toward its control level after washout 
of the peptide. However, the effect of CGRP was fully reproducible. A 
second exposure of the preparations to CGRP, after a washout period of at 
least 20 min, caused a hyperpolarization of -8.5 ± 0.7 mV (n=5; p>0.05) 
(figure 3B). CGRP also hyperpolarized vessels which were previously 
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exposed to methanandamide. A representative tracing is shown in figure 
3A. 
 
 
Figure 3: Original long-term recordings of the membrane potential (Em)  recorded in 
vascular smooth muscle cells of small gastric arteries, showing substantial hyperpolarization 
in response to CGRP (3 × 10-9 M) after a first application and washout of (A) 
methanandamide (METH, 10-5 M) or (B) CGRP (3 × 10-9 M). Notice the reproducibility of the 
response to CGRP. 
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5.3.2.2. Influence of blocking the TRPV1 receptor 
In a next series of experiments, we investigated the influence of 
capsazepine, a selective antagonist of the TRPV1 receptors, on 
hyperpolarizations induced by methanandamide and CGRP. Incubation 
with capsazepine (3 µM) slightly depolarized the resting membrane 
potential of the vascular smooth muscle cells (1.3 ± 1.3 mV). In the 
presence of the antagonist, the response to methanandamide was 
completely abolished (0.0 ± 0.0 mV; n=4; p<0.01). A representative tracing 
is shown in figure 4A, while the mean values are given in figure 5A. The 
hyperpolarization induced by acetylcholine in these preparations was 
completely unaffected (-7.0 ± 2.7 mV; n=4) (figure 4A, 5A).  In contrast to 
the methanandamide-induced response, the hyperpolarization induced by 
exogenous CGRP was totally  unaffected by preincubation with 
capsazepine (-6.9 ± 1.1 mV vs –6.8 ± 1.2 mV in control conditions; n=4; 
p>0.05; or vs –7.3 ± 0.8 mV in all control experiments; n=14; p>0.05) 
(figure 4A, 5A). 
 
 
5.3.2.3. Effect of glibenclamide 
In a separate series of experiments, the role of ATP-sensitive potassium 
(KATP) channels in the membrane electrical response to CGRP, 
methanandamide and acetylcholine was investigated using the selective 
inhibitor glibenclamide (10 µM). In the presence of glibenclamide, the 
hyperpolarizing responses to CGRP and to methanandamide were 
completely abolished (figure 4B). In fact, the mean membrane potential 
change obtained from 4 experiments in which CGRP was tested (figure 5B) 
was a slight depolarization of the resting potential (2.1 ± 1.2 mV, p<0.05). 
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Similar findings were obtained with methanandamide. In the presence of 
glibenclamide, the cannabinoid significantly (p<0.01) depolarized the 
smooth muscle cells (1.1 ± 0.4 mV, n=4, figure 5B). Conversely, 
hyperpolarizations in response to acetylcholine were not affected (figure 
4B). 
 
 
Figure 4: (A) Tracing of rat gastric artery smooth muscle cell membrane potential (Em) 
responses to application of methanandamide (METH, 10-5 M), acetylcholine (ACh, 3 × 10-6 
M) and exogenous CGRP (3 × 10-9 M) after pre-exposure to capsazepine (3 × 10-6 M), a 
selective vanilloid receptor antagonist. The latter trace was obtained from a different 
preparation. (B) Influence of CGRP (3 × 10-9 M), methanandamide (METH, 10-5 M) and 
acetylcholine (ACh, 3 × 10-6 M) on the membrane potential in the presence of glibenclamide, 
a KATP channel inhibitor. 
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Figure 5: (A) Influence of capsazepine (CZP, 3×10-6 M) on the membrane potential 
response of gastric artery smooth muscle cells to methanandamide (METH, 10-5 M), CGRP 
(3×10-9 M) and acetylcholine (ACh, 3×10-6 M). (B) Influence of glibenclamide (GLIB, 10-5 M) 
on the membrane potential response of gastric artery smooth muscle cells to CGRP (3×10-9 
M) and methanandamide (10-5 M). Data are means ± SEM and  represent the change in 
membrane potential from the resting level (∆Em) before and after application of the inhibitors. 
*, p<0.05; #, p<0.01. 
 
Essentially similar results were obtained in small mesenteric arteries. Thus 
the application of anandamide or methanandamide produced slowly 
developing hyperpolarizations averaging 9.6 ± 1.3 mV (n=7) and 3.9 ± 0.6 
mV (n=7), respectively (figure 6). The acetylcholine-induced 
hyperpolarizations in these subsets of experiments averaged –11.4 ± 2.0 
mV (n=3) and –9.6 ± 1.3 mV (n=7), respectively. While the responses to the 
cannabinoids desensitized, exogenous CGRP caused fully reproducible 
hyperpolarizations displaying a similar time course (-7.0 ± 0.3 mV and –6.5 
± 0.7 mV after a washout period of at least 20 min, n=3, p>0.05) (figure 
7A).  
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Figure 6: Comparison of the influence of glibenclamide on the hyperpolarization induced by 
anandamide (ANAND, 10-5 M), methanandamide (METH, 10-5 M), acetylcholine (ACh, 3×10-
6 M) and CGRP (3×10-9 M) in small mesenteric arteries. The columns represent the 
hyperpolarization before and after preincubation with glibenclamide (10-5 M). Values are 
means ± SEM. *, p<0.05; #, p<0.01. 
 
 
 
 
Figure 7: Typical tracings of the membrane potential (Em) of rat small mesenteric arteries 
smooth muscle cells showing (A) the responses to two successive applications of CGRP 
(3×10-9 M), and (B) the effect of preincubation with glibenclamide (10-5 M), an inhibitor of 
KATP channels, on the response to CGRP (3×10-9 M).  
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After pre-exposure to the KATP channel inhibitor glibenclamide the 
membrane potential responses to anandamide and methanandamide were 
significantly inhibited (-1.1 ± 0.8 mV, n=5, p<0.05 and -1.1 ± 0.9 mV, n=6, 
p<0.05, respectively) while there was no effect on the hyperpolarizations to 
acetylcholine in these preparations (respectively -13.0 ± 1.0 mV, n=4, 
p>0.05 and -8.0 ± 1.6 mV, n=5, p>0.05 in these subsets of experiments). 
Moreover, the hyperpolarizations to CGRP were completely abolished by 
glibenclamide (+0.5 ± 0.5 mV vs 7.4 ± 0.5 mV in control conditions, n=4, 
p<0.01) (figure 6, figure 7B). 
 
 
5.4. DISCUSSION 
In the present study, we explored the influence of cannabinoids on the 
membrane potential of small gastric artery smooth muscle cells, compared 
it with that observed in mesenteric arteries, and investigated their 
mechanism of action. The main new findings are that (1) in gastric arteries, 
methanandamide hyperpolarizes the smooth muscle cells; (2) this effect is 
mediated by stimulation of vanilloid TRPV1 receptors since completely 
inhibited by capsazepine; (3) CGRP causes a comparable, but reproducible 
hyperpolarization in both rat small gastric and mesenteric arteries; (4) both 
the responses to CGRP and to methanandamide are completely abolished 
by glibenclamide, in gastric as well as in mesenteric arteries. 
 
In this study, we found methanandamide to induce concentration-
dependent relaxation of small gastric arteries of the rat, consistent with the 
known potent vasodilatory effect described for cannabinoids in a variety of 
other vascular preparations 16,23-26. Since in rat small mesenteric and 
guinea-pig carotid arteries, anandamide and methanandamide have been 
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shown to hyperpolarize the membrane potential of the smooth muscle cells 
19,27, a change absent in some vessels which fail to show tension responses 
to these cannabinoids 27, it was reasonable to assume that at least part of 
the observed vasorelaxation is due to the associated membrane potential 
change. Besides confirming the potent hyperpolarizing action of 
anandamide and methanandamide in small mesenteric arteries 19, the 
present study reports a similar electrical response in small gastric arteries. 
To the best of our knowledge, gastric artery smooth muscle cell membrane 
potential changes to cannabinoids have not been reported before either. 
 
The mechanism by which cannabinoids induce vasodilation is as yet 
unclear. While some studies propose a direct activation of CB1 receptors on 
the vascular smooth muscle 24,25,28-32, several others report an indirect 
action, either by activation of endothelial receptors stimulating the release 
of vasorelaxing substances such as NO or EDHF 25,27,33, or by activation of 
TRPV1 receptors on perivascular sensory nerves, causing the release of 
vasodilatory neuropeptides such as CGRP 16,31,32,34. Moreover, recent 
evidence suggests that the vasodilation to cannabinoids is mediated by 
stimulation of a novel non CB1/CB2 receptor 35-38. Earlier membrane 
potential measurements in rat mesenteric arteries showed that the 
hyperpolarization was abolished by capsaicin pre-treatment and blocked by 
capsazepine 19, supporting the involvement of TRPV1 receptors on 
perivascular nerves in the electrical response to anandamide 19. In the 
present membrane potential measurements in gastric arteries, we similarly 
found that the methanandamide-induced hyperpolarization was completely 
inhibited by capsazepine. Unless the used agonists/antagonists have 
unknown or aspecific actions, this shows the central role of the perivascular 
nerve TRPV1 receptor in promoting the cannabinoid-induced 
hyperpolarization in these vessels.  
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Exogenous application of CGRP similarly produced a substantial 
hyperpolarization of the membrane potential, both in  small gastric and 
mesenteric arteries. The time-course of this response was comparable to 
that of the cannabinoids, both in onset and recovery. In contrast to the 
cannabinoid response, the hyperpolarization induced by exogenous CGRP 
was completely unaffected by preincubation with capsazepine.  
 
Whereas exogenous CGRP caused fully reproducible hyperpolarizations, a 
second application of cannabinoids failed to affect the membrane potential. 
Consistent with the expected desensitizing influence of cannabinoids on 
peptidergic primary afferent nerves in isolated vessel preparations 39, our 
findings suggest that the irreversibility of methanandamide-induced 
hyperpolarization in the present in vitro experiments might be due to 
depletion of CGRP and/or desensitization of TRPV1 receptors of the 
perivascular nerves, and further confirm the role of these nerves in the 
hyperpolarization to cannabinoids. 
 
Glibenclamide fully abolished or even reversed the CGRP-induced 
membrane potential change in gastric and in mesenteric arteries, 
suggesting that activation of KATP channels is responsible for the 
hyperpolarization induced by the peptide. This is consistent with literature 
reports on the action of CGRP. In rabbit mesenteric arteries, glibenclamide 
similarly blocked the CGRP-induced membrane potential change 40. In rats, 
an increase in gastric mucosal blood flow was reported after administration 
of exogenous CGRP, sensitive to glibenclamide 41. In the present study, 
also the hyperpolarizations to methanandamide were found to be abolished 
in the presence of glibenclamide in small mesenteric as well as in gastric 
arteries, extending earlier observations with anandamide in mesenteric 
arteries 27. Therefore, the similar mechanism of hyperpolarization induced 
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by cannabinoids and by CGRP at the level of the smooth muscle cells 
further corroborates the view that the former stimulate TRPV1 receptors on 
perivascular nerves, thereby releasing CGRP  which activates the smooth 
muscle KATP channels. 
 
Several vasodilators such as acetylcholine relax arteries by releasing 
vasoactive substances from the endothelium, such as NO, prostacyclin and 
an as yet unidentified EDHF. In some arteries, also CGRP induces 
endothelium-dependent relaxation 15,42. To exclude the involvement of NO 
and prostanoids, the present experiments were all performed in the 
combined presence of L-NA and indomethacin. The hyperpolarization 
caused by acetylcholine, therefore, might be totally attributed to EDHF. This 
hyperpolarization, however, which had a completely different time course 
than that observed with the cannabinoids or with exogenous CGRP, was 
found to be resistant to glibenclamide, both in mesenteric and gastric 
arteries. These findings exclude a role for EDHF in the membrane electrical 
response to CGRP or cannabinoids in these vessels. For the mesenteric 
artery, this is consistent with earlier reports showing that the 
hyperpolarization or the relaxation induced by cannabinoids 19, by CGRP 
43,44 or by activating the primary afferent nerves 14,43 is entirely endothelium-
independent. The present findings suggest a similar direct action of CGRP 
on the vascular smooth muscle cells in gastric arteries. Moreover, they 
show that in gastric arteries the endocannabinoid anandamide is not an 
EDHF, as was reported for other vessels 19,30,45. 
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5.5. CONCLUSION 
In summary, we have shown that methanandamide hyperpolarizes the 
membrane potential of the vascular smooth muscle cells of rat isolated 
small gastric and mesenteric arteries. This hyperpolarization is due to 
activation of KATP channels of the vascular smooth muscle cells and the 
response is mimicked by exogenous CGRP. The similarity of the 
membrane potential changes induced by exogenous CGRP, their similar 
sensitivity to glibenclamide, the desensitizing action of the cannabinoids 
and their full inhibition by capsazepine all point to stimulation of TRPV1 
receptors on perivascular CGRP containing nerves as primary cause for 
the cannabinoid-induced hyperpolarization of the arteries. Since membrane 
hyperpolarization is a powerful mediator of vasorelaxation, this local action 
of the cannabinoids might prove to be a novel mechanism providing 
gastroprotection. 
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Abstract 
In the present study, the relaxant effect of the cannabinoid 
methanandamide was explored in rat gastric arteries. Since in some 
vessels cannabinoids have been shown to release CGRP from 
perivascular nerves, the influence of methanandamide was compared 
with that of exogenous CGRP. Methanandamide and CGRP elicited 
concentration-dependent, endothelium-independent relaxations. 
Methanandamide-induced relaxations were unaffected by the CB1 
receptor antagonist AM251, the CB2 receptor antagonists AM630 and 
SR144528 and combined pre-exposure to AM251 and SR144528. Pre-
exposure to O-1918, an antagonist of a novel non-CB1/CB2 cannabinoid 
receptor, did not influence the relaxations to methanandamide. 
Capsaicin or capsazepine treatment slightly inhibited methanandamide-
induced relaxations. Preincubation with 30 mM extracellular K+ or TEA 
had no significant effect on the responses elicited by methanandamide, 
but reduced CGRP-induced relaxations. Relaxation to 10-5 M 
methanandamide was significantly blunted by Bay-K8644 and by 
preincubation with nifedipine. Furthermore, 10-5 M methanandamide 
significantly inhibited CaCl2-induced contractions in norepinephrine-
stimulated vessels previously depleted of intra- and extracellular Ca2+. 
Finally, preincubation with 10-5 M methanandamide almost completely 
abolished high K+-induced contractions. These findings suggest that the 
vasorelaxant action of methanandamide in rat gastric arteries is not 
mediated by stimulation of known cannabinoid receptors, and only partly 
related to stimulation of TRPV1 receptors on perivascular nerves. At high 
concentrations, methanandamide might induce relaxation by reducing 
Ca2+ entry into the smooth muscle cells. 
 
Keywords: vasoactive agents, endothelial factors, vasorelaxation, 
cannabinoid receptors, vanilloid receptors 
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6.1. INTRODUCTION 
Plant derived cannabinoids have been used for centuries for their 
psychoactive properties. In the early 1990s, endogenous cannabinoids 
were described. The first of these endocannabinoids identified was N-
arachidonoylethanolamide (anandamide) 1. Since their discovery, the 
effects of both synthetic and endogenous cannabinoids have been 
extensively examined. In addition to their neurobehavioral effects, they 
have a profound influence on the cardiovascular system 2. Moreover, they 
influence gastrointestinal function. Reported effects include inhibition of 
gastrointestinal motility and of gastric acid secretion 3. In rats, cannabinoids 
were accordingly found to reduce stress-induced gastric ulceration 4. 
 
Mucosal injury and peptic ulcers may also result from disturbances in 
gastric mucosal blood flow. The production and secretion of mucus, the 
secretion of bicarbonate ions which protect the mucosal barrier, and the 
removal of back-diffusing protons all depend on an appropriate mucosal 
microcirculation. The influence of cannabinoids on mucosal blood flow, 
however, has not been studied yet. 
 
In a variety of isolated vascular preparations, potent vasodilatory effects of 
synthetic and endogenous cannabinoids have been shown 5-8. Their 
mechanisms of action, however, are complex and seem to vary with 
species, vessel type and even size 9, 10. To date, two distinct receptor 
subtypes for cannabinoids have been identified and cloned. CB1 receptors 
are mainly localized on neurons but are also present in some peripheral 
tissues including heart, lung and gastrointestinal tissues and in vasculature 
11. In contrast, CB2 receptors are primarily expressed in immune cells, 
although there is some evidence that these receptors are also expressed 
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by neuronal tissue 11. Both receptor types are coupled through G-proteins 
to adenylyl cyclase and mitogen activated protein kinase. Cannabinoids 
reduce the cAMP concentration via pertussis toxin-sensitive G-proteins 12, 
13. 
 
In several arteries, the vasorelaxant effect of cannabinoids is mediated by 
stimulation of CB1 receptors. Indeed, SR141716A, a CB1 receptor 
antagonist, inhibits relaxations by anandamide in rat mesenteric arteries,  
coronary arteries and kidney arterioles 6, 7, 14 and in cat cerebral arteries 15. 
However, recent evidence suggests that, at least in some vessels, the 
vasodilator response of cannabinoids is caused by stimulation of an as yet 
unidentified non-CB1/CB2 receptor 10, 16, 17. On the other hand, the 
vasorelaxant influence of cannabinoids has also been reported to be due to 
stimulation of vanilloid TRPV1 receptors on primary afferent perivascular 
nerves and the subsequent release of sensory neuropeptides such as the 
powerful vasodilator calcitonin gene related peptide (CGRP). In rat hepatic 
and small mesenteric arteries, the vasorelaxant influence of anandamide 
was antagonised by the TRPV1 receptor antagonist capsazepine and the 
CGRP receptor antagonist CGRP(8-37), but not by the CB1 receptor 
antagonist SR141716A 8. The picture is further complicated by more recent 
studies that identified endocannabinoids as potential activators of the 
endothelial vanilloid TRPV4 receptor 18. 
 
Stimulation of the CB1 receptor modulates the activity of several types of 
ion channels via G-proteins. For example, it has been shown that 
(endo)cannabinoids block voltage gated N-, L- and P/Q-type Ca2+-channels 
15, 19-21 and stimulate inwardly rectifying K+-channels 20, 22. Moreover, 
endocannabinoids can directly target and inhibit voltage gated Ca2+-
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channels 23-26, Na+-channels 27 and various types of K+-channels 28-31, 
although usually at higher concentrations. 
 
In the present study, we analysed the influence of methanandamide on 
isolated small gastric arteries. This cannabinoid is a stable derivative of 
anandamide with slightly higher affinity for the CB1 receptor (Anandamide: 
Ki=89 nM and 371 nM at CB1 and CB2 receptors respectively; 
methanandamide: Ki=20 nM and 815 nM at CB1 and CB2 receptors 
respectively 32-34). Since CGRP containing sensory neurons were described 
in the gastric mucosa 35, we compared the response to methanandamide 
with that exerted by exogenous CGRP to assess a possible action of the 
cannabinoid via stimulation of perivascular nerves. Furthermore, by using 
selective agonists and antagonists, we investigated the involvement of CB1, 
CB2, non CB1/CB2 and TRPV1 receptors in the observed vasorelaxation to 
methanandamide. This vasorelaxation, however, was found to be 
endothelium-independent and largely independent from an action at the 
classical cannabinoid, the non CB1/CB2 or the TRPV1 receptor, but 
probably related to reduction of Ca2+ influx into vascular smooth muscle 
cells.  
 
 
6.2. MATERIALS AND METHODS 
 
6.2.1. Preparations 
The investigation conforms to the Guide for the Care and Use of Laboratory 
Animals (1996, published by National Academy Press, 2101 Constitution 
Ave. NW, Washington, DC 20055, USA). The experiments were performed 
on isolated small gastric artery ring segments taken from female Wistar rats 
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(180 – 280 g). Experiments were approved by the ethical committee on 
animal research of Ghent University. After the rats were killed by cervical 
dislocation, the stomach was rapidly excised and placed in cold (4°C) 
normal Krebs-Ringer bicarbonate (KRB) solution, bubbled with a 95% O2 – 
5% CO2 gas mixture. Second and third order branches of the gastric artery 
were dissected free and transferred to fresh oxygenated and chilled fluid, 
where they were cleaned from surrounding connective tissue and cut into 
segments of about 2 mm in length. 
 
 
6.2.2. Tension measurements 
The arterial segments were mounted into the organ bath of a small-vessel 
myograph, filled with 10 ml KRB solution. Two stainless steel wires (40 µm 
in diameter) were guided through the lumen of the segments. Each wire 
was fixed to a holder of the myograph: one holder was connected to a 
micrometer which was used to change the distance between the wires, the 
other holder was connected to a force-displacement transducer to measure 
the isometric tension changes. After mounting, the preparations were 
allowed to equilibrate for at least 30 min in warmed (37 °C), oxygenated 
(5% CO2 in O2; pH 7.4) KRB solution. The arteries were then normalised to 
obtain optimal conditions for active force development 36. The optimal 
lumen diameter of the vessels was calculated on the basis of the passive 
wall tension-internal circumferences relationship 36. At the start of each 
experiment the vessels were stretched to their optimal lumen diameter 
(316.3 ± 6.6 µm, n=151). Subsequently, all segments were repeatedly 
activated with a KRB solution containing 120 mM K+ (K120) and 10-5 M 
norepinephrine.  
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Thereafter, the gastric arteries were contracted by adding 10-5 M 
norepinephrine to the organ bath or by replacing the standard KRB solution 
in the organ bath by a KRB solution containing 120 mM K+. When a stable 
contraction was obtained, concentration-response curves were made by 
cumulative addition of an agonist under control conditions or in the 
presence of an antagonist. The presence of functional endothelium was 
assessed by the ability of 10 µM acetylcholine to provoke more than 80 % 
relaxation. It was noted that after a first application of methanandamide 
(from 10-7 to 10-5 M), norepinephrine (10-5 M) was unable to induce a 
substantial contraction level in most preparations tested. Therefore, all 
vessels were exposed to methanandamide only once and the experiments 
were performed unpaired. 
 
In some experiments, the influence of methanandamide on the influx of 
extracellular Ca2+ through plasma membrane Ca2+ channels was studied. 
For this purpose, intracellular Ca2+ stores were first depleted by washing 
the vessels with nominally Ca2+-free KRB solution (same composition as 
normal KRB solution, but without added CaCl2), exposing them 
subsequently to Ca2+-free, EGTA (1 mM) containing solution, and 
repeatedly challenging the vessels to 10-5 M norepinephrine. After 
thoroughly washing the preparations with Ca2+-free KRB solution, 
norepinephrine (10-5 M) was added and a concentration-contraction curve 
for CaCl2 (10-5 to 10-2 M) was constructed in control conditions and after 30 
min preincubation with 10-5 M methanandamide. Contractions were 
expressed as a percentage of the maximum contraction induced by CaCl2 
in control conditions (in the presence of norepinephrine). 
 
In some experiments the endothelium was removed from the vessels. For 
this purpose, the arteries were first unstretched in the myograph. Then, an 
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L-shaped micropipette was placed at the proximal end of the segment and 
gas (95 % O2 and 5 % CO2) was bubbled through the lumen of the 
preparations for 2 min. Subsequently, the vessels were again stretched to 
their optimal lumen diameter. After an equilibration period of 30 min, the 
absence of functional endothelium was confirmed by the lack of relaxation 
to acetylcholine.  
 
6.2.3. Drugs 
All experiments were performed in a Krebs-Ringer bicarbonate solution of 
the following composition (in mM): NaCl 135, KCl 5, NaHCO3 20, CaCl2 2.5, 
MgSO4.7H2O 1.3, KH2PO4 1.2, EDTA 0.026 and glucose 10. A KRB 
solution containing 30 mM or 120 mM K+ (K30 or K120 respectively) was 
obtained by equimolar substitution of NaCl with KCl.  Acetylcholine 
chloride, Nω-nitro-L-arginine (L-NA), indomethacin, norepinephrine, 
glibenclamide, capsazepine, EGTA, (S)-(−)-1,4-dihydro-2,6-dimethyl-5-
nitro-4-[2-(trifluoromethyl)phenyl]-3-pyridinecarboxylic acid methyl ester 
((S)-(−)-Bay K8644), nifedipine and tetraethyl ammonium chloride (TEA) 
were purchased from Sigma-Aldrich (St. Louis, MO). Noladin ether, (R)-(+)-
methanandamide, (-)-cannabidiol, levcromakalim, calcitonin gene-related 
peptide (CGRP Rat), JWH-015, AM251 and AM630 were obtained from 
Tocris (Bristol, UK). E-Capsaicin was purchased from Calbiochem (La 
Jolla, CA), AM1241 from Alexis Benelux (Zandhoven, Belgium) and O-1918 
from Cayman Chemical (Ann Arbor, MI). SR144528 was a kind gift from 
Sanofi-Synthélabo Recherche (Montpellier, France).  
 
For stock solutions, acetylcholine was dissolved in 50 mM potassium 
hydrogen phtalate buffer, pH 4.0. L-NA, CGRP, TEA and norepinephrine 
were dissolved in water; indomethacin, methanandamide, noladin ether, 
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cannabidiol, capsaicin, capsazepine and Bay K8644 in anhydrous ethanol; 
glibenclamide, levcromakalim, JWH-015, AM251, AM630, AM1241, 
SR144528 and nifedipine in dimethyl sulfoxide and O-1918 in methyl 
acetate. The final concentration of ethanol or dimethyl sulfoxide in the 
organ bath never exceeded 0.1%. All concentrations mentioned are 
expressed as final molar concentrations in the experimental chamber. 
 
 
6.2.4. Statistics 
Data were computed as means ± S.E.M. and evaluated statistically using 
Student’s t test for paired or unpaired data or repeated measures ANOVA 
with Bonferroni’s post hoc test, as appropriate. A P value < 0.05 indicates a 
significant difference. n represents the number of preparations tested, each 
obtained from a different rat. Relaxations are expressed as the percentage 
decrease in active tone. 
 
 
6.3. RESULTS 
 
6.3.1. Characterisation of vasorelaxing responses to 
methanandamide and CGRP 
In endothelium-intact norepinephrine-precontracted small gastric arteries, 
methanandamide (from 10-7 M to 10-5 M) elicited concentration-dependent 
relaxations (figure 1A). Similarly, the addition of exogenous CGRP (from 
10-10 M to 10-8 M) concentration-dependently relaxed precontracted arteries 
(figure 1B). 
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Figure 1: Effects of endothelium removal on the vasorelaxant responses to (A) 
methanandamide (control: n=10, -endothelium: n=5), (B) exogenous CGRP (n=5) and (C) 
acetylcholine (n=5). Effect of the combined exposure to indomethacin and L-NA on the 
vasorelaxant responses to (D) methanandamide (control: n=10, indo + L-NA: n=5), (E) 
CGRP (n=7) and (F) acetylcholine (n=5). Data are expressed as the percentage decrease of 
the tone induced by 10 µM norepinephrine (* p<0.05, **p<0.01). 
 
Removal of the endothelium, which significantly inhibited the relaxations 
induced by acetylcholine (10-9 M to 10-5 M, figure 1C), did not affect the 
responses to methanandamide or CGRP. Both, the relaxations elicited by 
methanandamide and CGRP were even larger after removal of the 
endothelium (figure 1A and B). Similarly, relaxing responses to both 
methanandamide and CGRP were not affected by pre-exposure of the 
vessels to the combination of L-NA (10-4 M) and indomethacin (10-5 M) to 
block the formation of NO and prostanoids respectively (figure 1D and E). 
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Although these inhibitors tended to decrease the responses to 
acetylcholine, this effect was not statistically significant (figure 1F). 
 
 
6.3.2. Role of cannabinoid receptors in the methanandamide-
induced vasorelaxation 
In contrast to methanandamide, the selective CB1 receptor agonist noladin 
ether (10-7 M to 10-5 M) only weakly affected tone of precontracted gastric 
arteries, suggesting a minor importance of CB1 receptors in these 
preparations (figure 2A). JWH-015 and AM1241, two selective agonists of 
the CB2 receptor, caused concentration-dependent relaxations similar to 
those elicited by methanandamide (figure 2A). Preincubation with the CB1 
receptor antagonist AM251 (10-6 M for 10 min; Ki = 7.49 nM at CB1) 37 did 
not significantly affect the relaxations elicited by methanandamide (figure 
2B). Pre-exposure to the CB2 receptor antagonists AM630 (10-5 M for 10 
min; Ki = 31.2 nM at CB2) 38 or SR144528 (10-5 M for 10 min; Ki = 0.3 nM) 39 
did not inhibit the relaxation response to methanandamide (figure 2C and 
D). Correspondingly, relaxing responses to methanandamide were not 
affected by pre-exposure of the vessels to the combination of AM251 and 
SR144528 to block both types of cannabinoid receptors (figure 2E). 
 
Preincubation with O-1918 (10-5 M), an antagonist of the novel non-
CB1/non-CB2 cannabinoid receptor which does not bind to CB1 or CB2 
receptors at concentrations up to 3 × 10-5 M 40, did not influence the 
relaxations induced by methanandamide (figure 2F). The influence of 
another reported antagonist of this receptor, cannabidiol, could not be 
tested on methanandamide-induced relaxations since the substance (3 × 
10-7 M to 10-5 M) relaxed the gastric arteries by itself.  
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Figure 2: Role of cannabinoid receptors in the methanandamide response in small gastric 
arteries. (A) Concentration response curves for the CB1 agonist noladin ether (n=4) and for 
the CB2 agonists JWH-015 (n=4) and AM1241 (n=7). (B-F) Concentration-response curves 
for methanandamide in control conditions (n=21) and after preincubation with (B) the CB1 
receptor antagonist AM251 (n=7), (C) the CB2 antagonist AM630 (n=4), (D) the CB2 
antagonist SR144528 (n=12), (E) combined CB1/CB2 antagonism by SR144528 + AM251 
(n=4) or (F) the non CB1/CB2 cannabinoid receptor antagonist O-1918 (n=4). 
 
 
6.3.3. Role of vanilloid (TRPV1) receptors in the 
methanandamide-induced vasorelaxation 
Addition of capsaicin, which depletes perivascular nerves by stimulating the 
TRPV1 receptor, caused small concentration-dependent relaxations of 
precontracted gastric arteries, confirming the presence of perivascular 
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nerves in these vessels (figure 3A). However, the responses were 
significantly less pronounced than those to methanandamide. 
Nevertheless, the small relaxations induced by the vanilloid receptor 
agonist were significantly inhibited by preincubation of the preparations with 
the TRPV1 antagonist capsazepine (3 × 10-6 M for 10 min; figure 3A). 
 
Figure 3: Role of TRPV1 receptors in the methanandamide-induced vasorelaxation. (A) 
Concentration-response curves for capsaicin in control conditions (n=8) and after 
preincubation with capsazepine (3 × 10-6 M, n=4). (B) Concentration-response curves for the 
relaxation induced by methanandamide in control conditions (n=21), in the presence of 
capsazepine (3 × 10-6 M, n=6) and after 1h preincubation with capsaicin (10-5 M, n=4). (* 
p<0.05, **p<0.01, control versus capsaicin or capsazepine) 
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As shown in figure 3B, relaxations to the smaller concentrations of 
methanandamide (3 × 10-7 M to 3 × 10-6 M) were slightly inhibited after 
depletion of the perivascular sensory nerves with capsaicin (10-5 M for 60 
min). This effect was significant at a concentration of 3 × 10-6 M 
methanandamide. Relaxation to the highest dose of methanandamide, 
however, was not affected. Similarly, preincubation with the TRPV1 receptor 
antagonist capsazepine (3 × 10-6 M for 10 min) tended to decrease the 
relaxations elicited by the lower concentrations of methanandamide while 
having no influence on the response to 10-5 M methanandamide. 
 
 
6.3.4. Involvement of potassium channel activation 
In a first subset of experiments, preparations were precontracted with a 
norepinephrine containing KRB solution supplemented with 30 mM K+, 
which is known to abolish membrane hyperpolarization in response to 
various vasorelaxant substances. After contractions reached steady state, 
concentration-response curves for methanandamide and CGRP were 
constructed. Although a tendency was noted for the relaxations induced by 
the lower concentrations of methanandamide to decrease in these 
conditions, this did not reach statistical significance (figure 4A). On the 
other hand, the relaxations induced by CGRP were significantly reduced by 
30 mM K+ (figure 4D).  
 
The involvement of KATP-channels in the relaxations induced by 
methanandamide and CGRP was tested by pre-treatment of the 
preparations with glibenclamide (10-5 M for 10 min), an inhibitor of KATP-
channels. Pre-exposure to glibenclamide, which completely inhibited 
relaxations by the KATP-opener levcromakalim (data not shown), had no 
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influence on the relaxations induced by both methanandamide and 
exogenous CGRP (figure 4B and E). 
 
 
Figure 4: Influence of an increased concentration of K+-ions (K30) on the relaxations 
induced by (A) methanandamide (control: n=21; K30: n=7) and (D) CGRP (n=7). Effect of 
treatment with 10-5 M glibenclamide on relaxations elicited by (B) methanandamide (control: 
n=10; glibenclamide: n=5) and (E) exogenous CGRP (n=4). Influence of preincubation with 
3 × 10-3 M TEA on the relaxing responses to (C) methanandamide (control: n=21; TEA: n=7) 
and (F) CGRP (n=5) in rat small gastric arteries (** p<0.01). 
 
 
The role of Ca2+ activated K+-channels (KCa) in the responses to 
methanandamide and CGRP was tested by preincubation of the 
preparations with 3 × 10-3 M tetraethyl ammonium (TEA, 20 min). At this 
concentration, TEA is known to be selective for KCa channels 41. The 
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relaxations induced by methanandamide were not significantly inhibited by 
TEA (figure 4C). The CGRP-induced responses, however, were 
significantly reduced (figure 4F). 
 
 
6.3.5. K120-induced contractions 
Replacing the standard KRB by K120 solution resulted in a stable 
contraction of 8.2 ± 0.6 mN (n=20).  Active tone in these conditions is 
increased mainly by Ca2+ influx through voltage-dependent Ca2+ channels, 
since the L-type Ca2+ channel blocker nifedipine  (10-9 to 10-6 M) totally 
relaxed the K120-preconstricted arteries, an effect counteracted by 10-6 M of 
the Ca2+ channel activator Bay K8644 (figure 5A). Methanandamide also 
caused concentration-dependent relaxation of the K120-precontracted 
vessels (figure 5B). As shown in this figure, activation of the L-type Ca2+ 
channels with Bay K8644 was similarly able to significantly blunt the 
relaxant response to the higher concentrations of the cannabinoid (95.6 ± 
0.5 % relaxation in the absence vs. 42.4 ± 6.0 % in the presence of Bay 
K8644, p<0.005). 
 
Since a second norepinephrine (10-5 M) application was found to be unable 
to re-induce active tension in most arteries which had been exposed to 
increasing concentrations of methanandamide, we tested whether the 
cannabinoid also inhibited contractions elicited by 120 mM K+. After 
preincubation of the vessel segments with methanandamide (10-5 M, 20 
min), increasing K+ to 120 mM caused an increase in active tension of 0.4 ± 
0.3 mN, substantially smaller than the mean stable contraction of 5.4 ± 0.8 
mN observed in these preparations before exposure to the cannabinoid 
(figure 5C). 
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Figure 5: Influence of treatment with 10-6 M (S)-(−)-Bay K8644 on the relaxations induced by 
(A) nifedipine (n=4) and (B) methanandamide (control: n=21; Bay K8644: n=4) in 
preparations contracted with K120. Data are expressed as the percentage decrease of the 
tone induced by K120. (C) Effect of preincubation with 10-5 M methanandamide on the K120-
induced contraction in small gastric arteries (n=4) (* p<0.05, ** p<0.01, # p<0.005). 
 
 
6.3.6. Influence of nifedipine-pretreatment on methanandamide-
induced relaxations 
Preparations were preincubated for 10 min with 10-6 M nifedipine. After 
stable contraction was reached with norepinephrine (10-5 M), a 
concentration-response curve for methanandamide was constructed. 
Although the relaxation induced by the lower concentrations of 
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methanandamide were not affected, preincubation with nifedipine 
significantly inhibited the responses to 10-5 M methanandamide (figure 6A). 
 
 
Figure 6: (A) Influence of preincubation with 10-6 M nifedipine on the relaxations induced by 
methanandamide (n=4). (B) Influence of preincubation with 10-5 M methanandamide on 
CaCl2-induced contractions in norepinephrine-stimulated vessels previously depleted of 
intracellular Ca2+ (n=4) (* p<0.05, # p<0.005; $ p<0.001). 
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6.3.7. Effect of methanandamide on CaCl2-contractions induced 
in the presence of norepinephrine 
After depletion of the intracellular Ca2+ stores and removal of extracellular 
Ca2+, preparations were exposed to norepinephrine (10-5 M) while kept in 
Ca2+-free KRB solution. Under these conditions, readdition of CaCl2 (10-5 to 
10-2 M) induced concentration-dependent contractions which were maximal 
at 10-3 M. Preincubation with methanandamide (10-5 M), substantially 
inhibited contractions to CaCl2 (figure 6B). Contraction to  10-3 M Ca2+ was 
reduced by more than 75 %. 
 
6.4. DISCUSSION 
In the present study we explored the influence and the mechanism of action 
of the stable endocannabinoid analogue methanandamide in gastric 
arteries. The main findings are that methanandamide produces 
concentration-dependent relaxations which are endothelium-independent 
and not mediated by stimulation of the known cannabinoid receptors. The 
responses to low concentrations of methanandamide are mediated in part 
by stimulation of TRPV1 receptors, while relaxations to higher 
concentrations of the cannabinoid are independent of membrane 
hyperpolarization and might be due to interference with Ca2+ influx through 
voltage activated Ca2+ channels or a further step in the contractile activation 
process.  
 
The site and precise mechanism of action of cannabinoids seem to differ 
among different vessels. In some vessels like the bovine coronary artery 42, 
the relaxant effect of anandamide is entirely dependent of the presence of a 
functional endothelium. Most studies, however, have shown that the 
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vasorelaxations caused by anandamide are completely 6 or partly 43 
endothelium-independent. In the present study we found that 
methanandamide elicited concentration-dependent vasorelaxations of rat 
gastric arteries which were not inhibited by removal of the endothelium. 
This endothelium-independency rules out the possible role of endothelium-
derived relaxing factors which have been reported to be involved in the 
cannabinoid induced relaxations in some isolated vascular preparations 5, 7.  
 
The endothelium-independent pathway by which cannabinoids induce 
vasodilatation is still elusive. Some studies report that cannabinoids directly 
stimulate cannabinoid receptors on the vascular smooth muscle cells 6, 43, 44. 
CB1 receptor expression was shown in cultured human aortic smooth 
muscle cells 45, acutely isolated cat cerebral artery myocytes 15 and in the 
medial wall of rat cerebral arteries in situ 46. In isolated cerebral artery 
smooth muscle cells, stimulation of the CB1 receptor by anandamide 
causes relaxation by concentration-dependent inhibition of L-type Ca2+ 
channels via pertussis toxin-sensitive G-proteins. Maximal inhibition (32 %) 
was found with 3 x 10-7 M of the cannabinoid 15. In the present study, the 
same concentration of methanandamide, which is slightly more selective for 
the CB1 receptor, hardly produced relaxation of gastric arteries. Moreover, 
the potent and selective CB1 receptor antagonist AM251 did not antagonise 
the relaxant effect of methanandamide, indicating that CB1 receptors play 
little role. This is consistent with the relatively small relaxations observed 
with noladin ether, an endogenous and selective agonist of the CB1 
receptor. Moreover, two structurally unrelated selective CB2 antagonists, 
AM630 and SR144528 did not antagonize the relaxations induced by 
methanandamide, ruling out the involvement of CB2 receptors. The finding 
that even the combined presence of AM251 and SR144528 did not 
attenuate methanandamide induced vasorelaxation further corroborates the 
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conclusion that neither CB1 nor CB2 receptors are involved. More recent 
studies propose that in some vessels the vasodilator response to 
cannabinoids is mediated by stimulation of a novel, not yet identified, non-
CB1/CB2 receptor located on the endothelium 10, 16, 17, 17, 47. However, we 
found that methanandamide induced relaxations of gastric arteries were 
completely unaffected by O-1918, a selective antagonist of this novel 
receptor 10, 40. Taken together with the finding that the effects of the 
cannabinoid are endothelium-independent, this strongly argues against the 
involvement of this endothelial non-CB1/CB2 receptor as well.  
 
The cannabinoid anandamide has also been shown to activate TRPV1 and 
TRPV4 receptors. The TRPV4 receptor is highly expressed on vascular 
endothelial cells, and its stimulation enhances Ca2+ influx, an essential 
trigger to release various vasoactive factors including NO, prostaglandins 
and the EDHF mechanism 48. Moreover, TRPV4 recently was also found in 
the myocytes of cerebral arteries, and its activation was shown to cause 
smooth muscle cell hyperpolarization via BKCa channel activation 49. In the 
present study in which methanandamide was found to induce endothelium-
independent relaxation, also the activation of a putative smooth muscle cell 
TRPV4 receptor can be ruled out, however, since the non-hydrolysable 
analogue methanandamide was used, whereas anandamide is known to 
stimulate TRPV4 indirectly, after conversion to its metabolite 5’,6’-
epoxyeicosatrienoic acid 18.  
 
TRPV1 receptors are activated by noxious stimuli including molecules with 
a vanilloid moiety such as capsaicin, but also by heat and protons. In the 
stomach, these TRPV1 receptors have been shown to be localized on 
perivascular, primary afferent nerves. Stimulation of this receptor triggers 
the local release of neuropeptides from these nerve endings, the most 
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important of which is the powerful vasodilator CGRP 50. The 
gastroprotective role of CGRP released from sensory nerves has been 
shown in various studies, and results from the vasodilatation and the 
emanating rise in mucosal blood flow 51-53. CGRP might act directly on the 
vascular smooth muscle cells and/or indirectly, by stimulating the 
endothelial cells to release their relaxing factors 54, 55. In the present study, 
application of exogenous CGRP evoked fully reproducible, concentration-
dependent relaxations of gastric arteries which were totally endothelium-
independent. Furthermore, preincubation with L-NA and indomethacin had 
no effect on the responses to CGRP, again eliminating the release of the 
endothelium-derived relaxing factors NO and prostacyclin and pointing to a 
direct relaxing influence of the peptide on the vascular smooth muscle cells. 
In addition, the functional presence of perivascular TRPV1 containing 
nerves in the isolated small gastric arteries used in our study was 
demonstrated by the fact that exposure to capsaicin decreased 
norepinephrine-induced tone, an effect abolished by treatment with the 
TRPV1 antagonist capsazepine. 
 
Since the original observation that vasorelaxation by cannabinoids can be 
mediated by stimulation of TRPV1 receptors on CGRP containing 
perivascular nerves 8, several studies have documented TRPV1 stimulation 
by anandamide or by methanandamide, and stressed that anandamide 
should be considered both an endocannabinoid and an endovanilloid 56, 57. 
In the present study, we found that the potency of capsaicin as a 
vasorelaxant was much lower than that observed for methanandamide or 
exogenous CGRP, suggesting a rather minor importance of the sensory 
nerves in our isolated preparations. Possibly, this might be related to the 
pre-exposures to 120 mM K+ before the start of the experiments (see 
methods). Nevertheless, the vasorelaxation produced by low 
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concentrations of methanandamide in the present conditions was 
completely inhibited after depletion of the perivascular nerves by pre-
exposure to capsaicin. Moreover, relaxations tended to decrease in the 
presence of the TRPV1 antagonist capsazepine. These findings suggest, 
therefore, that at least the lower concentrations of methanandamide act on 
capsaicin sensitive TRPV1 receptors on perivascular nerves in gastric 
arteries and stimulate the release of the vasorelaxing CGRP. The main 
route by which vasorelaxation is produced, however, involves another 
mechanism, probably located at the level of the smooth muscle. This is 
further corroborated by the different sensitivity to potassium channel 
blockers of the relaxations produced by methanandamide and by 
exogenous CGRP. The vasorelaxation produced by exogenous CGRP was 
sensitive to 30 mM extracellular K+ and to 3 × 10-3 M TEA, but not affected 
by the KATP channel inhibitor glibenclamide which indicates that smooth 
muscle membrane hyperpolarization at least contributes to the 
vasodilatation induced by CGRP. Conversely, relaxations to high 
concentrations of methanandamide were completely unaffected by 30 mM 
K+ and by the K+ channel blockers TEA or glibenclamide, pointing to a 
mechanism not requiring smooth muscle cell hyperpolarization. It should be 
remarked, however, that for these interventions that affected the CGRP 
response (30 mM K+, TEA), again a tendency was noted to diminish the 
vasorelaxing effect of the lower concentrations of methanandamide, 
although this failed to reach statistical significance.  
 
In a recent study in gastric arteries, we found that both methanandamide 
and exogenous CGRP caused a hyperpolarization of the membrane 
potential of the smooth muscle cells 58. Since these membrane potential 
changes were completely abrogated by glibenclamide, an activator of KATP 
channels seems to be mediating the response to both substances. The 
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apparent discrepancy that in the present tension measurements 
vasorelaxation to CGRP is sensitive to TEA and not to glibenclamide 
whereas in the membrane potential study hyperpolarization to CGRP was 
sensitive to the KATP channel blocker, suggests that the neuropeptide-
activated pathway (involving cAMP and PKA, see 59) might eventually result 
in the recruitment of a different K+ channel depending on the contractile 
tone of the artery. Thus, while in resting gastric arteries KATP channels are 
opened, in norepinephrine-stimulated vessels, the higher intracellular free 
Ca2+ concentration might facilitate the opening of KCa channels by PKA 
dependent phosphorylation. Perhaps, this might explain some of the 
controversy in literature concerning the type of K+ channel activated by 
CGRP 60-63. The membrane potential-independent, direct relaxing influence 
of high concentrations of methanandamide might overwhelm a similar 
mechanism occurring at the lower concentrations. 
 
Besides activating cannabinoid and vanilloid receptors, some cannabinoids 
such as anandamide and methanandamide have been shown to directly 
bind to other membrane proteins such as delayed rectifier K+ channels 29, 31 
and voltage activated Ca2+ channels 23-26, especially at higher 
concentrations. IC50 values reported for anandamide binding to different 
sites of the L-type Ca2+ channel protein, e.g., are 4, 8 and 15 µM 23, 64. 
Recently, also methanandamide has been shown to inhibit dihydropyridine 
binding to the voltage gated Ca2+ channel, with an IC50 value of 7 × 10-6 M 
65. In mesenteric arteries of the rat, anandamide at 10-5 M, but not at 10-6 M, 
inhibited contractions to readdition of Ca2+, directly indicating an 
interference with Ca2+ influx through voltage gated channels 26. In the 
present study, the L-type Ca2+-channel blocker nifedipine produced 
pronounced concentration-dependent relaxations of K120-precontracted 
arteries. This was expected, since tension development in depolarizing high 
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K+ solution is mediated almost entirely through opening of voltage gated 
Ca2+ channels 66. Bay K8644 significantly inhibited these relaxations, 
proving its effectiveness as Ca2+-channel activator. Bay K8644 also 
dramatically blunted the relaxations to the high concentration (10-5 M) of 
methanandamide, directly showing that activation of the Ca2+ channels is 
able to counteract at least part of the cannabinoid induced vasorelaxation. 
Furthermore, preincubation of the preparations with the selective L-type 
Ca2+ channel blocker nifedipine, significantly inhibited the relaxation 
induced by the highest concentration of methanandamide, while the 
responses to the lower concentrations of the cannabinoid were unaffected. 
This strongly argues for interference by 10-5 M methanandamide at the 
dihydropyridine binding site of the Ca2+ channel 65. The fact that 
norepinephrine and K120 were unable to induce contraction in arteries pre-
exposed to methanandamide, even suggests that the cannabinoid hardly 
dissociates from this binding site.  
 
Further evidence for the involvement of voltage activated Ca2+ channels in 
the response to methanandamide was obtained in the experiments in which 
we examined the effects of methanandamide on contractions induced by 
cumulative readdition Ca2+ to norepinephrine stimulated arteries previously 
depleted of intracellular Ca2+.  In these conditions, contractions obtained 
with CaCl2 are mainly due to Ca2+ influx through voltage activated Ca2+ 
channels on the vascular smooth muscle cells. Methanandamide 
substantially inhibited the CaCl2-induced contractions, suggesting a direct 
action on the voltage activated Ca2+ channels. Taken together with the 
aforementioned literature reports on inhibition of L-type Ca2+ channels by 
cannabinoids, these findings strongly suggest that high concentrations of 
methanandamide might relax the gastric arteries by inhibition of Ca2+ influx 
in the smooth muscle cells, although interference with a further intracellular 
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step in the contractile activation process may not be excluded. The 
experiments in which methanandamide almost abolished K120-induced 
contractions of these arteries further support this view.  
 
We previously described the existence of endothelium-dependent 
hyperpolarization in rat gastric arteries 67. The noted lack of influence of L-
NA and indomethacin on the vasorelaxation elicited by acetylcholine in the 
present study, points to a major role of the endothelium-dependent 
hyperpolarization in the endothelium-dependent relaxation response to 
acetylcholine. As mentioned, the relaxation induced by CGRP is at least 
partly mediated by hyperpolarization, whereas eventual hyperpolarization 
induced by the highest concentration of methanandamide does not seem to 
be necessary to cause the relaxation by the cannabinoid. This is fully 
consistent with the data supporting inhibition of L-type Ca2+ channels by the 
cannabinoid, since this is a downstream mechanism and Ca2+ channels, 
once inhibited, do not respond anymore to changes in membrane potential. 
 
In conclusion, the present study has demonstrated that methanandamide is 
a potent vasodilator in isolated rat small gastric arteries. The cannabinoid-
induced vasorelaxation is endothelium-independent, does not involve the 
activation of the classical CB1 or CB2 receptor or the non CB1/CB2 receptor, 
and is largely independent of membrane hyperpolarization. Activation of 
TRPV1 receptors on perivascular nerves might contribute to the relaxations 
induced by the lower concentrations of the cannabinoid. Higher 
concentrations (> 10-6 M) might interfere with Ca2+ influx into the smooth 
muscle cells. 
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Abstract 
Many cellular functions are regulated by changes in the intracellular Ca2+ 
concentration ([Ca2+]i). Those Ca2+ signals are highly organized in both 
time and space. It is generally accepted that modulation of [Ca2+]i is a 
critical determinant of vascular smooth muscle tone. Using confocal 
microscopy and fluorescent dyes, we examined the dynamic Ca2+ 
responses in smooth muscle cells of intact small mesenteric arteries of 
the rat. We observed the effect of stimulation with norepinephrine and 
evaluated the influence of membrane potential changes on the induced 
Ca2+ oscillations. It was found that stimulation with norepinephrine 
(3x10-6 M) evoked asynchronous Ca2+ spikes which were usually 
accompanied by a raise in basal fluorescence. After prolonged exposure 
to norepinephrine, the preparations showed a slight but significant 
reduction in both spiking activity and basal fluorescence. Addition of 
depolarizing concentrations of K+ (15 mM) to arteries stimulated with 
norepinephrine resulted in the synchronization of the Ca2+ oscillations 
and significantly increased both spiking frequency and basal 
fluorescence. In contrast, hyperpolarization of the membrane potential 
with levcromakalim (3x10-7 M) significantly reduced the spiking 
frequency and the level of basal fluorescence. This decline was larger 
than the spontaneous decrease observed in the prolonged presence of 
norepinephrine alone. Similar results were found with the vasodilatory 
neuropeptide calcitonin gene-related peptide (3x10-9 M). Small increases 
in the extracellular K+ concentration (5 mM) also significantly decreased 
the Ca2+ responses, suggesting a hyperpolarization of the membrane 
potential. Addition of the cannabinoid methanandamide significantly 
augmented the mean spiking rate and showed a slight but significant 
decrease of the basal fluorescence. Taken together, these findings 
confirm that stimulation with norepinephrine induces asynchronous Ca2+ 
oscillations in the vascular smooth muscle cells of small mesenteric 
arteries. Our results further suggest that depolarization is essential to 
synchronize these responses, while hyperpolarizing the membrane 
potential tends to decrease the Ca2+ dynamics. 
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7.1. INTRODUCTION 
Intracellular Ca2+ is an important second messenger mediating a variety of 
vascular endothelial and smooth muscle cell functions. The regulation of 
hemodynamics by variations in the vascular diameter results from the 
contraction and relaxation of the smooth muscle cells in the vascular wall. It 
is generally known that vasoactive agents constrict arteries by 
simultaneously increasing the mean cytosolic Ca2+ concentration ([Ca2+]i) in 
all smooth muscle cells of the vascular wall 1-4. Smooth muscle contraction 
has been thought to rely on both Ca2+ influx in the cell and Ca2+ release 
from intracellular stores. Contraction is initiated by Ca2+-calmodulin-induced 
activation of myosin light chain kinase, resulting in the formation of cross 
bridges between actin and myosin filaments of the contractile apparatus.  
 
Recently, it has been shown that the overall vessel Ca2+ concentration is 
not representative for the Ca2+ dynamics in the individual vascular smooth 
muscle cells 5-9. The smooth muscle cells respond to biological activators 
with oscillatory and propagating rises in [Ca2+]i caused by Ca2+ release from 
the sarcoplasmatic reticulum. These Ca2+ oscillations and Ca2+ waves are 
highly organized in both time and space and their frequency depends on 
the agonist concentration. Another type of Ca2+ signalling are Ca2+ sparks 
caused by local Ca2+ release events through ryanodine-sensitive Ca2+ 
release channels in the sarcoplasmatic reticulum 10-12.  
 
Much of the knowledge about Ca2+ signalling in vascular smooth muscle 
cells has been based on studies using enzymatically isolated or cultured 
cells. When stimulated, isolated and cultured smooth muscle cells show 
elevations of the intracellular free Ca2+ concentration ([Ca2+]i), which 
typically progress over the entire cell length, giving it the appearance of a 
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wave 13. However isolated cells display different characteristics as 
compared to smooth muscle cells in situ, in which intact gap junctions 
provide intercellular communication. The possible mechanism for the 
generation of agonist-induced Ca2+ waves in a smooth muscle cell begins 
with an elevation of inositoltrisphosphate (IP3) and a rise in [Ca2+]i. Binding 
of ligands with G-protein coupled receptors stimulates phospholipase C 
which catalyzes the hydrolysis of membrane phosphatidylinositol 4,5-
bisphosphate into IP3. IP3 activates the IP3 receptors on the sarcoplasmatic 
reticulum and sensitizes them to Ca2+. When the [Ca2+]i reaches a threshold 
concentration, the Ca2+ release channels open and Ca2+ is set free, 
resulting in a Ca2+ spike. The resulting increase in [Ca2+]i in the cytoplasm 
promotes the opening of adjacent channels, which gives rise to a Ca2+ 
wave which propagates down the length of the cell.  
 
Recent advances in digital imaging techniques on the subcellular level have 
made it possible to study vascular cells in intact vessels and explore the 
spatiotemporal characteristics of Ca2+ spikes and waves. It has been shown 
that in rat tail artery, individual smooth muscle cells show asynchronous 
Ca2+ oscillations after electrical and pharmacological stimulation 14. The 
Ca2+ oscillations are not in phase among different individual cells and 
oscillatory features are lost when the Ca2+ response was averaged. It was 
shown that the two sources of Ca2+ may work in a collaborative manner. 
Upon stimulation with norepinephrine, Ca2+ stores were released 
intermittently to produce Ca2+ oscillations. The influx of Ca2+ is used mainly 
to assist replenishment of the Ca2+ stores. These results have later been 
confirmed in the same vessel type 15 and in intact pressurized mesenteric 
small arteries of the rat 16. Sometimes, especially in experiments with 
higher levels of activation,  the Ca2+ oscillations in different smooth muscle 
cells synchronize to yield overall oscillations in intracellular Ca2+ and, 
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hence, in vascular tone, called vasomotion 7, 17. However, the exact 
mechanism responsible for the conversion of asynchronous into 
synchronous oscillations is as yet unclear. It has been postulated that, at 
least in rat mesenteric arteries, Ca2+ released from the sarcoplasmatic 
reticulum activates a depolarizing current, which spreads to all smooth 
muscle cells 8. When this current reaches a sufficient magnitude, it causes 
simultaneous depolarization of all cells 18 with subsequent synchronous 
influx of Ca2+ through voltage dependent Ca2+ channels. This leads to a 
synchronized release of Ca2+ from the sarcoplasmatic reticulum and hence 
produces synchronous Ca2+ oscillations. It has been shown that 
vasomotion or synchronous Ca2+ oscillations do not appear when the 
membrane potential is clamped and is only present with high levels of 
cGMP. Also, a current pulse or another brief depolarization was sufficient to 
synchronise cells 8. 
 
As far as we know, only little information exists about the influence of the 
membrane potential on Ca2+ signalling in the vascular smooth muscle cells. 
In the present experiments we investigated the influence on the 
noradrenaline induced Ca2+ responses of levcromakalim, calcitonin gene-
related peptide (CGRP) and 5 mM KCl, which have all been shown to 
hyperpolarize the membrane potential in several vascular preparations. We 
furthermore studied the effect of methanandamide on the Ca2+ oscillations, 
since we have shown in earlier reports that this cannabinoid has also a 
hyperpolarizing action on rat small mesenteric artery smooth muscle cells 
19, 20. Finally, we tested the influence of a depolarizing concentration of K+-
ions on the Ca2+ dynamics in the vascular wall. 
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7.2. MATERIALS AND METHODS 
 
7.2.1. Tissue Preparation 
Small mesenteric arteries from female Wistar rats (180 – 280 g) were used. 
The experiments were approved by the ethical committee on animal 
research of Ghent University. The animals were anaesthetised by a lethal 
dose (200 mg kg-1) of pentobarbitone and killed by cervical dislocation. 
Branches of the small mesenteric arteries were dissected from the 
abdominal cavity and rapidly placed in cold (4°C) normal Krebs-Ringer 
bicarbonate (KRB – composition defined further) solution bubbled with a 
95% O2 – 5% CO2 gas mixture. The arteries were cleaned from 
surrounding connective tissue and cut into segments of about 5 mm in 
length. 
 
Subsequently, the vessel segments were cannulated with a thin glass 
capillary (borosilicate glass, Hilgenberg, Malsfeld, Germany) with flame 
polished tip that was inserted into the lumen over the entire segment length 
(figure 1A). The diameter of the glass capillary was slightly (~15 %) larger 
than the vessel lumen diameter and cannulation was done to stabilize the 
preparation against possible smooth muscle contractions after challenging 
with norepinephrine. Imaging experiments showed that the endothelium 
was absent in most preparations. Figure 2 shows an image of an optical 
section of the arterial wall, as perceived when focussing more luminally. 
Autofluorescence of the internal elastic lamina was observed, and no 
endothelial cells were detected.  
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Figure 1: Illustration of the method of recording Ca2+ dependent fluo-3 fluorescence in intact 
small mesenteric arteries of the rat. (A) Schematic diagram of an artery cannulated with a 
thin glass capillary. Cannulae were slightly larger than the vessel lumen diameter. The 
arrows labelled ‘x’ and ‘y’ indicate the plane of laser scanning. For ease of illustration, the 
scanning plane was drawn on the upperface of the artery. In the actual experiments, 
however, the bottom of the arteries was scanned. (B) Optical section of the arterial wall, as 
observed after fluo-3 loading, with the smooth muscle cells vertically oriented. The arrows 
correspond to those similarly labelled in panel A. Images were typically 123 x 93 µm. 
 
20 µm
 
Figure 2: Optical section of the arterial wall, showing the internal elastic lamina (IEL). The 
wholes in this IEL represent fenestrae, through which projections of the endothelial cells 
contact adjacent smooth muscle cells, allowing formation of myoendothelial gap junctions. 
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7.2.2. Calcium imaging 
Ca2+ was measured with the fluorescent Ca2+ probe fluo-3 in combination 
with laser scanning confocal microscopy. The cannulated arterial segments 
were loaded with the Ca2+ dye by incubation overnight at 4°C in a loading 
buffer (Hanks’ balanced salt solution buffered with 25 mM HEPES (HBSS-
HEPES)) containing 20 µM fluo-3-AM and 0.05 % pluronic. The morning of 
the experiments, the preparations were transferred to loading buffer (same 
fluo-3-AM concentration) now at 37°C and incubated for 90 min. The 
arteries were then washed in HEPES-buffered physiological salt solution 
(PSS, pH 7.4).  
 
Ca2+ imaging was done with a custom developed real-time laser scanning 
microscope built around a Nikon Eclipse TE300 (Analis, Ghent, Belgium) 21 
and a x40 oil immersion objective with high numeric aperture (CFI Plan 
Fluo, Nikon - 1.4 NA). A cannulated vessel segment was placed on a glass 
coverslip and immobilized by covering it with a fine nylon mesh attached to 
a ring. The coverslip with the vessel was placed on the stage of the 
inverted microscope and was continuously superfused in situ with PSS at a 
rate of 1 ml/min. Excitation was done with the 488 nm line of an argon-laser 
(type 543R-AP-A01, Melles Griot, Carlsbad, CA, U.S.A.), the dichroic mirror 
was a dual-wavelength type (490-550DBDR) and the emission light was 
bandpass filtered at 522 nm (25 nm bandwith - all filters from Omega 
Optical, Brattleboro, VT, U.S.A. - details can be found in 21). Images of an 
optical section of the arterial wall (~ 123 µm x 93 µm and containing about 
30-40 cells, figure 1B) were obtained at 2 frames s-1 and transferred directly 
to a PC equipped with an image acquisition and processing board 
(DT3155, Data translation, Marlboro, MA, USA). Off-line image analysis 
was done with software (Fluoframes) developed in Microsoft Visual C.  
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7.2.3. Experimental procedures and analysis 
After recording 2 min (240 images) in control conditions, norepinephrine (3 
x 10-6 M) was added to the superfusate and recording was continued for 
another 3 min (360 images). Thereafter, still in the presence of 
norepinephrine, the tissues were exposed to various pharmacological 
agents and the responses were monitored over another 8 min (960 images; 
for levcromakalim, CGRP, 5 mM KCl or methanandamide) or 3 min (360 
images; for 15 mM KCl), as appropriate.  
 
The first stage image analysis consisted of counting the number of cells 
showing clear Ca2+ responses under control conditions, in the presence of 
norepinephrine and in the presence of the various pharmacological 
substances. The responding cells were subdivided in those showing 
oscillatory spiking activity upon stimulation with norepinephrine and those 
reacting with an increase in fluorescence relative to the baseline level. 
 
In a second stage of the analysis, the number of fluorescence peaks per 
cell (peaks with an amplitude of at least two times the amplitude of the 
noise were considered as true Ca2+ spikes), the spiking frequency (over the 
last 240 frames, expressed as spikes per minute) and the change in 
fluorescence relative to the baseline level was calculated (from the last 150 
frames, baseline level was set to 100%). The experimental traces illustrated 
represent averaged fluorescence signals from the imaged vessel part in 
view or the fluorescence change in a single cell, as indicated in the text.  
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7.2.4. Solutions and drugs 
The used KRB solution had the following composition (in mM): NaCl, 135; 
KCl, 5; NaHCO3, 20; CaCl2, 2.5; MgSO4.7H2O, 1.3; KH2PO4, 1.2; EDTA, 
0.026; glucose, 10. The solution was gassed with 95% O2 – 5% CO2  (pH 
7.4). HBSS-HEPES contained (in mM): NaCl, 137; KCl, 5.36; Na2HPO4. 
2H2O, 0.18; CaCl2.2 H2O, 0.95; MgSO4.7H2O, 0.81; KH2PO4, 0.44; HEPES, 
25 mM; glucose, 5.55 (pH 7.4, adjusted with NaOH). PSS contained (in 
mM): NaCl, 130; KCl, 5; NaH2PO4. H2O, 1; CaCl2, 1; MgSO4.7H2O, 0.5; 
HEPES, 20 mM; glucose, 10 (pH 7.4, adjusted with NaOH). 
 
Norepinephrine was purchased from Sigma-Aldrich (St. Louis, MO). 
Methanandamide, levcromakalim and CGRP were obtained from Tocris 
(Bristol, UK). Fluo-3 acetoxymethyl ester (fluo-3-AM) and pluronic were 
obtained from Molecular Probes (Eugene, Oregon, USA). Norepinephrine 
and calcitonin gene-related peptide (CGRP Rat) were dissolved in water; 
methanandamide in anhydrous ethanol and levcromakalim, fluo-3-AM and 
pluronic in anhydrous dimethyl sulfoxide. All concentrations mentioned are 
expressed as final molar concentrations in the experimental chamber. 
 
 
7.2.5. Statistics 
Results are expressed as means ± SEM. Statistical evaluation was 
performed using student’s t test for paired or unpaired data, as appropriate. 
Values of P<0.05 were considered significantly different. The number of 
cells is indicated as n. When appropriate, the number of preparations was 
mentioned. For one single series of experiments, preparations of at least 3 
different animals were used. 
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7.3. RESULTS 
7.3.1. Influence of norepinephrine 
In the 44 different vessel segments studied, on average 6.4 ± 0.7 cells per 
frame showed spontaneous and asynchronous Ca2+ spiking activity in the 
absence of norepinephrine. Addition of norepinephrine (3 x 10-6 M) 
significantly increased the number of spiking cells to 13.9 ± 0.9 per frame 
(n=44, P<0.05, figure 3). Spiking activity remained non-synchronized and 
was usually associated with an increase in fluo-3 fluorescence and thus 
[Ca2+]i. Typical examples of fluorescence traces in individual cells are 
shown in figure 4 (A-C). Figure 4 D illustrates the time course of 
fluorescence changes averaged over the whole frame in view. A mean 
fluorescence increase from 100 %  in control to 107.1 ± 3.5 % in 
norepinephrine (P<0.05, n=44) was observed in these experiments. 
Because of the asynchronous nature of spiking activity, the spikes 
disappeared in the whole frame trace. 
In a subset of these experiments we investigated the effect of prolonged 
(660 sec) exposure to norepinephrine. Figure 4 shows representative 
traces of such an experiment, and the results are summarized in figure 5 
(CTRL). In these experiments, 67 cells showed oscillatory spiking activity in 
response to norepinephrine (figure 5A), while 58 cells showed an increase 
in fluorescence (figure 5B) (data from 3 different preparations). In the 
preparations with spiking activity, the mean number of spikes per minute 
was 3.4 ± 0.2 (n=67, figure 5C). The largest part (n=62) of the cells 
oscillating in response to addition of norepinephrine still showed spike 
activity after prolonged exposure. Thus, in 32 cells spiking activity was 
unchanged, in 12 cells it was increased, whereas it was decreased in 23 
cells (figure 5A).  
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Figure 3: Ca2+ responses in small mesenteric arteries of the rat in response to stimulation 
with 3 x 10-6 M norepinephrine. The images represent a detailed fragment of the original 
confocal images and show the fluorescence change over time in different smooth muscle 
cells upon stimulation with norepinephrine. The images are taken at 16 time points, with 5 
seconds time difference (taken from a series of images recorded at 1 frame s-1). ‘*’ indicates 
the entrance of norepinephrine in the bath. In control conditions, little or no cells showed 
Ca2+ oscillations, while stimulation with norepinephrine induced asynchronous Ca2+ 
oscillations in most cells. 
 
 
However, the spiking rate slightly, but significantly decreased to 3.0 ± 0.2 
spikes per minute (n=67, P<0.05). Furthermore, in 32 of the 58 cells 
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reacting with an increase in basal fluorescence upon stimulation with 
norepinephrine, the level of fluorescence decreased with exposure time. In 
fact, the fluorescence significantly diminished from 169.9 ± 5.2 % to 135.2 ± 
5.4 % (n=58, P<0.0001, figure 5D). 
 
Figure 4: Representative tracings of the fluorescence change in smooth muscle cells of rat 
mesenteric arteries upon addition of 3 x 10-6 M norepinephrine (NOR). (A-C) Representative 
changes in fluorescence in selected individual smooth muscle cells; (D) mean fluorescence 
change averaged over the whole frame in view. (A.U. = arbitrary units) 
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Figure 5: (A, B) Comparison of the influence of levcromakalim (LEVCR), CGRP,  5 mM K+ 
(K5), 15 mM K+ (K15), and methanandamide (METH), administered 3 min after induction of 
spiking activity (A) or an increase in basal fluorescence (B), with the influence of prolonged 
exposure to norepinephrine alone (CTRL). The total number of cells responding to 
norepinephrine in each series of experiments is indicated under the bars. The numbers on 
top of each bar represent the number of cells showing an equal (=), an increase (+) or a 
decrease (-) in spiking activity (A) or basal fluorescence (B). For ease of comparison 
between series, Y-values were expressed as the percentage of cells. (C, D) Average 
number of peaks per minute (C) or absolute fluorescence (D) in the responding cells during 
the first 3 min after norepinephrine exposure and in the prolonged presence of 
norepinephrine alone (CTRL) or following addition of levcromakalim (LEVCR), CGRP,  5 mM 
K+ (K5), 15 mM K+ (K15), and methanandamide (METH). Average fluorescence is 
expressed relative to the fluorescence level in control conditions before exposure to 
norepinephrine, which is set to 100 %.  * p<0.05; § p<0.01; ** p<0.005; # p<0.0001. 
 
7.3.2. Influence of levcromakalim 
In the next series of experiments, we used levcromakalim, an opener of 
ATP sensitive K+- channels (KATP), to assess the influence of 
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hyperpolarization of the membrane potential of the vascular smooth muscle 
cells on the Ca2+ dynamics. In this series, spiking activity in response to 
norepinephrine was observed in 50 cells, while 37 cells reacted with an 
increase in fluorescence level relative to baseline (data from 5 different 
preparations, figure 5). Levcromakalim (3x10-7 M) accentuated the 
spontaneous small decrease in spiking rate and [Ca2+]i observed in the 
prolonged presence of norepinephrine. Typical examples are depicted in 
figure 6 (A-C).  
 
Figure 6: Representative tracings showing the influence of levcromakalim (LEVCR) on the 
Ca2+ responses evoked by norepinephrine (NOR). (A-C) Representative changes in 
fluorescence in selected individual smooth muscle cells; (D) Trace of the mean fluorescence 
averaged from over the whole frame. (A.U. = arbitrary units) 
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It can be clearly seen that in this preparation, spiking activity decreased 
after application of levcromakalim. From the 50 cells which oscillated in 
response to norepinephrine, 35 cells (70 %) showed a reduction in spike 
frequency, while only 4 cells (8 % of the total number of responding cells) 
respond with an increase (figure 5A). This ratio is much larger than in 
control conditions where only 34 % (23 out of 67 cells) of the responding 
cells showed a decrease. Additionally, the mean spike frequency 
significantly decreased from 1.6 ± 0.1 spikes per minute in norepinephrine 
to 1.0 ± 0.1 peaks per minute in the presence of levcromakalim (n=50, 
p<0.0001, figure 6C). Moreover, in the presence of levcromakalim, the 
majority of the cells (24 cells from 37) showed a decrease in fluorescence 
compared to the level in the presence of norepinephrine alone (figure 5B). 
The average fluorescence (from the entire frame) was significantly reduced 
from 131.6 ± 2.8 % in norepinephrine to 105.2 ± 2.8 % in levcromakalim 
(n=37, P<0.0001, figure 5D). 
 
 
7.3.3. Influence of calcitonin gene-related peptide 
Similar changes were observed with calcitonin gene-related peptide 
(CGRP), which is also known to cause substantial hyperpolarization in this 
preparation 20. From the 126 cells oscillating in the presence of 
norepinephrine, 70 smooth muscle cells displayed a reduction in the spiking 
frequency after addition of CGRP (3x10-9 M, figure 5A) (data from 8 
different preparations). More specifically, the mean spike rate was 
significantly lowered from 3.5 ± 0.1 spikes per minute in norepinephrine to 
2.9 ± 0.1 spikes per minute in the combined presence of norepinephrine 
and CGRP (n=126, P<0.0001, figure 5C). In this subset of experiments, 98 
cells responded to incubation with norepinephrine with an increase in 
 194
Membrane potential and Ca2+-oscillations 
fluorescence relative to baseline. In 54 of these cells, application of CGRP 
induced a lowering of the fluorescence (figure 5B). The average 
fluorescence was lowered from 147.3 ± 4.0 % to 123.7 ± 5.0 % (n=98, 
P<0.0001, figure 5D). 
 
 
7.3.4. Influence of addition of 5 mM K+ 
In the experiments in which we increased the KCl concentration of the KRB 
solution with 5 mM (yielding 10 mM K+ in total), 49 cells oscillated in 
response to norepinephrine (data from 5 different preparations). Typical 
examples are depicted in figure 7 (A-C). After addition of 5 mM KCl, the 
spiking activity decreased in the majority of these cells (n=40, figure 5A, 
figure 7). The mean spike frequency was significantly reduced from 2.8 ± 
0.2 peaks per minute in norepinephrine to 1.3 ± 0.2 peaks per minute in the 
presence of 5 mM K+ (n=49, P<0.0001, figure 5C). Additionally, from the 51 
cells showing an increase in fluorescence after addition of norepinephrine, 
this fluorescence decreased in 34 cells after incubation with 5 mM KCl 
(figure 5B, figure 7C). The average fluorescence significantly lowered from 
119.5 ± 2.1 % to 97.4 ± 2.7 % (n=51, P<0.0001, figure 5D). 
 
7.3.5. Influence of  addition of 15 mM K+ 
In a next series of experiments, we investigated the influence of the extra 
addition of 15 mM K+ on the Ca2+ responses elicited by norepinephrine. 
This concentration is expected to depolarize the smooth muscle cell 
membrane potential by about 20 mV 22. Incubation of the vessels with 15 
mM K+ increased spiking activity. Of the 97 cells oscillating in response to 
norepinephrine, 70 cells showed a higher spiking activity in the presence of 
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15 mM KCl (figure 5A) (data from 6 different preparations). 
Correspondingly, the number of spikes per minute increased significantly 
from 2.2 ± 0.1 in norepinephrine to 4.0 ± 0.2 in the presence of 15 mM KCl 
(n=97, P<0.0001, figure 5C). Individual traces are depicted in figure 8 (A-
C).  
 
Figure 7: Representative tracings showing the influence of an extra 5 mM K+ on the Ca2+ 
responses evoked by norepinephrine in selected individual smooth muscle cells from the 
same preparation. (A.U. = arbitrary units) 
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Figure 8: Representative tracings showing the influence of 15 mM K+ on the Ca2+ 
responses evoked by norepinephrine (NOR). (A-C) Representative changes in fluorescence 
in selected individual smooth muscle cells; (D) trace of the mean fluorescence averaged 
over the whole frame. Note that application of 15 mM K+ synchronizes the spiking activity 
which is reflected in the tracing of the average fluorescence (D). (A.U. = arbitrary units) 
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Furthermore, the observed oscillations became synchronized as 
demonstrated by the appearance of oscillations in the tracing of the 
average fluorescence from the entire frame, illustrated in figure 8D. The 
enhanced spiking activity was associated with an increase in [Ca2+]i. From 
the 55 cells responding with a increase in fluorescence to norepinephrine, 
36 cells further increased fluorescence after addition of 15 mM K+ (figure 
5C). The average fluorescence significantly increased from 112.5 ± 3.2 % 
to 143.4 ± 5.2 (n=55, P<0.0001, figure 5D). 
 
 
7.3.6. Influence of methanandamide 
In the last series of experiments we tested the influence of 
methanandamide (10-5 M) on the Ca2+ responses. Some representative 
tracings of individual smooth muscle cells are depicted in figure 9 (A-C). In 
these preparations 128 cells oscillated in response to norepinephrine. 
Addition of methanandamide did not notably alter the number of oscillating 
cells, 56 of them responding with an increased spiking activity (data from 8 
different preparations). However, as can be observed in figure 5A, the 
slowly decreasing trend as observed in the prolonged presence of 
norepinephrine was clearly reversed, although not to the same level as 
obtained with 15 mM K+. Indeed, the number of cells reacting with an 
increase in spiking activity is twice as large as the number of cells showing 
a decrease (56 vs 28 cells, respectively). Moreover, the mean spike rate 
was significantly augmented (from 3.4 ± 0.2 spikes per minute in 
norepinephrine to 3.9 ± 0.2 spikes per minute in the presence of 
methanandamide, n=128, P<0.01, figure 5C). Apart from addition of 15 mM 
K+, the application of methanandamide is the only condition in which 
spiking rate increases (figure 5C). In the presence of methanandamide, 
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oscillations remained asynchronous. The changes in spiking activity were 
accompanied by a small, but significant decrease in [Ca2+]I as fluorescence 
lowered from 143.8 ± 3.5 % in norepinephrine versus 130.3 ± 3.0 % after 
addition of methanandamide (n=89, P<0.005, figure 5D), slightly less than 
observed in the prolonged presence of norepinephrine alone. 
 
 
Figure 9: Representative tracings showing the effect of methanandamide (METH) on the 
Ca2+ responses evoked by norepinephrine (NOR). The different traces (A-C) represent 
selected individual smooth muscle cells from the same preparation. (A.U. = artbitrary units) 
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7.4. DISCUSSION 
In the present study we investigated smooth muscle cell Ca2+ responses 
induced by norepinephrine and the way they were influenced by changes of 
the membrane potential. As far as we know, this study is the first to 
investigate the role of the membrane potential in the Ca2+ dynamics of 
vascular smooth muscle cells. We found that most smooth muscle cells of 
small mesenteric arteries of the rat showed substantial Ca2+ responses 
upon stimulation with low concentrations of norepinephrine: asynchronous 
spiking activity was usually accompanied by an increase in basal 
fluorescence. Agents known to hyperpolarize the membrane potential, such 
as levcromakalim and CGRP, significantly suppressed the increase in 
intracellular Ca2+ and spiking activity triggered by norepinephrine. Similarly, 
addition of low concentrations of extracellular K+ tended to decrease the 
Ca2+ activity. In contrast, depolarizing concentrations of K+ increased Ca2+ 
responses and synchronized spiking activity of the smooth muscle cells.  
 
 
Vessels activated with vasoconstrictors such as norepinephrine, 
phenylephrine or vasopressin, show an increase in spatially averaged or 
whole tissue [Ca2+] to a maintained level 1, 23. However, it has recently been 
shown that this sustained increase of the Ca2+ concentration is not 
representative for the Ca2+ dynamics in the individual smooth muscle cells 
of both arteries and veins 5-9, 24. In a variety of smooth muscle cells, it has 
now been clearly demonstrated that agonists produce cytosolic Ca2+ 
oscillations which are highly organized in both time and space. It has been 
shown that upon activation, the cellular Ca2+ level oscillates with a 
frequency that varies with agonist concentration and that changes in Ca2+ 
propagate as Ca2+ waves during exposure to the agonist 14-16. In general, 
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low concentrations of an agonist elicit asynchronous Ca2+ oscillations and 
waves 6-9, 24, while high concentrations present synchronous Ca2+ 
responses and elicit vasomotion 7, 17. 
 
The exact mechanism leading to synchronization of the Ca2+ responses is 
not yet fully understood. It has been suggested that Ca2+ released from the 
sarcoplasmatic reticulum activates a depolarizing current which can spread 
to the adjacent smooth muscle cells, probably through gap junctions, finally 
causing simultaneous depolarization of all smooth muscle cells 18. The 
resulting synchronous Ca2+ influx through voltage dependent Ca2+ channels 
will likely result in a synchronized Ca2+ release from the sarcoplasmatic 
reticulum 25. The Ca2+ waves in the individual smooth muscle cells are then 
synchronized, initiating vasomotion 8. 
 
The influence of changes in the membrane potential on the Ca2+ responses 
is still elusive. Studies in rat mesenteric arteries revealed that applying a 
current pulse or an other brief depolarization to arteries stimulated with 
norepinephrine was sufficient to change the asynchronous oscillations into 
synchronized Ca2+ responses 8. Hyperpolarizing the membrane potential 
with pinacidil, however, seemed to have no influence on the Ca2+ 
responses in this study. 
 
In the present study we investigated the Ca2+ oscillations in vascular 
smooth muscle cells of mesenteric arteries of the rat. Under control 
conditions, in the absence of norepinephrine, only a very small fraction of 
the smooth muscle cells in the vascular wall exhibited spontaneous Ca2+  
oscillations. This is consistent with previous reports in these arteries 6, 16. 
Upon stimulation with norepinephrine asynchronous Ca2+  oscillations 
appeared in a significantly larger number of cells. Since asynchronous 
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transients do not sum, this oscillatory response was not reflected in the 
tracings of averaged fluorescence determined over the whole frame. 
Furthermore, the asynchronous spiking activity was usually accompanied 
by a rise in fluorescence and thus [Ca2+]i. However, after prolonged 
exposure to norepinephrine our preparations showed a decrease of the 
spiking activity and a slight but significant reduction of the fluorescence 
increase. This is consistent with other reports in smooth muscle cells of 
small mesenteric arteries, showing that the mean Ca2+ level 9, 26 and the 
oscillation frequency 6, 7 decreased during maintained exposure to 
vasoconstrictors. These effects could be due to receptor or channel 
desensitization. 
 
In our experiments, addition of depolarizing concentrations of K+ (15 mM) 
resulted in the synchronization of the Ca2+ oscillations, as observed in the 
traces of fluorescence averaged over the whole frame. Moreover, these 
high concentrations of K+ increased the spiking frequency and further 
raised the fluorescence. Taken together, these results are consistent with 
the view that a membrane depolarization is essential to synchronize the 
Ca2+ oscillations 8. 
 
Since depolarization and an increased Ca2+ influx through voltage 
dependent Ca2+ channels are able to increase oscillatory activity, it might 
be expected that hyperpolarization of the membrane potential could have 
the inverse effect. However, earlier reports had shown that hyperpolarizing 
the membrane potential did not influence the Ca2+ responses 8. In the 
present study, application of levcromakalim to preparations previously 
stimulated with norepinephrine influenced the Ca2+ activity in the smooth 
muscle cells. In the presence of this hyperpolarizing agent, the majority of 
the active smooth muscle cells showed a reduction of the spiking frequency 
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and the fluorescence level was significantly reduced. This decline in the 
Ca2+ responses was larger than the spontaneous decrease observed in the 
prolonged presence of norepinephrine alone, suggesting that the induced 
hyperpolarization additionally attenuated the Ca2+ activity in the vascular 
smooth muscle cells. Similar results were found for calcitonin gene-related 
peptide (CGRP). CGRP is a powerful vasodilator in a number of vascular 
preparations 27, 28 and was recently demonstrated to cause substantial 
hyperpolarization in isolated small mesenteric and gastric arteries of the rat 
through the activation of KATP channels 20.  
 
Contradicting reports have been published concerning the mechanism of 
action of small rises in the extracellular K+ concentration and its effect on 
the vascular smooth muscle cells. Some studies in mesenteric and hepatic 
arteries of the rat reported that increasing the extracellular K+ concentration 
with 5 mM induced a hyperpolarization of the smooth muscle membrane 
potential both in intact and endothelium-denuded unstimulated arteries 29-31. 
Upon stimulation with phenylephrine, the K+-induced hyperpolarizations 
turned endothelium-dependent and became more sensitive to gap junction 
uncoupling 29. It was suggested that small increases in extracellular K+ 
activate smooth muscle Na+/K+ ATPases and inward rectifying K+ (KIR) 
channels and hence induce hyperpolarization. However, stimulation of 
smooth muscle cells with phenylephrine, which is known to increase basal 
K+ efflux from the myocytes, might saturate the Na+/K+ pumps and may 
favour the spread of endothelial hyperpolarization through myoendothelial 
gap junctions. Other studies in guinea-pig carotid, porcine coronary and rat 
gastric arteries reported, however, that small increases in the extracellular 
K+ concentration had no significant hyperpolarizing effect on the membrane 
potential of resting arteries 32, 33. Strikingly, in norepinephrine-stimulated rat 
gluteal arteries 34 non cumulative additions of small amounts of K+ (1 to 5 
 203
Chapter 7 
mM) induced large vasorelaxations. In the present study, increasing the 
extracellular concentration of K+ with 5 mM had similar effects as seen with 
the application of levcromakalim and CGRP. The majority of the cells 
responded with a significant decrease of the spiking frequency and the 
average basal fluorescence was significantly lowered. These results were 
similar to those obtained with levcromakalim and CGRP, suggesting that 
small amounts of K+ may indeed hyperpolarize the membrane potential. 
 
In a last series of experiments we tested the influence of methanandamide, 
a stable derivative of the endocannabinoid anandamide. Methanandamide 
slightly but significantly decreased the norepinephrine-induced rise in basal 
fluorescence but clearly reversed the decrease of the spiking rate observed 
in the prolonged presence of norepinephrine. Taken together with the 
results obtained with the hyperpolarizing agents, we can conclude that 
methanandamide does not substantially hyperpolarize the smooth muscle 
cells but, taking into account the increase in spiking activity, might have a 
small depolarizing effect in the present conditions. It should be noted that 
previous studies in the same preparation 19, 20 reported substantial 
hyperpolarizations of the membrane potential induced by methanandamide. 
This hyperpolarization was ascribed to the stimulation of TRPV1 receptors 
on the perivascular nerves, since fully blocked in the presence of 
capsazepine and capsaicin. However, under the present experimental 
conditions only little contribution of the perivascular nerves could be 
expected, since prolonged incubation has been reported to deplete the 
perivascular nerves 35. Therefore, these results are fully consistent with 
earlier results, showing that methanandamide causes a small 
depolarization of the membrane potential after elimination of the influence 
of the perivascular nerves 19, 20. 
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Taken together, the present study demonstrates that norepinephrine 
induces asynchronous Ca2+ spiking activity in rat mesenteric arteries, which 
is usually associated with a rise in the average intracellular free Ca2+ 
concentration. Hyperpolarizations induced by levcromakalim, CGRP, and 
presumably by small increases in the extracellular K+ concentration 
diminish these responses. Finally, depolarization of the vascular smooth 
muscle initiates the synchronization of Ca2+ spiking activity. 
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8.1. GENERAL DISCUSSION 
The blood supply to a given vascular bed is regulated by neuronal, humoral 
or local chemical mechanisms altering the diameter of the vessels of the  
specific tissue. It is now generally accepted that the vascular endothelium 
plays a crucial role in the control of blood vessel tone and blood flow. 
However, the endothelium is not the sole mediator of vascular tone. For 
example, several substances released from the perivascular nerves may 
also influence the cardiovascular system. In the present study we 
investigated the role of substances released from both the endothelium and 
the perivascular nerves in the reactivity of the vascular wall. 
 
Although the role of the endothelium-dependent vasorelaxing factors NO 
and PGI2 is well established, the exact mechanism involved in endothelium-
dependent hyperpolarization is, despite extensive research, still a subject of 
intense discussion. While some studies point to a diffusible factor (EDHF) 
released from the endothelial cells, other reports support the idea of an 
electrical current or small messenger molecule being spread through 
myoendothelial gap junctions. 
 
 
Endothelium-dependent hyperpolarization in rat gastric arteries: an 
important mediator of gastric mucosal blood flow? 
 
During the search for the mechanism underlying endothelium-dependent 
hyperpolarization, it has become clear that there are considerable tissue 
and species differences 1, 2. It has therefore been generally accepted that 
different hyperpolarizing mechanisms may exist in different vascular beds. 
Moreover some arteries such as the femoral artery of the rat even lack any 
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endothelium-dependent hyperpolarizing responses 3. Thusfar, most of the 
membrane potential experiments in our lab were performed in small 
mesenteric arteries of the rat. The existence of EDHF in these arteries has 
been described in detail and the search for its exact mechanism of action 
has been a subject of many investigations. Since previous studies in our 
lab demonstrated endothelium-dependent, but L-NA and indomethacin 
resistant vasorelaxations in isolated small gastric arteries of the rat in 
response to acetylcholine 4, we performed membrane potential 
measurements to confirm the existence of an endothelium-derived 
hyperpolarizing factor in these vessels. Indeed, we found that acetylcholine 
hyperpolarizes the membrane potential of the vascular smooth muscle cells 
of small gastric arteries. This hyperpolarization seemed to be totally 
endothelium-dependent but independent of the NO or PGI2 pathway. Since 
membrane potential is expected to alter vessel tone immediately, this first 
demonstration of endothelium-dependent hyperpolarization in gastric 
arteries could reveal an important and rapid regulator of gastric mucosal 
blood flow. However, the identity of EDHF and its mechanism of action in 
gastric arteries are far from revealed. We found, although, that the EDHF 
response in gastric arteries did not seem to rely on the stimulation of KIR 
channels or Na+/K+-ATPases on the smooth muscle cells.  
 
 
Endothelium-dependent hyperpolarization in rat mesenteric arteries: a 
story about K+-clouds and myoendothelial gap junctions. 
 
Since the discovery of the existence of endothelium-dependent 
hyperpolarizing factors, extensive research has been performed to unravel 
the exact mechanism of action. Several possible candidates for the EDHF 
have been proposed, among which K+. In resting rat hepatic and small 
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mesenteric arteries it was proposed that stimulation with acetylcholine 
results in an IKCa- and SKCa-mediated hyperpolarization of the endothelial 
cells with accompanying endothelial release of K+ in the myoendothelial 
space (figure 1A). It was found that the EDHF-response was significantly 
inhibited by the combination of Ba2+ and ouabain, selective inhibitors of KIR 
channels and Na+/K+-ATPases, respectively. Therefore it was suggested 
that local transient increases in the extracellular K+ concentration would 
activate Na+/K+ -ATPases and KIR channels in the membrane of the 
adjacent smooth muscle cells, leading to their hyperpolarization 5, 6. 
However, other studies found no evidence for the presence of KIR in smooth 
muscle cells of rat small mesenteric arteries and suggested that these 
channels were restricted to the endothelial cells7. In the present study, no 
evidence was found for the involvement of KIR channels in the endothelium-
dependent hyperpolarization of rat small mesenteric arteries, while the 
involvement of Na+/K+-ATPases could not be completely excluded. This is 
somewhat different from the results obtained in gastric arteries, where the 
involvement of both KIR channels and Na+/K+-ATPases could be excluded. 
Our results in rat mesenteric arteries rather point to the activation of an as 
yet unidentified, but Ba2+ resistant K+ current accounting for a significant 
fraction of the endothelium-dependent hyperpolarization of the smooth 
muscle cells (figure 1A). On the other hand, we found that gap junctions 
play some role in the acetylcholine-induced hyperpolarization of the smooth 
muscle cells since carbenoxolone decreased the responses (figure 1A). 
This is consistent with other studies in rat mesenteric arteries, indicating 
that both K+-coupling and gap junctional communication play a role in the 
EDHF-response.  
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Figure 1: Schematic presentation of the proposed pathway for the endothelium-derived 
hyperpolarization (EDH) in rat small mesenteric arteries. (A) In control conditions (in the 
presence of L-NA and indomethacin), both gap junctions (GJ) and an as yet unidentified, but 
Ba2+ resistant K+ current (Kx) play a role in the endothelium-dependent hyperpolarization 
induced by acetylcholine (ACh). The involvement of Na+/K+-ATPases could not be 
completely excluded. (B) After pre-incubation with Ba2+, to modulate the myoendothelial 
extracellular K+ concentration, the presumed local depletion in extracellular K+ decreases 
the role of GJ in the EDH-pathway and favours K+ efflux through KX. (oua = ouabain; cbx = 
carbenoxolone; KIR = inwardly rectifying K+ channel; IKCa = intermediate conductance Ca2+ 
activated K+ channel; SKCa = small conductance Ca2+ activated K+ channel; hyperpol = 
hyperpolarization; EC = endothelial cell; VSMC = vascular smooth muscle cell; R = receptor) 
 
 
Under basal conditions, Na+/K+-ATPases containing α2- and/or α3-subunits 
are suggested to be responsible for the observed K+-induced effects 8. 
Moreover, it was found that stimulation of the arteries with phenylephrine 
favoured the gap junctional pathway for smooth muscle hyperpolarization 6, 
9. Therefore, it was suggested that activation of the smooth muscle cells, 
which is known to increase K+ efflux from the myocytes, results in a K+ 
cloud in the myoendothelial spaces in these conditions 10. This would fully 
activate and saturate Na+/K+-pumps containing α2- and/or α3-subunits on 
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the smooth muscle cells so that the acetylcholine-induced endothelium-
dependent hyperpolarization would now rely more on gap junctional 
coupling.  
 
If local accumulations of extracellular K+ favour gap junctional coupling, 
local depletion might be expected to have the adverse effect. In the present 
study, we used the KIR channel inhibitor Ba2+ to modulate the 
myoendothelial extracellular K+ concentration (figure 1B). Blocking the KIR 
channels by preincubation with Ba2+ might indeed be expected to reduce 
the steady state extracellular K+ concentration around the smooth muscle 
cells. We found that under these circumstances, the endothelium-
dependent hyperpolarization relies to a lesser extent on gap junctional 
coupling (figure 1B). This is fully consistent with the hypothesis in the 
mesenteric arteries that local accumulations in basal K+ concentration 
would shift the acetylcholine-activated  EDHF mechanism to gap junctional 
coupling. However, since in our experiments KIR channels are not involved, 
the hyperpolarization of the smooth muscle cells possibly relies on another 
mechanism. In part, this may include Na+/K+-pumping. It should be noted, 
however, that depletions or accumulations of basal extracellular K+ not only 
affect the activity of the Na+/K+-pumps, but are likely to affect all 
transmembrane K+ fluxes.  
 
Other evidence for the hypothesis that EDHF relies on both K+-coupling 
and gap junctional communication was obtained from experiments in which 
the extracellular K+ concentration was raised with a few mM. However, 
contradicting reports have been published concerning this topic, even in the 
same vessel type. Studies in hepatic and small mesenteric arteries of the 
rat showed that increasing the extracellular K+ concentration with 5 mM 
induced a hyperpolarization of the smooth muscle membrane potential in 
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both intact and endothelium-denuded resting arteries 9, 10. Upon stimulation 
with phenylephrine, the K+ responses became endothelium-dependent and 
relied more on gap junctional coupling. This is consistent with the 
hypothesis of a K+-cloud, as a result of stimulation with phenylephrine, 
which saturates the Na+/K+-pumps and makes the hyperpolarizing effects of 
K+ on the endothelial cells more important. The hyperpolarization of the 
endothelial cells is subsequently transferred to the smooth muscle cells via 
myoendothelial gap junctions. Consistently, in rat gastric arteries 
(unpublished data) and in rat gluteal arteries 11 stimulated with 
norepinephrine, small increases in the extracellular K+ concentration with 1-
5 mM induced large, concentration-dependent vasorelaxations. In contrast, 
other studies in guinea-pig and porcine coronary arteries reported that 
small increases in the extracellular K+ concentration had no significant 
hyperpolarizing effect on the membrane potential of resting arteries 12. 
Similarly, no K+-induced hyperpolarizations were obtained in resting rat 
gastric arteries 4. In the same study, cumulative addition of K+ (up to 15 
mM) to norepinephrine precontracted arteries caused no substantial 
relaxation.  
 
The present study supports the view that in rat small mesenteric arteries, a 
small increase in the extracellular K+ concentration might induce a 
hyperpolarization of the membrane potential of the smooth muscle cells. 
Indeed, the results obtained with the Ca2+ imaging experiments also 
suggest a hyperpolarization of the membrane potential induced by 
increasing the extracellular K+ concentration with 5 mM. Since in rat gastric 
and gluteal arteries, such small increases in the K+ concentration induce 
potent relaxation, a membrane potential change as suggested in the 
present study could be the principle mediator of vasorelaxation.  
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Endocannabinoids: multiple pathways leading to vasodilatation. 
 
Another candidate proposed as EDHF was the endocannabinoid 
anandamide 13. However, this hypothesis has widely been argued and it is 
now generally accepted that anandamide is not EDHF. Besides their 
neurobehavioral effects, both endogenous and synthetic cannabinoids 
influence the cardiovascular system and have potent vasodilator effects in 
a number of vascular preparations 13-15. This was confirmed in our 
experiments. We found that methanandamide, a stable analogue of 
anandamide, potently hyperpolarized the smooth muscle cells of both rat 
gastric and mesenteric arteries. This hyperpolarization showed a different 
time course and pharmacological profile as compared to the EDHF-
response, excluding a role for EDHF in the membrane electrical response 
to cannabinoids in these preparations. 
 
The exact mechanism by which cannabinoids induce vasodilatation is still 
unknown. Some studies have reported that they directly stimulate 
cannabinoid CB1 or CB2 receptors on the smooth muscle cells. 13, 14, 16. 
Recently, it was suggested that in some vessels, the response to 
cannabinoids could be ascribed to the stimulation of a not yet identified 
non-CB1/non-CB2 receptor located on the endothelial cells. Several studies, 
including previous experiments in our own laboratory 17, have identified 
anandamide as an endovanilloid, acting by stimulation of TRPV1 receptors 
on perivascular nerves, causing the release of vasodilator neuropeptides 
such as CGRP. We studied and compared the membrane electrical 
responses to methanandamide and exogenous CGRP. We found that 
methanandamide and exogenous CGRP caused similar membrane 
potential changes which were sensitive to the KATP channel inhibitor 
glibenclamide. Furthermore, hyperpolarizations induced by 
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methanandamide, unlike those elicited by CGRP, were sensitive to 
inhibition of TRPV1 receptors with capsazepine. We concluded that 
stimulation of TRPV1 receptors on perivascular CGRP containing nerves is 
the primary cause for the cannabinoid-induced hyperpolarization in the 
mesenteric and gastric arteries. The released CGRP subsequently 
hyperpolarizes the resting vascular smooth muscle cells through activation 
of KATP channels (figure 2A). 
 
Strikingly, the Ca2+ imaging experiments do not point to a hyperpolarization 
induced by methanandamide, since the addition of methanandamide 
seemed to have only little direct influence on the membrane potential in the 
norepinephrine-stimulated arteries. Maybe a small depolarization might 
possibly be expected. Taken the long incubation period and the fact that 
the preparations were loaded at 4°C, a rather small contribution of the 
perivascular nerves is expected under these experimental circumstances. 
Indeed, it has been shown that cooling abolishes the vasodilator response 
to (endo)cannabinoids, probably by desensitization and/or degeneration of 
the perivascular nerves 18. After desensitization of the perivascular nerves 
with capsaicin 17 or inhibition of the TRPV1 receptor with capsazepine 
(present study) in the membrane potential measurements, 
methanandamide was unable to induce hyperpolarization, and in some 
preparations even caused a small depolarization of the membrane 
potential. Therefore, the Ca2+ imaging experiments are consistent with the 
hypothesis that methanandamide induces hyperpolarization of the 
membrane potential by stimulation of the perivascular sensory nerves.  
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Figure 2: Schematic presentation of the proposed pathway for the methanandamide (Meth)-
induced responses. (A) Membrane potential measurements in rat gastric and mesenteric 
arteries (in the presence of L-NA and indomethacin (indo)) suggest that Meth stimulates 
TRPV1 receptors on perivascular nerves (PVN), causing the release of vasodilator 
neuropeptides such as CGRP. CGRP subsequently hyperpolarizes (Hyperpol) the vascular 
smooth muscle cells (VSMC) through the activation of ATP sensitive potassium channels 
(KATP). (B) Tension measurements suggested that low concentrations of Meth might 
stimulate TRPV1 receptors on the PVN, inducing the release of CGRP, followed by 
relaxation of the VSMC. On the other hand, higher concentrations of Meth were shown to 
inhibit the influx of Ca2+ in the VSMC through voltage gated Ca2+ channels (VGCC).(EC = 
endothelial cell; NO = nitric oxide; N Pept = neuropeptides; EDHF = endothelium-derived 
hyperpolarizing factor; PGI2 = prostacyclin; glib = glibenclamide; CAPS = capsaicin; CZP = 
capsazepine; NIF = nifedipine) 
 
 
Since membrane hyperpolarization can be a powerful mediator of 
vasorelaxation, we characterized the vasorelaxing properties of 
cannabinoids in the gastric arteries. We found that methanandamide is also 
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a powerful vasorelaxant in isolated small gastric arteries of the rat. The 
induced vasorelaxation was endothelium-independent, consistent with 
reports in other arteries 13, 16. In the present tension measurements we 
found no evidence that methanandamide induced relaxation through 
activation of one of the above mentioned cannabinoid receptors. While the 
hyperpolarization seemed to rely completely on activation of TRPV1 
receptors on perivascular nerves (figure 2A), we found that this mechanism 
could not fully account for the methanandamide-induced relaxation. 
However, it might contribute to the relaxations induced by the lower 
concentrations of the cannabinoid (figure 2B).  
 
Taken together with the results obtained from the membrane potential 
measurements, these findings suggest that hyperpolarization only plays a 
minor role in the relaxation induced by cannabinoids in norepinephrine 
contracted gastric arteries and that the main route by which higher 
concentrations produce vasorelaxation involves another mechanism. This 
was further corroborated by the fact that CGRP and methanandamide 
showed different sensitivity to potassium channel blockers. Studies with 
high K+, TEA and glibenclamide showed that membrane hyperpolarization 
was at least involved in the vasorelaxation to exogenous CGRP, while the 
methanandamide-induced relaxation did not require smooth muscle cell 
hyperpolarization.  
 
Interestingly, we found that higher concentrations of methanandamide 
might eventually relax the arteries by inhibition of Ca2+ influx in the smooth 
muscle cells (figure 2B). The former possibility is consistent with other 
reports about the direct inhibitory action of cannabinoids on voltage 
dependent Ca2+ channels or a further step in the excitation-contraction 
coupling 19-21. In the Ca2+ imaging study, we found that addition of 
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methanandamide slightly, but significantly decreased the basal free Ca2+ 
concentration of the smooth muscle cells.  
 
 
Membrane potential and Ca2+ oscillations. 
Vasorelaxation and vasoconstriction involve changes of the mean cytosolic 
Ca2+ concentration of the smooth muscle cells in the arteriolar wall. It has 
been shown that the overall vessel Ca2+ concentration is not representative 
for the Ca2+ reactions in the individual smooth muscle cells 22-26. Upon 
stimulation with vasoconstrictors, smooth muscle cells of rat tail artery and 
small mesenteric arteries showed asynchronous Ca2+ oscillations which 
were not reflected in the average Ca2+ responses 27-29. When higher 
concentrations of contracting agents were used, the Ca2+ waves appeared 
synchronously between the different smooth muscle cells and give rise to 
oscillations in vascular tone, called vasomotion 24, 30. It has been suggested 
that the switch to synchronisation of the Ca2+ oscillations and waves 
involves a simultaneous depolarization of all the smooth muscle cells. 
Indeed, application of a depolarizing current was sufficient to synchronise 
the cells 25. In the last part of this thesis, we studied the influence of the 
membrane potential on norepinephrine-induced Ca2+ oscillations in smooth 
muscle cells of intact small mesenteric arteries of the rat. We found that 
stimulation with low concentrations of norepinephrine induces 
asynchronous Ca2+ spikes in the smooth muscle cells usually accompanied 
by a sustained increase of the basal fluorescence. A small reduction of the 
responses was seen in the prolonged presence of the vasoconstrictor. 
Depolarizing concentrations of K+ increased the Ca2+ responses and 
initiated synchronization of the oscillations, confirming other reports about 
the initiation of vasomotion. Taken into account the effect of a 
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depolarization on the oscillatory behaviour, it could be expected that a 
hyperpolarization of the membrane potential would have inverse effects. 
Indeed, addition of hyperpolarizing agents such as levcromakalim 
significantly reduced the Ca2+ responses. Similar results were obtained with 
exogenous CGRP. It is suggested, therefore, that while methanandamide is 
unable to induce release of CGRP in these conditions, the exogenous 
application of this peptide directly acts on the vascular smooth muscle cells 
causing hyperpolarization. As mentioned, increasing [K+]o with 5mM 
similarly causes a membrane hyperpolarization, although not as large as 
obtained with levcromakalim. 
 
 
8.2. GENERAL CONCLUSIONS 
The results of the present study emphasize the importance of EDHF in the 
gastrointestinal circulation. Furthermore, the mechanism by which agents 
derived from the endothelium or the perivascular nerves modulate the 
reactivity of the vessel wall is further elucidated. The main findings 
presented in this thesis can be summarized as follows: 
 Endothelium-dependent hyperpolarization is present in mesenteric and 
gastric arteries and might play an important role in the regulation of the 
gastro-intestinal circulation. 
 In mesenteric arteries, endothelium-dependent hyperpolarization 
involves both gap junctional coupling and activation of an as yet 
unidentified, but Ba2+-resistant, K+ current. 
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 The hyperpolarization induced by methanandamide in gastric and 
mesenteric arteries involves the stimulation of the TRPV1 receptor on 
perivascular nerves and the subsequent release of CGRP. 
 The relaxation induced by methanandamide in gastric arteries might 
involve multiple pathways: low concentrations may stimulate the TRPV1 
receptor on CGRP-containing perivascular nerves, while higher 
concentrations elicit their effects by inhibition of voltage dependent Ca2+ 
channels in the smooth muscle cells. 
 Stimulation of mesenteric arteries with norepinephrine induces 
asynchronous Ca2+ oscillations in the vascular smooth muscle cells, 
which become synchronized upon depolarisation of the membrane 
potential. Hyperpolarization tends to decrease the Ca2+ dynamics. 
 
 
8.3. LIMITATIONS OF THIS STUDY 
Some limitations should be mentioned for the experiments used in this 
thesis. First, based on the knowledge that EDHF shows tissue and species 
specificity, the use of only two different arteries from a single species 
implies some restraints. Furthermore, it has been shown that different 
EDHFs might even exist within the same vascular bed, depending on the 
size of the arteries and the used experimental conditions. Therefore, 
extrapolation of the obtained results to other vessels or species, or to 
human level, should be done with great caution. 
  
Second, in the present in vitro studies, the influence of neuropeptides 
(CGRP) released by the perivascular sensory nerves is investigated. 
Sensory neurons all have their cell bodies in the dorsal root ganglia, where 
the neuropeptides are synthesised. Upon isolation of the arteries, however, 
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the perivascular nerves are cut, so that after depletion, the nerve endings 
can not be refilled with freshly synthesised neuropeptides (CGRP). This is 
most likely the reason why the hyperpolarizing effect of methanandamide is 
not reproducible in our study. Therefore, it is very important in in vitro 
studies to pay attention to the reproducibility of a response. On the other 
hand, it should also be noted that, if the present in vitro studies point to an 
important role for the release of CGRP, then one could expect that its 
involvement would be considerably more important in vivo. 
 
Third, three different techniques were used to obtain the results comprised 
in this thesis. The distinct techniques used in the present study were 
performed in totally different experimental conditions. While the results 
obtained with one technique were often consistent with results from another 
and corroborative for general conclusions, this was not always the case. 
The main apparent discrepancy arose from the findings that 
methanandamide caused substantial hyperpolarization, whereas relaxation 
measurements implied a minor role for this hyperpolarization because the 
substance apparently affected a downstream mechanism in the excitation-
contraction coupling. This can be taken as a typical case for many 
conflicting data and discrepancies in literature. It illustrates the risks 
involved e.g. when extrapolating results from relaxation studies to 
conclusions about membrane potential, or vice versa. 
 
 
8.4. FUTURE PERSPECTIVES 
In this study, the importance of endothelium-dependent hyperpolarization 
(EDH) has been demonstrated for the first time in isolated gastric arteries of 
rats. Although the involvement of Na+/K+ ATPases and KIR channels has 
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been ruled out, the exact mechanism by which acetylcholine hyperpolarizes 
the smooth muscle cells has not been elucidated yet. Therefore, additional 
electrophysiological and tension measurements would be useful to further 
investigate the exact mechanism of action of EDH in these arteries and to 
reveal its identity. For example, the involvement of myoendothelial gap 
junctions can be studied using known gap junction uncouplers such as the 
peptide gap-27. Furthermore, the involvement of possible EDHF candidates 
can be tested using specific inhibitors, such as cytochrome P450 inhibitors 
to assess the involvement of epoxyeicosatrienoic acids. 
 
A second series of membrane potential experiments suggested the 
involvement of an as yet unidentified, but Ba2+-resistant K+ channel in the 
acetylcholine-response in rat mesenteric arteries. In the future, it would be 
interesting to further extend these results with patch clamp techniques, to 
learn more about the characteristics and the identity of Ba2+-resistant K+ 
currents accounting for a significant fraction of the endothelium-dependent 
hyperpolarization. 
 
To further investigate if the suggested hypothesis of the K+-cloud 10 is 
correct, the results should be extended with additional membrane potential 
and tension measurements. For example, we could test if indeed small 
increases in the extracellular K+ concentration induce hyperpolarizations of 
the membrane potential of norepinephrine-stimulated vessels and could 
cause relaxation of small mesenteric arteries. If this is the case, the 
pharmacological properties of these responses should be further 
investigated. 
 
Furthermore, it might be interesting to test the influence of both 
methanandamide and CGRP on the membrane currents of isolated smooth 
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muscle cells of the gastric arteries, using patch-clamp techniques. Also, 
further Ca2+ imaging experiments could be useful to clarify the exact 
mechanism by which methanandamide relaxes the smooth muscle cells. In 
this perspective, it would be useful to develop a set-up for simultaneous 
tension and Ca2+ measurements. 
 
Finally, in the Ca2+ imaging experiments, glass cannulae were inserted into 
the lumen of the arteries to avoid motion artefacts. However, under these 
circumstances, it was impossible to apply intralumenal pressure and the 
arteries could not develop myogenic tone. Also, endothelium-dependent 
agonists such as acetylcholine could not be tested, because the cannulae 
damaged the endothelium. Therefore, experiments with pressurized and 
perfused arteries could be of interest for future experiments. Such an 
experimental set-up would allow studies on the effect of EDHF on the Ca2+ 
responses in the vascular smooth muscle cells and make it possible to 
investigate endothelial effects. However, this is limited to the resistance 
arteries since preparation depth is a limiting factor in these experiments 
and it would not be possible to visualise the endothelium in preparations 
thicker than 100 µm. 
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Vascular blood flow is regulated by a complex series of mechanisms which, 
by altering the diameter of the vessels of a given tissue, maintain tissue 
homeostasis. Vasodilatation plays an important role in the regulation of the 
perfusion of vascular beds. The aim of this thesis was to investigate the 
importance and the mechanism of action of several vasodilatory 
substances in isolated gastric and small mesenteric arteries of the rat and 
to elucidate their role in gastrointestinal blood flow. We measured 
membrane potential changes with conventional microelectrode techniques, 
isometric tension changes with a wire myograph and observed the Ca2+ 
dynamics in the smooth muscle cells using confocal microscopy. These 
techniques are extensively described in chapter 2. 
 
It is now generally accepted that the vascular endothelium plays a crucial 
role in the control of blood vessel tone and blood flow and the role of the 
endothelium-dependent vasorelaxing factors nitric oxide (NO) and 
prostacycline (PGI2) is well established. However, despite extensive 
research, the exact mechanism involved in endothelium-dependent 
hyperpolarization is still a subject of intense discussion. While some studies 
point to a diffusible factor (EDHF) released from the endothelial cells, other 
reports support the idea of an electrical current or small messenger 
molecule spread through myoendothelial gap junctions. In chapter 3, we 
found that gap junctions indeed play some role in the endothelium-
dependent hyperpolarization of rat small mesenteric arteries, while no 
evidence was found for the involvement of inward rectifying K+ (KIR) 
channels in this response. The involvement of Na+/K+ pumps could not be 
totally excluded, however, our results point to the activation of an as yet 
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unidentified, but Ba2+ resistant K+ current accounting for a significant 
fraction of the endothelium-dependent hyperpolarization. We used the KIR 
channel inhibitor Ba2+ to reduce the steady state extracellular K+ 
concentration around the smooth muscle cells. We found that under these 
circumstances, the endothelium-dependent hyperpolarization relies to a 
lesser extent on gap junctional coupling.  
 
During the search for the mechanism underlying endothelium-dependent 
hyperpolarization, it has become clear that there are considerable tissue 
and species differences and that various hyperpolarizing mechanisms may 
exist in different vascular beds. Moreover, some arteries even lack any 
endothelium-dependent hyperpolarizing responses. In chapter 4, we 
demonstrated the existence of an EDH(F) in rat gastric arteries stimulated 
with acetylcholine. The induced hyperpolarization seemed to be 
endothelium-dependent but independent of the NO or PGI2 pathway and 
did not seem to rely on the stimulation of KIR channels or Na+/K+ pumps. 
The demonstration of endothelium-dependent hyperpolarization in these 
arteries could reveal an important and rapid regulator of gastric mucosal 
blood flow. 
 
Since the discovery of the existence of EDHF, several possible candidates 
have been proposed, among which the endocannabinoid anandamide. 
However, this hypothesis has widely been argued and it is now generally 
accepted that anandamide is not EDHF. This was further confirmed in 
chapter 5 for rat mesenteric and gastric arteries. We found that 
methanandamide, a stable analogue of anandamide, potently 
hyperpolarized the smooth muscle cells of both rat gastric and mesenteric 
arteries. This hyperpolarization, however, showed a different time course 
and pharmacological profile as compared to the EDHF-response, excluding 
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a role for EDHF in the membrane electrical response to cannabinoids in 
these preparations. We showed that stimulation of TRPV1 receptors on 
perivascular CGRP containing nerves is the primary cause for the 
cannabinoid-induced hyperpolarization in the mesenteric and gastric 
arteries. The released CGRP subsequently hyperpolarizes the vascular 
smooth muscle cells through activation of ATP sensitive K+ (KATP) channels. 
 
Membrane hyperpolarization is a powerful mediator of vasorelaxation. 
Therefore, in chapter 6 we characterized for the first time the 
vasorelaxation to cannabinoids in rat gastric arteries. We showed that 
methanandamide is a powerful vasorelaxant in isolated rat small gastric 
arteries. The induced relaxation is endothelium-independent and does not 
involve the activation of the CB1 or CB2 cannabinoid receptor or the 
recently described non CB1/CB2 cannabinoid receptor. We found that 
activation of TRPV1 receptors does not fully account for the 
methanandamide-induced relaxation, but might contribute to the relaxations 
induced by the lower concentrations of the cannabinoid. Furthermore, 
higher concentrations of methanandamide might possibly relax the arteries 
by inhibition of Ca2+ influx in the smooth muscle cells.  
 
In chapter 7 we studied the Ca2+ dynamics in the smooth muscle cells of 
rat small mesenteric arteries. More specifically, we observed the influence 
of hyperpolarization and depolarization of the membrane potential on 
norepinephrine-induced Ca2+ oscillations in smooth muscle cells of intact 
small mesenteric arteries of the rat. We confirmed that stimulation with low 
concentrations of norepinephrine induces asynchronous Ca2+ spikes in the 
smooth muscle cells usually accompanied by a sustained increase of the 
basal fluorescence. Depolarization (with 15 mM KCl) caused a significant 
increase in the Ca2+ responses and synchronized the oscillations. In 
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contrast, hyperpolarization (with levcromakalim, CGRP or eventually with 5 
mM KCl) significantly reduced the Ca2+ responses. 
 
In conclusion, the different studies compiled in this thesis further elucidate 
the characteristics and the mechanism of action of EDHF and 
endocannabinoids, both important mediators of the arterial tone. 
Additionally, the influence of the membrane potential on the Ca2+ dynamics 
of the smooth muscle cells was to some extent clarified. 
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Samenvatting 
Weefseldoorbloeding wordt geregeld door een complexe reeks 
mechanismen die, hoofdzakelijk door het regelen van de diameter van de 
bloedvaten, zorgen voor het behoud van de weefselhomeostase. 
Vasodilatatie speelt een belangrijke rol in de regeling van de doorbloeding 
van een bepaald vaatbed. Het voornaamste doel van het onderzoek 
verricht in het kader van deze thesis, was meer te weten te komen over het 
belang en de werkingsmechanismen van verschillende vasodilaterende 
stoffen in geïsoleerde maag- en mesenterische arteriën van de rat om zo 
tot een beter inzicht te komen over hun rol in de gastro-intestinale 
doorbloeding. In dit onderzoek werd gebruik gemaakt van verschillende in 
vitro technieken op geïsoleerde bloedvaten: membraanpotentiaalmetingen 
met behulp van conventionele micro-elektroden, isometrische 
tensiemetingen met een draadmyograaf en calcium bepalingen door middel 
van confocale microscopie. Deze technieken werden uitvoerig beschreven 
in hoofdstuk 2. 
 
Het is op heden algemeen aanvaard dat het vaatendotheel een belangrijke 
rol speelt in de controle van de vaattonus en de bloedstroom. Terwijl de rol 
van de endotheel-afhankelijke vasorelaxerende factoren stikstof monoxide 
(NO) en prostacycline (PGI2) al grondig gekend is, heeft men het exacte 
mechanisme verantwoordelijk voor de endotheel-afhankelijke 
hyperpolarisatie nog steeds niet achterhaald. Volgens sommige studies 
betreft het een diffunderende factor die vrijgesteld wordt uit het endotheel 
(EDHF). Andere experimenten wijzen eerder op een elektrische stroom of 
kleine boodschappermolecule die de hyperpolarisatie van het endotheel 
naar de gladde spiercellen overbrengt via gap juncties. In hoofdstuk 3 
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werd aangetoond dat gap juncties inderdaad een rol spelen in de 
endotheel-afhankelijke hyperpolarisatie in mesenterische arteriën van de 
rat. Er werd geen bewijs gevonden dat KIR kanalen betrokken zijn in deze 
respons, terwijl een rol voor de Na+/K+ pompen niet kon worden uitgesloten. 
Onze resultaten suggereren eerder dat de activering van een nog niet 
geïdentificeerde, Ba2+ resistente K+ stroom verantwoordelijk is voor een 
aanzienlijk deel van de endotheel-afhankelijke hyperpolarisatie. Met behulp 
van Ba2+, een KIR inhibitor, reduceerden we de extracellulaire K+ 
concentratie in de omgeving van de gladde spiercellen, wat ertoe leidde dat 
gap juncties minder inbreng kregen in de endotheel-afhankelijke 
hyperpolarisatie. 
 
In de loop der jaren is gebleken dat endotheel-afhankelijke 
hyperpolarisaties heel wat weefsel- en speciesverschillen vertonen. Diverse 
hyperpolariserende mechanismen kunnen voorkomen in verschillende 
vaatgebieden, maar ze kunnen in bepaalde bloedvaten ook helemaal 
ontbreken. In hoofdstuk 4 werd endotheel-afhankelijke hyperpolarisatie 
aangetoond in rat gastrische arteriën na toevoegen van acetylcholine. Deze 
hyperpolarisatie bleek volledig onafhankelijk van NO en PGI2. Er werd 
aangetoond dat zowel KIR als Na+/K+ ATPasen helemaal geen rol spelen in 
deze respons. Deze hyperpolarisatie zou een belangrijke en snelle 
regulator kunnen betekenen voor de maagdoorbloeding. 
 
Sinds de ontdekking van EDHF zijn al uiteenlopende kandidaten naar voor 
geschoven, onder wie de endocannabinoid anandamide. Op heden is het 
echter algemeen aanvaard dat anandamide geen EDHF kan zijn. Dit werd 
bevestigd in hoofdstuk 5 voor de gastrische en de mesenterische arteriën 
van de rat. Daarin werd aangetoond dat methanandamide, de stabielere 
analoog van anandamide, een sterke hyperpolarisatie veroorzaakt in de 
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gladde spiercellen van zowel de maag- als de mesenterische bloedvaten. 
Het tijdsverloop en de farmacologische eigenschappen verschillen echter 
zeer sterk van deze van de EDHF-respons. Uit onze resultaten bleek dat 
methanandamide de membraanpotentiaal hyperpolariseert door stimulatie 
van de TRPV1 receptoren op de perivasculaire zenuwen. De 
daaropvolgende vrijstelling van CGRP hyperpolariseert de membraan van 
de gladde spiercellen door activering van ATP-gevoelige K+ (KATP) kanalen. 
 
Hyperpolarisatie ligt vaak aan de basis van vasorelaxatie. In hoofdstuk 6 
hebben we de relaxerende eigenschappen van cannabinoiden onderzocht 
in de maagarterie van de rat. Methanandamide lokte sterke endotheel-
onafhankelijke relaxaties uit, maar hyperpolarisatie bleek hier slechts een 
beperkte rol in te spelen. Bovendien toonden we aan dat geen enkele van 
de beschreven cannabinoid receptoren betrokken is in deze relaxaties. 
Activering van de TRPV1 receptor op de perivasculaire zenuwen droeg 
enkel bij tot de relaxaties veroorzaakt door de lagere concentraties 
methanandamide. Hogere concentraties van de cannabinoid zouden de 
arteriën kunnen relaxeren door inhibitie van de Ca2+ influx in de gladde 
spiercellen. 
 
Tot slot hebben we in hoofdstuk 7 de Ca2+ veranderingen bestudeerd in 
de gladde spiercellen van de mesenterische arteriën van de rat. 
Meerbepaald hebben we de invloed nagegaan van veranderingen in de 
membraanpotentiaal op Ca2+-oscillaties geïnduceerd door norepinephrine. 
Er werd aangetoond dat stimulatie met deze agonist asynchrone Ca2+ 
spikes uitlokt in de gladde spiercellen, die meestal gepaard gaan met een 
toename van de basale fluorescentie. Depolarisatie van de 
membraanpotentiaal (met 15 mM KCl) veroorzaakte een significante 
toename van de Ca2+ responsen en leidde tot synchronisatie van de 
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oscillaties. Daar tegenover staat dat hyperpolarisatie (met levcromakalim, 
CGRP en mogelijk ook met 5 mM KCl) zorgde voor een significante afname 
van de responsen. 
 
In conclusie, de verschillende studies gebundeld in deze thesis bieden 
meer inzicht in de eigenschappen en de werkingsmechanismen van EDHF 
en van cannabinoiden bij kleine bloedvaten. Daarnaast werd de rol van de 
membraanpotentiaal in de Ca2+ dynamiek van de gladde spiercellen 
uitgediept. 
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Tot slot had ik een woord van dank willen richten tot alle mensen die in de 
afgelopen zes jaar direct of indirect hebben bijgedragen tot het 
verwezenlijken van mijn doctoraat. Zo zijn er de mensen waarmee ik 
intensief heb samengewerkt in blok B en die stuk voor stuk hebben 
meegeholpen aan het realiseren van alle data die zich in dit proefschrift 
bevinden. Maar er zijn ook heel wat mensen die steeds voor me 
klaarstonden met raad en daad, die voor de nodige niet-wetenschappelijke 
afleiding zorgden en die me oppepten en me alles leerden relativeren als 
het me even teveel werd… Op deze laatste pagina’s hoop ik duidelijk te 
kunnen maken hoe elk van jullie zijn steentje heeft bijgedragen tot deze 
doctoraatsthesis. 
 
Vooreerst wil ik mijn promotor Prof. Bert Vanheel bedanken voor de kans 
die ik zes jaar geleden kreeg om dit onderzoek uit te voeren en voor de 
hulp om het tot een goed einde te brengen.  U leerde me de knepen van de 
elektrofysiologie en de trucjes voor het welslagen van de o zo delicate 
membraanpotentiaal metingen. Daarnaast waardeer ik ook uw hulp bij het 
uitvoeren van de experimenten, het schrijven van artikels en het 
presenteren van mijn onderzoeksresultaten. 
 
Mijn bijzondere dank gaat ook uit naar Prof. Johan Van de Voorde, voor 
zijn interesse en bezorgdheid, het kritisch nalezen van manuscripten (geen 
dubbele spatie kon aan uw oog ontglippen!) en vooral voor de prettige 
samenwerking. U heeft me wegwijs gemaakt in de wereld van de relaxaties 
en contracties en in de periode dat de resultaten met de 
membraanpotentiaal metingen wat tegenvielen kon ik op de tweede 
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verdieping terecht voor enkele tensiemetingen. Uw enthousiasme en inzet 
kenden geen grenzen, wat ik enorm heb geapprecieerd. 
 
Prof. Luc Leybaert zou ik willen bedanken voor het ter beschikking stellen 
van de confocale microscoop en het kritisch nalezen van artikels. U hebt 
me binnengeleid in de wereld van de Ca2+-golven, hielp me bij het 
opmaken van de vele foto’s en beelden en stond steeds klaar voor een 
woordje uitleg. Ook Prof. Gaspard De Ley zou ik willen bedanken voor de 
samenwerking tijdens de practica. 
 
Prof. Dr. Em. J. Weyne en Prof. Dr. J.-L. Pannier, vakgroepvoorzitters van 
de vakgroep Fysiologie en Fysiopathologie, ben ik dankbaar voor het ter 
beschikking stellen van de middelen en het personeel van het labo. Prof. 
Weyne, u volgde mijn werk met veel enthousiasme en ik kon steeds 
rekenen op uw hulp en begrip. 
 
Prof. Dr. H. Bult, Prof. Dr. G. Callewaert, Prof. Dr. W. Derave, Prof. Dr. R. 
Lefebvre, Prof. Dr. G. Joos, Prof. Dr. J. Van de Voorde en Prof. Dr. L. 
Leybaert, de leden van de examencommissie, wil ik graag bedanken voor 
hun kritische evaluatie van deze thesis en voor hun opbouwende 
suggesties. 
 
Tijdens de jaren onderzoek die een doctoraat voorafgaan kom je heel wat 
verwachte en onverwachte hindernissen tegen en dankzij de hulp van heel 
wat mensen op het labo ben ik er in geslaagd deze stuk voor stuk te 
overwinnen.  Indien ik alles op mijn eentje had moeten verwezenlijken, dan 
ben ik er steevast van overtuigd dat ik vaak zou zijn blijven steken zijn in 
‘onoverkomelijke’ problemen. Julien, jij was steeds het zonnetje in blok B 
en zorgde voor de nodige ‘entertainment’. Voor praktische probleempjes 
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kon ik steeds bij jou terecht: jij toverde in een handomdraai de nodige 
draadjes, naaldjes of buisjes tevoorschijn. Daarnaast zorgde je steeds dat 
iedereen voldoende energie had om zijn proeven uit te voeren: chocolade, 
snoepjes, koffiekoeken, ijsjes, fruit,…je legde ons echt in de watten! Dirk, jij 
stond niet alleen paraat om computer- en andere technische problemen op 
te lossen, maar je was ook steeds te vinden voor een gezellige babbel. Nu 
je op pensioen bent zullen de computerfrustraties in blok B 
hoogstwaarschijnlijk sterk toenemen. Ook Cyriel zou ik willen bedanken 
voor de technische hulp. Eric zou ik willen bedanken voor de hulp bij het 
uitvoeren van de tensiemetingen en het maken van oplossingen. André 
was steeds op post voor het oplossen van administratieve en 
organisatorische problemen en heeft menigmaal gefunctioneerd als 
‘telefoonboek’ van blok B. Marc stond altijd klaar met advies en hulp bij het 
maken van figuren en posters en was een vaste waarde voor de practica. 
Graag wil ik ook Eliane Dewulf bedanken, die tot haar pensioen instond 
voor het maken van de perfusie en de vele oplossingen. Ook Daniël zou ik 
willen bedanken voor de organisatorische hulp. 
 
Ik mag ook zeker mijn collega doctoraatsstudenten niet vergeten! De 
frustraties, tegenslagen en ‘dipjes’ verdwijnen in het niets als ik terugdenk 
aan de vele fijne uurtjes die we in blok B hebben beleefd. Koen, Siska en 
Ine, de anciens, wil ik bedanken voor de leuke koffiekletskes, de soms 
hilarische momenten, maar ook voor de hulp bij proeven, de steun en het 
luisterend oor. Daarnaast wil ik ook Sofie en Nele en de vele andere 
(ex)doctoraatsstudenten bedanken die mijn verblijf in het labo aangenaam 
gemaakt hebben. 
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Ook mijn familie, schoonfamilie en vrienden verdienen een woordje van 
dank voor hun nimmer aflatende steun, interesse en vooral voor de nodige 
afleiding na de werkuren. 
 
Een speciaal plaatsje in dit dankwoord is voorbehouden aan mijn ouders. 
Mama en papa, het is een onmogelijke opdracht in enkele regels te 
omschrijven hoe groot jullie bijdrage was aan dit eindresultaat. Jullie gaven 
me de kans om te studeren, zorgden dat ik nooit iets tekort kwam en 
steunden me bij elke beslissing. Jullie leerden me door te bijten en alles te 
relativeren als het eens moeilijk ging. Ik kon steeds bij jullie terecht om mijn 
hart te luchten en jullie deelden mijn geluk. Jullie stonden ook steeds klaar 
voor mij en boden zoveel hulp als jullie maar konden: taxidienst, 
boodschappenservice, restaurant, lay-out advies, noem maar op,… 
Hartelijk dank daarvoor! 
 
Kristof, mijn doctoraat is af! Ik kan je voor zoveel dingen bedanken. 
Ondanks je drukke praktijk en de lange werkdagen die je klopt, bleef je me 
door dik en dun steunen. Je luisterde naar mijn werk-frustraties, toonde 
begrip, overleefde mijn kuren en motiveerde mij om door te zetten in 
moeilijker tijden. Je zorgde voor de nodige afleiding op de momenten dat ik 
die nodig had. Je bent er één-uit-de-duizend! 
 
Allemaal zeer hartelijk dank! 
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